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Abstract 
New Zealand experienced its first recognised outbreak of shellfish 
poisoning around Northland in early 1993. The poisoning symdrome 
was characterised as neurotoxic shellfish poisoning (NSP) from the 
observed symptoms. The major causative toxins were isolated and 
characterised by the Japanese research groups of Professor Ishidaa 
(University of Shizuoka) and Professor Yasumotob,c (Tohoku 
University). The toxins were identified as brevetoxin B derivatives. 
Diarrhetic shellfish poisoning (DSP) was suspected as responsible for 
further poisoning around this area. Yessotoxin (YTX), a suspect DSP 
toxin, was isolated as part of this research and is the first reported 
instance of YTX in New Zealand. 
A stereochemical study was carried out on a desulfated YTX 
derivative. The results suggested anomalies in the reported 
conformation of YTX. Attempted synthesis of haptens of YTX for 
development of an ELISA is outlined in this thesis. 
Another incident of shellfish contamination occurred around Foveaux 
Strait in early 1994. The toxicity was characterised by NSP symptoms 
In mice. The causative toxin, gymnodimine, was first reported by a 
Japanese research group, although independent parallel structure 
elucidation was carried out as part of this research. 
a Ishida, H.; Nozawa, A.; Totoribe, K.; Muramatsu, N.; Nukaya, H.; Tsuji, K.; Yamaguchi, 
K.; Yasumoto, T.; Kaspar, H.; Berkett, N.; Kosuge, T. Tetrahedron Lett., I995, 36, 725-
728. 
b Yasumoto, T. Marine Toxins Occurring in the Oceanian Waters. Symposium On Oceanian-
Japanese Organic Chemistry Synthesis and Natural Products: Socs 12 - Tokushima, I996. 
Tokushima Bunri University, Japan. 
c Morohashi, A.; Satake, M.; Murata, K.; Naoki, H.; Kaspar, H.F.; Yasumoto, T. Tetrahedron 
Lett., 1995, 36, 8995-8998. 
Abstract 
The absolute stereochemistry of gymnodimine was solved by X-ray 
analysis of a synthetically modified derivative. Gymnodimine haptens 
were prepared for development of an ELISA. A chromatography 
based assay has been developed for the specific detection of 
gymnodimine in shellfish and alga. This work was modified from the 
extremely efficient isolation procedure for gymnodimine developed as 
part of this research. 
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Chapter One 
Shellfish Toxins 
Chapter One - Shellfish Toxins 
1 . 1 Introduction 
1.1.1 Phytoplankton1 
Phytoplankton are a diverse group of unicellular and colonial 
organisms, most of which are classified as algae. These microscopic 
plants form the base of the food chains in aquatic environments and 
support the bivalve and fin fisheries. Under favourable environmental 
conditions, phytoplankton populations multiply rapidly (or bloom) to 
reach high cell densities (105-108 cells per litre) and discolour the 
water, hence the term red tide. 
The majority of phytoplankton species are harmless. However, some 
can be noxious or toxic, for example the dinoflagellates Gymnodinium 
cf. breve and Alexandrium minutum (Fig 1.1.1). Dense blooms of 
algae may deplete oxygen levels through nocturnal respiration or 
decay, leading to massive fish and shellfish mortalities. Some species 
of algae may kill fish through gill damage, whereas others produce 
toxins that pass through the food chain and may kill vertebrate 
predators. It is estimated that world-wide there are 2000 cases of 
shellfish poisoning caused by algal toxins each year, of which about 
15% are fatal. 
In addition to human health problems, considerable economic losses 
result from the presence of algal toxins. These losses stem from 
closure of bivalve farms and fisheries, through deaths of fish in sea 
cages and from consumer resistance to seafood products. 
5 
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Fig 1.1.1 Scanning Electron Micrographs of Gymnodinium ct breve 
(left) and Alexandrium minutum (right) 
1. 1.2 Shellfish Toxins 
Shellfish toxins are generally classed in groups with reference to their 
physiological effects produced. The main groups are detailed in the 
following sections: Paralytic Shellfish Poisoning (PSP, Section 1.2), 
Neurotoxic Shellfish Poisoning (NSP, Section 1.4), Diarrhetic Shellfish 
Poisoning (DSP, Section 1.5), Amnesic Shellfish Poisoning (ASP, 
Section 1.6), and Ciguatera Poisoning (Section 1.7). As ciguatera 
poisoning is prevalent in tropical fish and hence is not strictly a 
shellfish toxin, the similar symptoms and mode of action to NSP 
warrant its inclusion in this chapter. Tetrodotoxin poisoning (Section 
1.3), although caused by a symbiotic bacterium, shows similar action to 
PSP, and so is included for completeness. Various miscellaneous toxins 
(Section 1.8), not within these groups, but possibly implicated in 
pmsomng are also discussed. Finally, Section 1.9 reveals current 
methods used in detection of shellfish toxins. 
6 
Chapter One - Shellfish Toxins 
1.2 Paralytic Shellfish Poisoning 
Numerous dinoflagellate species are known to produce the toxins 
causing PSP: Alexandrium spp. (formerly Gonyaulax or 
Protogonyaulax), Gymnodinium catenatum and Pyrodinium bahamense 
var. compressum. 2 The toxins responsible have been named the 
saxitoxins. 
PSP is by far the most lethal form of shellfish toxicity. It has been 
documented for over 50 years as a cause of deaths in North America 
and during the last 10 years has killed more than 40 people in the 
Philippines. In a single outbreak in Guatemala some years ago, 26 
people were killed by eating PSP contaminated shellfish. 3 
The symptoms of PSP are numbness, or hypersensitivity of the mouth 
and skin, a floating sensation and motor signs including ataxia, muscle 
weakness, paralysis and death, due to respiratory failure. The 
symptoms are usually rapid in onset (hours), but can vary from being 
acute, resulting in death, to prolonged, with less severe symptoms.4 
1.2.1 Saxitoxins 
Structurally the saxitoxins can be divided into two maJor groups: 
represented by saxitoxin (STX, 1) and neosaxitoxin (NEO, 7), 
depending on the functionality on Nl. The compounds in both groups 
7 
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are further distinguished by the presence of 11-0-sulfates (eg. GTX2, 
3) and 21-N-sulfates (eg. B1, 2).5•6 
H 
N 0 R/2IT'' 4 13 
200 H H 
6 Rc:k
3 
5 )=+ NH2 16 
N H2N+ N 12 H 
1o OH 
n,, 17 OH1s 
,, 
,, 
,, 
R3 
Rt R2 R3 R4 
STX (1) H H H H 
B1 (2) H H H so3-
GTX2 (3) H H oso3- H 
C1 (4) H H oso3- so3-
GTX3 (5) H oso3- H H 
C2 (6) H oso3- H so3-
NEO (7) OH H H H 
B2 (8) OH H H so3-
GTX1 (9) OH H oso3- H 
C3 (10) OH H oso3- so3-
GTX4 (11) OH oso3- H H 
C4 (12) OH oso3- H so3-
Other members of the saxitoxin family, eg. dcSTX (13),7 do not 
possess the carbamoyl moiety of saxitoxin (1). 
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1.2.2 
HO 
H )=NH2 
N 
H 
OH 
,, OH 
H -----oso3-
dcSTX (13) 
Mode of Action of Saxitoxins 
Saxitoxins alter the function of sodium channels, which are essential for 
the production of action potentials in excitable cells such as neurons. 
Normally, a change in membrane potential causes sodium channels to 
open, allowing sodium ions to flow through and rapidly depolarise the 
nerve membrane. The result is that a wave of depolarisation is 
propagated along the nerve. Saxitoxin binds to the outside of the 
sodium channel, blocking the ion flow, thus slowing, or even 
abolishing, the propagation of the action potential (Fig 1.2.1.). 
9 
Chapter One - Shellfish Toxins 
S.xrt01ttn oVId ~~O)IIfl s11et1<.e thf ntui'OI\S llwt ~ on mus le cf'lls. 
Sod! I'll liOn$ (/lold) mta flolv IIIlO llf'IUOM {" 1111 Jqf) In ordtf for 'IN 
nNIOM to t llv Impulses (f.t) co Mbtr cdls. Snttnx'ln ~ necKilC to M ~ 
(IJM jphu lit right) ~ ~ ~lion by ~lltlnq tht loflS 
trom PiJI»ICIQ jii(O tht 1'1CUlon • ~ the MtW c~Us tbus qu ed. 
mus " h. I'K~ no 5llmula110n i1nd omt pan.lyz«<. 
Fig 1.2.1 Mode of Action of Saxitoxin and Neosaxitoxin8 
Since saxitoxins are charged, water soluble molecules, it is probable 
that they do not penetrate the blood-brain barrier well and the majority 
of their effects are on peripheral nerves. 9 
10 
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1 a 3 Tetrodotoxin Poisoning 
The primary source of tetrodotoxin (TTX, 14) was traced to a dietary 
alga and finally to a symbiotic bacterium. 10 The bacterium was first 
assigned as a Pseudomonas sp., then changed to Alteromonas sp. and 
finally described as a new species, Shewanella alga. 11 Subsequently, a 
broad spectrum of bacteria have been reported to produce the 
toxin.l2,13,14 
HO 
o-
OH 
H + 
N~NH2 
N 
H 
Tetrodotoxin (TTX, 14) 
TTX derives its name from the puffer fish family (Tetraodontidae) and 
is frequently involved in fatal food poisoning. The toxin has a unique 
structure and a similar mode of action to saxitoxin (1), causing the 
blockage of sodium channels of excitable membranes. 
Analogues of TTX have been reported occurring in puffer fish, newts 
and a frog. Their presence was determined by the use of pre-column 
derivatisation with sodium hydroxide and detection of products by 
HPLC (High Performance Liquid Chromatography) fluorescence. 15,16 
11 
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1 . 4 Neurotoxic Shellfish Poisoning 
The dinoflagellate that is responsible for NSP is Gymnodinium breve 
and the causative toxins have been named the brevetoxins. 
Brevetoxins are potent fish toxins and have been responsible for mass 
fish mortalities along the Florida coast. 17 
NSP is characterised by a range of neurological and gastrointestinal 
symptoms, including paraesthesia, changes in thermoreception, muscle 
weakness, incoordination, headache, muscle and joint pains, malaise, 
chills, diarrhoea, nausea and vomiting. One distinct feature of 
brevetoxin-containing blooms is their ability to trigger respiratory 
distress when involved in sea spray. 
In terms of symptoms, NSP overlaps significantly with PSP. However, 
time of onset and duration of illness are generally longer for NSP. 
Also, NSP is more likely to cause muscle weakness, rather than the 
paralysis associated with PSP. Importantly, NSP has never been 
recorded as causing death. 18 
A distinctive neurosensory feature of NSP is a change in 
thermoreception, such as reversal of this sensation. This has never 
been reported for PSP, although it also occurs with ciguatera poisoning 
(Section 1.7). 
12 
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1.4. 1 Brevetoxins 
Brevetoxin B (BTX-B, 15) was the first member of this class of 
compounds. Its structure was established by X-ray crystallography in 
1980, and has a ladder-like skeleton consisting of trans-fused polyether 
rings. 19 All brevetoxins found subsequently have the same backbone as 
BTX-B. 
0 
0 
H ~ ~ 0 
OH 
0 
0 
H 
Brevetoxin B (15) 
Brevetoxin A (16) 
0 
H 
0 
H 
H 
0 
Brevetoxin A (BTX-A, 16) is the most potent of the toxins produced 
by G. breve. Its lethality against zebra fish is reportedly 3 ppb. The 
13 
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structure was elucidated by X-ray crystallography and the most unusual 
structural feature of BTX-A is its fused central rings (EFG), which 
have been shown to undergo slow conformational changes.5 
1.4.2 Mode of Action of Brevetoxins 
Brevetoxins act on the sodium channel at a site distinct from that 
affected by the saxitoxins. They cause the channel to remain open 
longer and stabilise the pre-open and open states. This then allows 
greater sodium ion inflow to occur, leading to neuronal membrane 
depolarisation and eventually causing nervous system failure. 20 
In addition to neurotoxicity, cardiac and respiratory toxicity also 
occur. The former is caused by increased sodium influx allowing 
greater sodium-calcium exchange, thus inducing increased 
catecholamine release. The latter is due to both peripheral effects on 
respiratory reflexes and muscle function There are also central effects 
on respiratory and cardiovascular control.21 
Brevetoxins, being lipid soluble, should penetrate the blood-brain 
barrier easily and affect the central nervous system.9 
14 
Chapter One - Shellfish Toxins 
1 . 5 Diarrhetic Shellfish Poisoning 
The causative organisms of DSP have been identified as several 
dinoflagellates in the genus Dinophysis.22 These algae produce okadaic 
acid (17) and the closely related dinophysis toxins, eg. DTX -1 (18). 
Other toxins, suspected of being involved in DSP, eg. the 
pectenotoxins23 and yessotoxin (YTX, 19),24 have been isolated from 
Japanese scallops. However, the causative algae were of unknown 
origin. The dinoflagellate Protoceratium reticulatum has recently been 
established as the organism responsible for production of YTX. 25 DSP 
has wide distribution around the world and the poisoning is a serious 
problem, both to public health and to the shellfish industry. DSP was 
first recognised in 1976, when a mussel poisoning case occurred in 
Northeastern Japan. 26 
The prominent human symptoms of DSP are gastrointestinal disorders 
such as diarrhoea, nausea, vomiting, and abdominal pain. 
Histopathological investigations have revealed that pectenotoxin-1 (20) 
is hepatotoxic by inducing rapid necrosis of hepatocytes.27 
1.5.1 Okadaic Acid 
Okadaic acid (17) and the closely related dinophysis toxins, eg. DTX -1 
(18) are the major causative agents of DSP. Okadaic acid was first 
isolated from the sponge Halichondria okadai28 and subsequently was 
found in dinoflagellates Prorocentrum lima29 and Dinophysis sp. 30 
15 
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0 OH ~ 0 0,, ,,,, 
HO ,, 
,,, 
,, 
0 ~,,,,,,, ,, 0 ,,' OH 
'',,,OH 0 ~D OH 
R = H Okadaic acid (17) 
R =Me DTX-1 (18) 
1.5.2 Mode of Action of Okadaic Acid 
Aside from causing symptoms of diarrhoea, okadaic acid is known to 
be a potent carcinogen and to cause neuronal cell damage in cultured 
neurons.9 The cause of diarrhoea and carcinogenicity are a result of a 
potent and specific inhibition of the serine/threonine protein 
phosphatases, PP1 and PP2A. This inhibition allows the build-up of 
phosphorylated proteins in cells that leads to pronounced "second 
messenger" production, eg. calcium influx, cyclic AMP and 
prostaglandin production. 
1.5.3 Pectenotoxins and Yessotoxin 
Pectenotoxin-1 (20) was isolated as one of the diarrhetic shellfish 
toxins from the digestive glands of the scallop Patinopecten yessoe'nsis 
found in Northeastern Japan. The structure was revealed to be a novel 
polyether lactone by X-ray crystallography.23 
Chapter One - Shellfish Toxins 
0 
,,, 
OH 0'''' 
OH 
Pectenotoxin-1 (20) 
Y essotoxin (YTX, 19) was first isolated from Japanese scallops and the 
structure elucidated to be a brevetoxin-like polyether. 24 Its structural 
features include two sulfate groups and an olefinic C9 side chain. The 
relative31 and absolute32 stereochemistry of YTX has only recently 
been determined. Three new analogues of YTX have recently been 
discovered from shellfish, viz homo YTX (21), 45-hydroxy YTX (22) 
and 45,46,47-trinor YTX (23). 31 •33 YTX has since been discovered in 
New Zealand shellfish, around the Coromandel Peninsula (Fig 2.1.1) 
and Wedge Point, Marlborough Sounds (Fig 4.1.1). 34•35 
17 
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R X 
YTX (19) ~ 1 
~ 2 homo YTX (21) 
45-0H YTX (22) ~ 1 
OH 
45,46,47-trinor YTX (23) ~H 1 
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1 B 6 Amnesic Shellfish Poisoning 
In late 1987 a mysterious and serious outbreak of food poisoning 
occurred in Canada. Symptoms of the poisoning included vomiting and 
diarrhoea. In some cases, this was followed by confusion, memory 
loss, disorientation and coma. Three elderly patients died and other 
victims still suffer from neurological problems.36 The compound was 
identified as domoic acid (24) a compound first identified in crude 
extracts of certain seaweed found in the waters around Japan. 37 The 
Japanese used it as a folk medicine remedy for intestinal worm 
infestation. This argues against domoic acid as a toxin, however the 
higher doses found in the shellfish showed the obvious difference 
between therapeutic and toxic doses. 
Domoic acid (24) 
Further research showed that domoic acid was produced by a diatom 
Nitzschia pungens forma multiseries.38•39 
19 
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1. 6.1 Mode of Action of Domoic Acid 
Domoic acid stimulates the kainate-sensitive type of glutamate receptor 
on nerves, causing depolarisation, influx of calcium and eventual cell 
death. Extracts may be more lethal because of synergism between 
domoate and other excitatory amino acids such as glutamate.9 
20 
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1 . 7 Ciguatera Poisoning 
There are two groups of compounds implicated in ciguatera poisoning: 
the main responsible toxins are ciguatoxin (CTX, 25) and its 
congeners, and the other is maitotoxin (MTX, 26). Both groups are 
produced by the epiphytic dinoflagellate Gambierdiscus toxicus,40•41 
transferred to herbivorous fish and subsequently to carnivores. 
Ciguatera is a seafood poisoning prevalent in circum tropical areas. 
The poisoning is caused by ingestion of coral reef fish that have 
become toxic through their diet. 
The clinical symptoms are diverse.42 Neurological disturbances are 
prominent. For example, reversal of thermoreception (as in NSP), 
called "dry ice sensation", is one of the most characteristic symptoms of 
ciguatera pmsomng. Other symptoms include joint pain, miosis, 
erethism, cyanosis and prostration. Gastrointestinal disorders are 
nausea, vomiting, and diarrhoea. Cardiovascular disturbances are low 
blood pressure and bradycardia. 
1. 7. 1 Ciguatoxin 
Ciguatoxin (25) was first isolated in 1980 by Scheuer et al and 
characterised as a polyether compound. 43 Insufficient material 
prevented the structural elucidation. In 1989, Murata et al elucidated 
the full structure of CTX and its congener, CTX-4B (27). 44 Since 
21 
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1989, ciguatoxin congeners have been isolated, either from toxic fish,45 
or from cultured G. toxicus. 46 
Ciguatoxin (25) 
CTX-4B (27) 
R1 = -CH(OH)-CH20H; R2 = OH 
R1 = -CH=CH2; R2 = H 
An interesting aspect is that the moray eel, which is at the top of the 
coral ecosystem, tends to contain more polar (more oxygenated) 
congeners, while the dinoflagellate produces less polar ones. 
Ciguatoxin itself, the most oxygenated member of this class of toxins is 
absent in the dinoflagellates. These data suggest that the less polar 
congeners produced by the dinoflagellate are precursors to the more 
polar toxins found in fish, the latter toxins formed by oxidative enzyme 
systems in the fish. The toxicity is also increased in the oxidised 
metabolites, with CTX being 11 times more toxic than its plausible 
precursor CTX -4 B. 5 
1. 7.2 Mode of Action of Ciguatoxin 
Many studies have been carried out on the pharmacological and 
toxicological actions of CTX. In earlier studies, the primary action of 
22 
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CTX was thought to be inhibition of choline esterase,47 until Rayner et 
al revealed that it stimulated the sodium ion influx into cells. 48 
1. 7.3 Maitotoxin 
Maitotoxin (MTX, 26) is suspected of diversifying the ciguatera 
symptoms and is found particularly in herbivorous fish. MTX is an 
extremely potent polyether compound (LDso against mice is ca. 50 
ng/kg, ip)49 constructed from a C142 carbon chain containing 32 ether 
rings, 28 hydroxyl groups, and two sulfate esters. With a molecular 
weight of 3422 Da, MTX is the largest non-peptidic natural product 
elucidated. The relative50•51 and absolute51 stereochemistry of MTX 
have recently been elucidated. 
23 
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H 
OH 
maitotoxin (26) HO 
OH 
OH 
OH 
OH 
OH 
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1 . 8 Miscellaneous Toxins 
1.8.1 Neosurugatoxin and Prosurugatoxin 
In 1965, there were 26 reported cases of intoxication after ingestion of 
the Japanese ivory shell, Babylonia japonica. Reported symptoms were 
visual defects, thirst, numbness of lips, constipation and dysuria. The 
toxins responsible were isolated from the digestive glands of the ivory 
shell and named neosurugatoxin (28) and prosurugatoxin (29).52•53•54 
1.8.2 
H<O H OH 
OR 
HO 
oo 0 
N eosurugatoxin (28) 
Prosurugatoxin (29) 
NH 
Br 
R = ~-xylos 
R=H 
Polyoxygenated Compounds 
The group of polyoxygenated compounds, named the amphidinolides 
eg. amphidinolide B (30), wete isolated from the dinoflagellate 
Amphidinium sp., which is symbiotic to the flatworm Amphiscolops 
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breviviridis.55 The number of compounds in this series has recently 
been extended to include up to amphidinolide Q.56 The majority of the 
macrolides in this group exhibit extremely potent cytotoxicity against 
the L1210 and KB celllines.56 
0 
-
0 
0 
amphidinolide B (30) 
The dinoflagellate, Amphidinium klebsii, was found to produce 
amphidinol (31), which belongs to a new class of polyhydroxypolyene 
compounds, showing potent antifungal and haemolytic activity. 57 A 
new member of this class, amphidinol 2, has recently been reported. 58 
HO OH 
amphidinol (31) 
HO 
OH 
OH 
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The antifungal compound, goniodomin A (32) has been isolated from 
the tide pool dinoflagellate, Gonyaudoma pseudogonyaulax and 
elucidated as a novel polyether lactone.59 
OH 
goniodomine A (32) 
1.8.3 Nitrogen Containing Macrocycles 
Prorocentrolide (33) has been isolated from the ciguatera-associated 
dinoflagellate, Prorocentrum lima. The structure was elucidated as a 
new type of nitrogenous polyether lactone. 60 The closely related 
congener, prorocentrolide B has recently been isolated from the 
tropical dinoflagellate, Prorocentrum maculosum Faust.61 
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OH 
OH 
prorocentrolide (33) 
The imine moiety, seen in prorocentrolide, is also found in a suite of 
recently isolated toxins. These compounds are further distinguished by 
the inclusion of a spiro-centre. The biological properties of these 
toxins are unique and characterised by the rapid onset of symptoms in 
the mouse bioassay. 62 
Pinnatoxin A (34) was isolated from the Okinawan bivalve, Pinna 
muricata. 63 The relative stereochemistry of pinnatoxin A was 
elucidated64 along with a second analogue, pinnatoxin D (35). 65 
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pinnatoxin A (34) 
0 
OH 
pinnatoxin D (35) 
Spirolide B (36) and spirolide D (37) were isolated from the digestive 
glands of mussels, (Mytilus edulis) and scallops, (Placopecten 
magellanicus).66 Subsequently, spirolide E (38) and spirolide F (39) 
were isolated as biologically inactive keto amines from the same 
shellfish extracts.62 The biological inactivity of spirolides E and F 
suggests the common pharmacophore, in this class of compounds, is the 
cyclic imine/iminium moiety. 
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0 
0 
spirolide B (36) R = H 
spirolide D (37) R = Me 
spirolide E (38) il2•3 
spirolide F (39) 
Gymnodimine ( 40) is a nitrogen containing macrolide isolated from 
oysters Tiostrea chilensis, from Foveaux Strait in New Zealand,67 and 
is toxic to mice when administered intraperitoneally. The absolute 
stereochemistry of gymnodimine was elucidated as part of this research 
and is described in Section 5.3. 
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1 . 9 Detection Methods for Shellfish 
Toxins 
Assay techniques for the toxicity testing of shellfish are dependent on 
the type of poisoning under consideration. Each poisoning syndrome is 
caused by one or more toxins, either multi-component (eg. PSP, DSP, 
NSP) or single component (eg. ASP) . The contribution of each 
component to overall toxicity, within a multi-component toxic shellfish 
poisoning (TSP), is variable. The testing and monitoring for TSP 
requires knowledge of the range and levels of each contributing 
component. 68 
An excellent example is the multi-component PSP toxin class. 
Toxicities of each member in the class vary substantially (Fig 1.9 .1 ), 69 
providing evidence that specific toxin testing is essential for accurate 
toxicity determination. 
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A suitable toxicity test must be accurate, specific and reliable towards 
the type of toxin(s) assayed against. In addition, the test must provide 
quantitative measurements of toxicity for relating observed public 
health effects to toxicity. From this knowledge regulatory thresholds 
may be set. 68 
Shellfish biotoxin toxicity testing is most often performed using the 
mouse bioassay.70•71 Extracts for testing are assayed by performing 
inoculations into the peritoneal cavities of mice and observing 
symptoms and death times. This approach suffers from poor 
reproducibility, low sensitivity and interference from certain 
matrices. 72 
The mouse bioassay is relatively non-specific, except in the case of NSP 
and PSP testing. The extraction method can also give some indication 
of the type of TSP toxicity (Table 1.9.1). 
Table 1.9.1 Shellfish Toxins, Extraction Methods and Mouse 
Bioassay68 
TSP Extraction Method Observation In Mouse 
Bioassay 
ASP Aqueous extraction Non-specific behaviour 
DSP Lipid extraction Non-specific behaviour 
NSP Lipid extraction Characteristic behaviour 
PSP Aqueous acid extraction Characteristic behaviour 
Furthermore, the barbaric nature of the mouse bioassay is causing 
world-wide intolerance of this as an acceptable method for routine 
monitoring. Much current research is focused on the identification and 
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confirmation of the toxins responsible for each TSP, by specific, 
humane methods. 
The testing for specific toxins (or groups of toxins, in the case of 
multi-component systems) can occur in a variety of ways. The most 
common assays include: the ELISA (Enzyme Linked /mmunoSorbent 
Assay) , currently under investigation for most TSP, RIA (Radio 
ImmunoAssay) , for NSP analysis, and PPA (Protein Phosphatase 
enzyme Assay) for DSP testing (Table 1.9.2). In addition, highly 
specific chemical assays, such as HPLC with specific detection, are 
being developed for the major TSP incidents encountered (Table 
1.9.2). 
Table 1.9.2 
TSP 
ASP 
DSP 
NSP 
PSP 
Chemical Assay Techniques for Shellfish Toxin 
Testing68 
Specific Techniques 
HPLCwith UV 
HPLC/Fluorescence with pre-column derivatisation 
Enzyme Immunoassays (ELISA) 
Phosphatase enzymes 
HPLCwith UV 
Sodium channel binding assays (N2A) 
Radio immunoassays (RIA) 
HPLC/Fluorescence with post-column reaction 
Enzyme Immunoassays (ELISA) 
At present, most of the above techniques are "in-house" developed or 
research techniques. Few have been subjected to inter-laboratory 
collaborative trials and, for each TSP category, there is no specific 
toxin assay that is "officially recognised" world-wide. 
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Chapter Two - Investigation of Toxicity In Coromandel Mussels 
2. 1 Introduction 
On 4 January 1993 the initial indications of New Zealand's first 
recognised outbreak of shellfish toxicity became apparent. In 
Whangarei, several cats were diagnosed by local veterinary surgeons as 
having been poisoned after consuming shellfish. Owners of the 
affected animals were also found to have experienced toxic symptoms 
after consuming shellfish. Publicity led to further notifications of 
human illness following shellfish consumption. In addition, respiratory 
irritation was reported by people present near Orewa beach. 18 These 
reports were consistent with reported incidents of a syndrome 
associated with red tides of Gymnodinium breve in Florida. 73 The 
illness is caused by an aerosol containing particles of G. breve, a 
particularly fragile species, which is broken up by the pounding action 
of surf. As a result, the New Zealand coastline was progressively 
closed for shellfish harvesting. The entire coastline was closed from 22 
January 1993, and was progressively re-opened as the levels of 
biotoxins dropped below the regulatory limit. 18 
Four specific toxin groups were detected in shellfish from different 
localities around New Zealand. For three of the toxin groups, the 
specific toxin was identified by bioassay or chemical means. These 
were the saxitoxins (PSP), domoic acid (ASP) and okadaic acid (DSP). 
The fourth group were the brevetoxins (BTX), which are responsible 
for neurotoxic shellfish poisoning (NSP). The majority of NSP cases 
reported were from the upper NE coast of New Zealand's North 
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Island, between North Cape and East Cape, and could be related to 
shellfish collected from coastline between Northland and Bay of Plenty. 
However, mouse bioassays indicated that the area where shellfish were 
affected with lipid soluble toxins was between Bay of Islands and Bay 
of Plenty, hence around the Coromandel Peninsula (Fig 2.1.1). 18 
North Cape 
\ 
Bay of Islands 
I 
/ Whangarei Harbour 
• -~- Coromandel Peninsula 
Auckland Bay of Plenty 
East Cape 
Wellington --~ 
Fig 2.1.1 New Zealand's North Island 
It was initially thought that the onset of characteristic NSP symptoms 
ie. respiratory irritation, had been caused by brevetoxins. This was 
supported by cross-reaction with antibodies specific to brevetoxins, 
positive results against neuroblastoma cell lines 74 and the identification 
of Gymnodinium species in the areas. 1 These findings are summarised 
in Table 2.1.1. 
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Table 2.1.1 Summary of the Clinical Symptoms Observed and 
Biotoxins Demonstrated During the 1993 Crisis 
Prototype Causative Clinical Phytoplankton Toxin 
Clinical Toxins Syndrome Observed Demonstrated 
Syndrome Observed By 
PSP Saxitoxins Doubtful Alexandrium Mouse bioassay 
minutum 
A. tamarense 
NSP Brevetoxins Yes Gymnodinium Mouse bioassay 
breve 
Respiratory Brevetoxins Yes G. breve 
irritation 
DSP Okadaic acid Probable Dinophysis sp. Chemical assay 
and related 
compounds 
ASP Domoic acid Doubtful Nitzschia pungens Chemical assay 
However, subsequent work at the Institute of Environmental and 
Scientific Research (ESR) laboratories in New Zealand, as well as 
research findings from the USA and in Japan, suggested that the toxins 
involved were not any of the known brevetoxins. Differences in 
chromatographic behaviour and in mode of action suggested that the 
toxic reaction was caused by a compound (or compounds) that might 
have some relationship to the brevetoxins, but may be in a unique class. 
Tonne quantities of commercial green shell mussels (Perna canaliculus) 
were contaminated by the NSP toxins. As a result, an investigation into 
the chemical nature of the toxins contained in these mussels was carried 
out as part of this research. Particular emphasis was placed on the 
determination of their structure and stereochemistry. The investigation 
into the toxic component(s) of the shellfish is described in Section 2.2. 
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2.2 Investigation of Toxicity 
The establishment of a mouse bioassay was deemed as essential for the 
isolation of the toxic components in the shellfish. The mouse bioassay 
(Appendix 1) shows total toxicity in the extracts although it had three 
limitations. The assay was run at the Communicable Diseases Centre 
(CDC) in Porirua, where samples were sent for analysis. This made 
for long turn-around times between sending the samples off and 
receiving the results, slowing progress measurably. The infancy of the 
mouse bioassay in New Zealand and the lack of experienced technicians 
at the time, meant that major problems existed while the assay was 
being run. The most important problem was the difficulty 1n 
dissolving highly lipid soluble samples in a detergent/saline solution. 
The slow turn around times and handling problems forced alternative 
ways of detecting the toxicity in the extracts. The marine group at the 
University of Canterbury has an "in house" P388 murine leukaemia 
assay (Appendix 1). The P388 assay is a very sensitive, cytotoxicity 
based assay that is used extensively for following biological activity in 
natural product isolation. The advantages of the P388 assay over the 
mouse bioassay were threefold. First, the P388 assay is a well 
established procedure. Second, it has a turn around time of 3 days. 
Third, solvents such as methanol and mixtures of up to 50% 
dichloromethane may be used, hence facilitating the management of 
highly lipid soluble fractions. 
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A total lipid extract, prepared by the NZ acetone extraction method75 
and supplied by ESR, was assayed and the result was an ICso value of 
50 ~g/mL. This result, although only showing mild cytotoxicity, 
prompted further investigation of the suitability of the P388 assay to 
detect the toxicity in the shellfish. 
The total lipid extract was partitioned between 80% methanol/water 
and petroleum ether (b.p. range 50-70 °C). The P388 assay revealed 
that all the cytotoxicity was in the aqueous methanol phase, with an 
ICso value of 20 ~g/mL. Mouse bioassays were then run on both 
fractions. Mouse toxicity occurred in the aqueous/methanol phase only, 
hence supporting a likely correlation between the two assays. 
Following this, reverse phase Cl8 column chromatography of the 
aqueous phase was performed with a gradient solvent system. The 
results of the P388 assay are shown in Fig 2.2.1. The column 
concentrated the cytotoxicity into three adjacent fractions, designated 
2.A3 - 2.A5. The cytotoxicity of these fractions was very strong, with 
P388 ICso values of < 975 ng/mL. An aliquot of 2.A4 was sent for 
mouse bioassays and proved very toxic, with 100% mouse deaths in 20 
minutes. As the correlation between P388 cytotoxicity and mouse 
toxicity was convincing, the P388 assay was adopted as the more 
appropriate assay for further research. 
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Fig 2.2.1 Graph Showing Cytotoxicity and Mass of Fractions off 
CI 8 Reverse Phase Column 
P388 cytotoxicity (u) =mass (mg)IICso (ng/mL) x Jo4 
Further purification was performed on fractions 2.A3 - 2.A4 by LH-20 
gel permeation chromatography. The column was run in 
dichloromethane and then stripped with dichloromethane/methanol to 
clean the column. All the observed cytotoxicity eluted in the methanol 
strips (2.B7 - 2.B8), as shown in Fig 2.2.2. 
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Fig 2.2.2 Graph Showing Cytotoxicity and Mass of Fractions off 
LH-20 Gel Permeation Column 
P388 cytotoxicity (u) =mass (mg)/ICso (nglmL) x Jo4 
Fractions 2.B7 and 2.B8 were then re-chromatographed on LH-20 
using 10% methanol in dichloromethane a eluti ng olvent. The 
cytotoxic compound(s) treaked badly on thi column. Con equently, 
most of the cytotoxicity was lost. The behaviour on LH-20 ugge ted 
toxin solubility problems in both dichloromethane and 10% methanol 
in dichloromethane. These results suggested that the compound( ) 
showing cytotoxicity are more polar than the known brevetoxins. 
This prompted an alternative method of extraction to be sought to 
replace the total lipid extraction method u ed for detecting NSP 
toxicity. 
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2.2.1 Alternative Extraction Method 
The new method involved freeze drying the frozen mussel tissue to 
remove the water (80% by weight). The dried shellfish were then 
crushed to release the contents of the cells and extracted with a 
succession of solvents from water, methanol, ethyl acetate through to 
dichloromethane. 
The water and methanol extracts were toxic in the mouse bioassay. 
This was consistent with the toxin solubility problems encountered 
earlier on LH-20. The use of highly polar extraction solvents has an 
advantage over a total lipid extraction. Shellfish have a high lipid 
content, of which only a minimal amount will be extracted by using 
water or methanol/water mixtures below 80% methanol/water. 
A method was developed based on this theory. Frozen mussels were 
freeze dried and extracted with water, 40% methanol/water and 70% 
methanol/water. The extracts, all of which showed mild P388 
cytotoxicity, were combined and concentrated to an aqueous solution. 
The resulting extract was partitioned against hexane and the water 
phase was kept. This was then desalted on a large C 18 reverse phase 
column and passed through a smaller C18 column, from which six 
fractions (2.C1 - 2.C6) were collected (Scheme 2.2.1). The 
cytotoxicity was contained predominantly in 2.C2 -2.C4. These 
fractions were combined and chromatographed on diol phase, from 
which fractions 2.D1 - 2.D10 were collected (Scheme 2.2.1). The 
P388 cytotoxicity was observed in two bands; early eluting 2.D1 and 
late eluting 2.D8 and 2.D9. 
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Fractions 2.D8 and 2.D9 exhibited the strongest total cytotoxicity and 
were chromatographed separately on LH-20 gel permeation columns. 
Fraction 2.D8 was fractionated into 2.E1 - 2.E10, with the majority of 
the cytotoxicity contained in 2.E6 - 2.E8 (Scheme 2.2.1). Fraction 
2.D9 was fractionated further into 2.F1 - 2.F1 0 with the cytotoxicity 
concentrated in 2.F5- 2.F6 (Scheme 2.2.1). 
Early promise for purification of fraction 2.D 1 on amino phase 
chromatographic sorbent was shown. However, when the full amount 
was passed through a column containing this phase, almost all 
cytotoxicity was lost. The acidic nature of the compound (hence strong 
binding to amino phase chromatographic material) was also observed 
for subsamples of 2.D8 and 2.D9. The large difference in 
chromatographic behaviour (as exhibited on diol phase 
chromatographic material) was unexplained but could be due to 
residual methanol still present, which was used to clean the diol 
material, before use. Thus, it was believed that the cytotoxic 
compound contained in 2.D 1 was the same as that exhibiting the major 
cytotoxicity in 2.D8 and 2.D9. 
At this stage a sodium channel sensitive assay using a neuroblastoma 
(N2A) cell line (Appendix 1) was setup at CDC, in Porirua. This assay 
was designed for analysis of BTX and STX containing samples. 
Fractions 2.E1 - 2.E10 and 2.F1 - 2.F10 were sent for analysis and the 
results are shown in Fig 2.2.3 and Fig 2.2.4. 
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Fig 2.2.3 Graph Showing Cytotoxicity and "BTX" of Fractions off 
LH-20 Gel Permeation Column 
"BTX" = breve toxin B equivalents from N2A assay 
P388 cytotoxicity (u) =mass (mg)IICso (ng/mL) x Jo4 
The results revealed an anomaly between the P388 cytotoxicity and the 
N2A activity. As shown in Fig 2.2.3, 2.E4 is the only fraction 
containing appreciable amounts of BTX-like material , whereas the 
P388 cytotoxicity is concentrated in 2.E6 - 2.E8. 
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Fig 2.2.4 Graph Showing Cytotoxicity and "BTX" of Fractions off 
LH-20 Gel Permeation Column 
"BTX" = breve toxin B equivalents from N2A assay 
P388 cytotoxicity (u) =mass (mg)IICso (ng/mL) x Jo4 
Fig 2.2.4 does not show such an obvious result, with BTX activity in 
2.F4 and 2.F5, but P388 cytotoxicity in 2.F5 and 2.F6. These data 
suggest overlapping areas of activity. 
As confirmation, a pure sample of BTX-A (supplied by ESR 
laboratories) was assayed against the P388 cell line. The result was an 
ICso value >812.5 ng/mL, evidently demonstrating no cytotoxicity. 
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From these data it became apparent that the P388 cytotoxicity was not 
caused by BTX-like compounds, but possibly a unique compound which 
has no effect on the sodium channel. 
2.2.2 Brevetoxins 
While this work was in progress, it was discovered that a large amount 
of toxic shellfish had been sent to two research groups in Japan. A 
personal communication with Dr Ishida of University of Shizuoka in 
Japan, resulted in the notification of the isolation and identification of 
the major causative toxin in this same 1993 New Zealand outbreak. A 
following publication of the results unveiled a BTX-B conjugate, 
named BTX-B 1 (41), isolated from cockles, which were collected 
during the 1993 outbreak.76 BTX-B1 differs from BTX-B only in the 
side chain, where a taurine group is conjugated at the aldehyde 
position. 
0 
0 
0 OH H Me 
BTX-B1 (41) 
Communication with Professor Yasumoto of Tohoku University in 
Japan, revealed that his group had isolated and identified similar 
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conjugates, BTX-B2, BTX-B3 and BTX-B4, from mussels collected 
during the 1993 New Zealand outbreak of shellfish poisoning. It was 
not until recently, however, that the chemical structures of BTX-B2 
(42)77 and BTX-B3 (43)78 were published. 
0 OH 
0 
Me 
-::. 
Me 
0 
H Me 
BTX-B2 (42) 
BTX-B3 (43) 
S./'yCOOH 
II ~ 
0 NH2 
OH 
COOH 
0 
All the new BTX conjugates contain functional groups, which enhance 
the polarity of each molecule. In particular, each contains acidic 
and/or basic groups, eg. BTX-Bl (S03Na!NH), BTX-B2 (COOH/NH2) 
and BTX-B3 (COOH). 
The nature of the molecules explains the predominantly polar 
chromatographic profiles observed in the preliminary examination. 
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This lead to the assumption of the possibility of an entirely new class of 
compound. 
None of the BTX conjugates have ever been isolated from the algae. It 
is postulated that the shellfish modify the toxins to less toxic, water 
soluble conjugates, which are able to be excreted. 79 
The similar chromatographic profile of the compound(s) exhibiting 
P388 cytotoxicity, suggested certain common characteristics to the 
newly discovered conjugated brevetoxins. 
2.2.3 Isolation of Cytotoxic Compound 
Although the causative NSP toxins had been identified from the 
mussels, the potent P388 cytotoxicity observed was of considerable 
interest. The priority of this research was then directed at elucidating 
the structure of the compound(s) which exhibited this activity. 
Fractions 2.E6 - 2.E8 and 2.F6 were all analysed by 1 H NMR (Nuclear 
Magnetic R esosnance) spectroscopy. The 1 H NMR spectrum of 
fractions 2.E6 and 2.E7 contained fatty acids as their major component, 
with other peaks appearing with only baseline intensity. The 1H NMR 
spectrum of 2.E8 contained sharp isolated resonances in the region of 4 
- 6 ppm, with a broad mass of resonances between 3 - 4 ppm, indicative 
of a glycoside structure. The 1 H NMR spectrum of 2.F6 revealed the 
same broad resonances as seen in 2.E8, however, sharp aromatic 
signals between 7 - 9 ppm suggested different structural features. Due 
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to the low mass of the active fractions, combined with no clear 
common peaks observed by 1 H NMR spectroscopy, these fractions were 
kept as reference samples for a larger scale extraction. 
A larger extraction was undertaken by ESR laboratories in Lower Hutt 
(using the protocol described in Section 6.2.3) on 6.5 kg of frozen 
mussels. 
The extract was sent to University of Canterbury as a methanol/water 
solution. The methanol was evaporated off and the resulting water 
solution run through a large C18 column. The resulting fractions 2.Hl 
- 2.H7 (Scheme 2.2.2) were assayed in both the P388 and N2A assays. 
The majority of the P388 cytotoxicity was concentrated in fractions 
2.H5 and 2.H6, while the BTX activity was in 2.H6. 
Fraction 2.H5 was further chromatographed on diol, from which 
fractions 2.11 - 2.111 (Scheme 2.2.2) were collected. Two distinct 
bands of activity eluted off the column and concentrated in 2.15 - 2.17 
and 2.19. LH-20 gel permeation chromatography of 2.15 - 2.17 
afforded fractions 2.Jl - 2.J7 (Scheme 2.2.2), of which 2.J6 had a very 
potent P388 cytotoxicity with an ICso value of 70 ng/mL. A 1 H NMR 
spectrum of fraction 2.J6 showed virtually 100% fatty acid material 
however minor baseline peaks were also present. Fraction 2.J6 was 
kept as reference until examination of fraction 2.19 was complete. 
Upon resuming this work, a P388 assay revealed the activity in fraction 
2.J6 had diminished. This suggested that probable degradation of the 
active component in this fraction had occurred. 
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methanol/water extract 
,Q. 
concentration to water 
,Q. 
C18 
3000 2000 2000 2000 2000 2000 2000 
H20 30%MeOH 50% 70% 80% MeOH MeOH/DCM 
2.Hl 2.H2 2.H3 2.H4 2.H5 2.H6 2.H7 
306.0 g 69.0 g 7.1 g 1.7 g 1.2 g 2.5 g 2.9 g 
>1250000 >125000 >125000 11000 <975 2800 26000 
(<2450) (<5520) (<570) (1550) (>12300) (8930) (1120) 
diol I 
250 150 150 150 150 150 150 150 150 150 250 
DCM 50% EtOAc EtOAc 5%MeOH 10% 10% 20% 20% 50% 50% MeOH 
I I I I I I I I I I I 
2.11 2.12 2.13 2.14 2.15 2.16 2.17 2.18 2.19 2.110 2.111 
94mg 193 mg 85 mg 54mg 41 mg 48mg 61 mg 51 mg 248mg 59mg 115mg 
7800 >12500 >12500 >12500 560 530 200 >12500 260 1260 3190 
(121) (<154) (<68) (<43) (732) (905) (3050) (<41) (9538) (468) (361) 
~0 H) 
LH-20 
200 35 35 35 35 50 75 (MeOH) 
2.Jl 2.J2 2.J3 2.J4 2.J5 2.J6 2.J7 
33mg 22mg 32mg 22mg 14mg 23mg 1 mg 
>2500 >2500 >2500 2200 500 70 490 
(<132) (<88) (<128) (100) (280) (3286) (20) 
175 35 35 35 50 50 75 
I I I I I I I 
2.Kl 2.K2 2.K3 2.K4 2.K5 2.K6 2.K7 
48mg 58mg 29mg 17mg 13 mg 5.3 mg 4.1 mg 
>2500 >2500 >2500 1660 220 <<19.5 <<19.5 
(<192) (<232) (<116) (102) (591) (»2718X»2103) 
LH-20 r 
(50% MeOH/DCM) 
2.Ll 2.L2 2.L3 2.L4 2.L5 2.L6 2.L7 
2.4mg 0.8mg 0.6mg 2.3 mg 1.2 mg 2.6mg 1.9 mg 
3 
For Legend See Scheme 2.2.1 (8667) 
Scheme 2.2.2 Isolation Scheme for The P388 Cytotoxic 
Component of Coromandel Mussels 
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Fraction 2.19 was separated into 2.K1 - 2.K7 on LH -20 gel permeation 
chromatography (Scheme 2.2.2). Fractions 2.K6 and 2.K7 exhibited 
very potent P388 cytotoxicity with ICso values of<< 19.5 ng/mL. 
The 1 H NMR spectra of 2.K6 and 2.K7 illustrated many well defined 
peaks, common to both fractions. Multiple signals in the 3 - 4 ppm 
region were characteristic of a polyether compound. This confirmed 
the earlier assumption that the compound(s) exhibiting P388 
cytotoxicity had similar characteristics to those of the conjugated 
brevetoxins. 
Final purification was achieved by fractionating 2.K6 and 2.K7 on a 
second LH-20 column to give 2.L6 (Scheme 2.2.2) as 2.6 mg of pure 
toxin, exhibiting a very potent P388 cytotoxicity, with an ICso value of 
3 ng/mL. 
The 1 H NMR spectrum of 2.L6 demonstrated signals different from 
BTX with olefinic resonances at o 6.35, 5.91, 5.86, 5.12, 5.10 and 4.84 
ppm, suggesting an entirely different compound. 
Examination of the literature revealed that the potent cytotoxic 
compound was most likely yessotoxin (YTX, 19), a suspect DSP 
causing toxin isolated previously from Japanese scallops in 1987.24 
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YTX (19) 
An examination of the structure of YTX is described in chapter 3. 
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2.3 Conclusions 
The toxins responsible for the outbreak in seafood poisoning and 
respiratory irritation, around Coromandel Peninsula, in early 1993, 
were isolated and characterised by two Japanese research groups. 
These compounds were identified as polar brevetoxin-B conjugates, viz 
BTX-Bl - BTX-B4.76•77•78 
Y essotoxin (YTX) was isolated as the major P388 cytotoxic compound 
from these shellfish as part of this research. The extremely low levels 
of YTX in the shellfish suggested that the toxin was probably not a 
public health concern. However, this research was the first to identify 
YTX in New Zealand. 
A further cytotoxic component in the mussels was detected using a 
P388 cytotoxicity guided purification. Likely degradation of this 
compound occurred during examination suggesting that it was unstable. 
Subsequent research into the large scale isolation procedure of YTX 
(Section 3.5) was unsuccessful in detecting more of this compound. 
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3. 1 Introduction 
Yessotoxin (YTX, 19) was isolated from the New Zealand green lipped 
mussel, Perna canaliculus, harvested from the Coromandel Peninsula 
during the toxic shellfish outbreak in early 1993. YTX is a previously 
isolated shellfish toxin from J apan24 and the confirmation of its 
structure is detailed in Section 3 .2. 
YTX (19) 
The relative31 and absolute32 stereochemistry of YTX has only recently 
been published. However partial elucidation of the relative 
stereochemistry of YTX was performed independently as part of this 
research topic. This work is described in Section 3.3. 
YTX exhibits potent cytotoxicity against the P388 murine leukaemia 
cell line (ICso = 3 ng/mL) and shows cytotoxicity towards rat 
hepatocytes. 80 Other studies revealed that YTX induces acute heart 
failure in mice when administered intra-peritoneally (i.p.) (LDso = 286 
~glkg). However, YTX shows no toxic effects when given orally.27 
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For multi-component toxin systems, such as the "DSP shellfish poison 
complex", the mouse bioassay is unable to distinguish between the 
individual toxins in the system. The toxicity of YTX, observed in the 
mouse bioassay, requires the development of a more selective support 
assay to quantify the toxin in commercial shellfish samples. The rat 
hepatocyte assay, 80 used in conjunction with the mouse bioassay, for 
DSP toxins, is reasonably selective, although it provides no quantitative 
measure of the individual toxins. The most promising assay for 
detection of YTX is likely to be a YTX -specific ELISA. The 
development of an ELISA requires modification of the target 
compound. The modification of YTX for development of a YTX-
specific ELISA is described in Section 3.4. 
To enable future research on YTX to be undertaken, sufficient 
quantities of the pure toxin must be available. The very low level of 
YTX in the shellfish makes this an arduous exercise. The development 
of a large scale isolation procedure is detailed in Section 3.5. 
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3.2 Spectroscopic Assignment of YTX 
Negative ion LRFABMS (Low Resolution Fast Atom Bombardment 
Mass Spectrometry) on a pure sample of YTX revealed an ion at mlz 
1163.5. This ion corresponded closely to the published value of mlz 
1163 (M-Na)- for YTX. Subsequent positive ion HRFABMS (High 
Resolution Fast A tom Bombardment Mass Spectrometry) was 
performed on the mlz 1163.5 ion for accurate mass measurement. 
Acceptable high resolution mass determination was achieved, with the 
caesium adduct of YTX, which gave an ion with m/z 1539.1680 
corresponding to [M-2Na+3Cs]+ (CssHso021S2Cs3). 
A full spectroscopic NMR assignment of YTX was essential for 
conclusive proof of chemical structure. This was achieved by 1 H, 13C, 
COSY (COrrelation SpectroscopY) and HMQC (Heteronuclear Multiple 
Quantum Coherence) NMR experiments. 
The 13C NMR spectrum of the isolated YTX was compared with the 
published values of YTX (Table 3.2.1). The data collated extremely 
well, with no value differing by more than 0.1 ppm. 
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Ttlble 3.2.1 Comparisons Between Published (CpP 4 and 
Observed 13C NMR Data YTX 
Position o Cp 0 Co Position () 0 Co Position () 0 Co 
1 65.1 65.1 20 82.4 82.5 38 39.0 39.0 
2 40.1 40.2 21 33.2 33.1 39 143.1 143.1 
3 76.5 76.6 22 87.3 87.4 40 85.1 85.2 
4 78.4 78.4 23 77.0 77.0 41 78.4 78.4 
5 32.8 32.8 24 47.0 47.0 42 136.7 136.7 
6 78.4 78.4 25 32.8 32.8 43 130.6 130.6 
7 70.6 70.6 26 40.8 40.8 44 145.4 145.5 
8 36.5 36.5 27 89.4 89.5 45 37.8 37.8 
9 78.3 78.3 28 84.1 84.1 46 137.5 137.6 
10 78.3 78.3 29 40.0 40.0 47 116.6 116.5 
11 36.2 36.2 30 73.2 73.3 48 16.4 16.3 
12 77.6 77.6 31 79.6 79.6 49 23.9 23.9 
13 78.1 78.1 32 73.8 73.8 50 20.7 20.7 
14 38.0 38.0 33 76.7 76.8 51 22.4 22.3 
15 81.1 81.1 34 73.2 73.2 52 15.4 15.3 
16 82.2 82.2 35 31.7 31.7 53 115.7 115.7 
17 30.3 30.3 36 73.1 73.0 54 26.2 26.2 
18 41.1 41.1 37 73.0 73.0 55 116.6 116.5 
19 78.4 78.4 
All o values expressed in ppm. Solvent (CD30D) referenced too 49.0 ppm 
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YTX (19) 
The 1 H NMR spectrum of YTX (Fig 3.2.1) contained many 
overlapping peaks, especially in the ether and aliphatic regions. This 
required the use of COSY and HMQC experiments to elucidate some 
proton data assignments. 
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Chapter Three - Yessotoxin 
The olefinic resonances 8 5.85 (H46), 8 6.27 (H43) and 8 5.81 (H42) 
ppm were well isolated and assigned by direct comparison with 
published data. The COSY spectrum showed correlations from 8 5.85 
(H46) to two further resonances at 8 5.03 and 2.95 ppm, completing 
the H45-H47 spin system and allowing the assignment of both H47 as 8 
5.03/5.03 and H45 as 8 2.95/2.95 ppm. 
All six methyl resonances in the 1 H NMR spectrum were assigned 
conclusively by observation of lfcH couplings, from their respective 
carbon atoms, in an HMQC experiment. 
Geminal coupling between proton resonances at 8 5.07 and 4.96 ppm in 
the COSY spectrum suggested their assignment as an olefinic 
methylene. Assignment of these resonances as H55 was achieved by 
observation of an allylic COSY correlation to 8 2.95 (H45). The 
remaining olefinic resonances at 8 5.00 and 4.77 ppm, exhibited 
geminal coupling to each other and were assigned as H53. 
Proton resonances at 8 4.05, 3.86, 3.84 and 3.76 ppm were well 
removed from other signals in the 1 H NMR spectrum. Consequently 
they were assigned by direct comparison with literature values as H36, 
H40, H32 and H34 respectively. Similarly, the proton resonances, 
belonging to the H38 methylene (8 2.73/2.42 ppm), were well removed 
and assigned by direct comparison with the published data. The spin 
system H38-H34 was defined by the COSY spectrum, allowing the 
assignment of protons H37 (8 3.40), H36 (8 4.05), H35 (8 2.07/1.47 
ppm) and H34 (8 3.80). The spin system H32-H24 was also unravelled 
by the COSY spectrum, in conjunction with comparisons with 
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published proton chemical shift data, leading to the assignment of all 
protons in that system (Table 3.2.2). 
Resonances at 8 4.19 (H1) and 8 4.22 (H4) were well removed from 
other resonances in the 1 H NMR spectrum and were assigned by direct 
comparison with published data. COSY correlations from 8 4.19 (H1) 
to two other resonances at 8 2.30/1.90 ppm, were observed and 
assigned as the methylene protons belonging to H2. COSY correlations 
from 8 4.22 (H4) established the spin system only as far as H6 (Table 
3.2.2). This was due to inadequate resolution of signals, close in 
chemical shift, which lay further along the spin system. An attempt at 
solving the spin system by the use of an HMBC (H eteronuclear 
MultiBond Coherence) NMR experiment was unsuccessful. The small 
amount of toxin was the major contributing factor as poor quality data 
was obtained in the HMBC experiment. This made further structural 
assignments by this method impossible. 
The proton resonances that could be assigned, are summarised in Table 
3.2.2. The small differences, between the observed and published data, 
are presumably a result of concentration or temperature effects. 
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Table 3.2.2 Comparisons Between Published (Hpj24 and 
Observed (H0 ) 1 H NMR Data for YTX 
Position 8 H~ o Ho Position o H~ o Ho Position o H~ o Ho 
1 4.24 4.19 17 1.84 36 4.09 4.05 
1 4.24 4.19 18 1.89 37 3.43 3.40 
2 2.21 2.30 18 1.83 38 2.75 2.73 
2 1.99 1.90 20 3.46 38 2.47 2.42 
4 4.26 4.22 21 1.97 40 3.92 3.86 
5 1.77 1.70 21 1.79 42 5.86 5.81 
5 2.60 2.55 22 3.53 43 6.35 6.27 
6 3.09 3.10 24 1.77 1.75 45 3.00 2.95 
7 3.36 24 1.54 1.50 45 3.00 2.95 
8 2.22 25 1.75 1.75 46 5.91 5.85 
8 1.44 25 1.51 1.50 47 5.12 5.03 
9 3.18 26 1.74 1.65 47 5.10 5.03 
10 3.16 27 2.81 2.75 48 1.31 1.25 
11 2.30 28 3.34 3.30 49 1.29 1.24 
11 1.45 29 2.32 2.25 50 1.20 1.14 
12 3.06 29 1.58 1.49 51 1.74 1.01 
13 3.12 30 3.64 3.61 52 1.25 1.19 
14 2.34 31 3.22 3.25 53 5.05 5.00 
14 1.47 32 3.89 3.84 53 4.84 4.77 
15 3.37 34 3.80 3.76 54 1.43 1.37 
16 3.26 35 2.14 2.07 55 5.09 5.07 
17 1.99 35 1.53 1.47 55 5.01 4.96 
AH o values expressed in ppm. Solvent (CD30D) referenced too 3.30 ppm 
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3. 3 Stereochemical Assignment of YTX 
3.3.1 Desulfation of YTX 
The quality of the NMR data acquired on YTX was insufficient to 
carry out a stereochemical study. In addition to dealing with small 
amounts of sample, the data quality was affected by the need to use 
CD 3 OD as the NMR solvent. This was a consequence of the 
insolubility of YTX in CDCb. The insolubility of YTX in CDCb is an 
inevitable result of the two sulfate functional groups at Cl and C4. 
Removal of the sulfate groups was achieved by refluxing YTX in a 
solution of 50% pyridine/1,4-dioxane. After work-up, 0.8 mg of pure 
desulfated YTX, was achieved. The desulfated YTX used in this study 
is hereafter referred to as D-YTX ( 44). 
55 
43 
HQ /; ~ 54 ~ 45 
47 
53 
D-YTX (44) 
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3.3.2 Spectroscopic Assignment of D-YTX 
Positive ion LRFABMS on D-YTX revealed a base peak at m/z 965.5, 
assigned as [M-H20+H]+. Subsequent HRFABMS was performed on 
this ion, (accurate mass 965.5619 corresponding to CssHs1 014, [M-
H20+H]+). From this, a molecular formula of CssHs20 15 was 
confirmed for D-YTX. 
The low sample mass restricted the use of NMR experiments solely to 
1 H nuclei. As a result, a multitude of 1 H based NMR experiments were 
carried out on D-YTX, including; 1 H, TOCSY (TOtal Correlation 
SpectroscopY), NOESY (Nuclear Overhauser and Exchange 
SpectroscopY) and selective lD-TOCSY and NOE (Nuclear 
Overhauser Effect) experiments. 
Proton assignments were made for rings G-K in the following manner: 
D-YTX (44) 
The 1 H NMR spectrum of D-YTX showed slightly different chemical 
shifts, compared with those of YTX. The methyl peaks of D-YTX 
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were virtually identical in chemical shifts to those in YTX and, as such, 
were assigned by direct comparison. The olefinic region of D-YTX 
was also assigned predominantly by comparison with that of YTX (Fig 
3.3.1). However, a TOCSY experiment was needed to locate H53 (8 
5.09), which was concealed by the H47 resonances (8 5.09). The 
TOCSY spectrum was also used to assign both H55 methylene protons 
at 8 5.04/5.01. 
(b) 
H43 
(a) 
H43 
6.4 6.2 
Fig 3.3.1 
H42 
H46 
H42 
H46 
6.0 5.8 5.6 5.4 
H47 ---t f--HOD 
H53/H47 ---t 
5.2 
H53 
JH55 
J H53 
H55 
H H53 
5.0 4.8 ppm 
lH NMR Spectra of Olefinic Regions of (a) D-YTX 
and (b) YTX 
The major difference between the 1 H NMR spectra of D-YTX and 
YTX, was in the region 4.5-1.5 ppm (Fig 3.3.2). In the spectrum of 
D-YTX, the resonances Hl and H4 had moved substantially upfield to 
around 8 3.8. These upfield chemical shifts are consistent for the 
cleavage of the sulfate groups and comply with previously published 
data. 24 The proton resonances 8 3.94 (H40), 8 3.90 (H32), 8 2.73 
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(H27) and 8 2.49 (H38), were well resolved and able to be assigned by 
direct comparison with those in YTX (Fig 3.3.2). The latter three 
proton positions served as ideal entry points for both 2D and 1D 
TOCSY NMR experiments, allowing the assignment of the other 
resonances in rings G-K. 
Hl/H4 
(b) 
(a) 
H40 
H40 
H32 
.j 
H32 
.j 
4.4 4.2 4.0 3.8 3.6 3.4 3.2 3.0 2.8 2.6 2.4 2.2 2.0 1.8 ppm 
Fig 3.3.2 lH NMR Spectra of Ether Regions of(a) D-YTX and 
(b) YTX 
Long range allylic coupling was observed in the 2D TOCSY spectrum 
from the exocyclic methylene at 8 5.09/4.87 (H53), to the methylene at 
8 2.49 (H38). A trace through the resonance at 8 2.49 (H38), revealed 
correlations to 8 5.09, 4.87 (H53) and further unassigned resonances 8 
3.80, 3.68, 3.42, 2.11 and 1.57. A 1D TOCSY experiment, using 
excitation at 8 2.49 (H38) and different mixing times (Fig 3.3.3), was 
used to solve the sequence of resonances in the spin system H38-H34. 
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(c) 50 ms 
(b) 25 ms 
(a) 10 ms H37 
4.4 4.2 4.0 3.8 3.6 3.4 3.2 3.0 2.8 2.6 2.4 2.2 2.0 1.8 ppm 
Fig 3.3.3 1D TOCSY Spectrum of D-YTX With Excitation At H38 
and Mixing Times of(a) 10 ms, (b) 25 ms, (c) 50 ms and (d) 100 ms 
At a mixing time of 10 ms (Fig 3.3.3(a)), one strong correlation to () 
3.42 was observed and assigned as H37. At 25 ms (Fig 3.3.3(b)), 
additional strong correlations could be seen for () 3.80 and weak 
correlations for () 1.57. These were assigned as H36 methine and one 
diastereotopic H35 methylene proton respectively. At 50 ms (Fig 
3.3.3(c)), a further correlation appeared at () 3.68 (H34). In addition, 
the resonance at () 1.57 (H35) was of increased strength and a weak 
signal, at () 2.11 (H35), was observed. The trace, at a mixing time of 
100 ms (Fig 3.3.3(d)), confirmed the correlation to() 2.11 (H35). This 
completed the assignment of the spin system H38-H34. 
The doublet at() 3.90 was assigned as H32 by direct comparison with 
YTX (Fig 3.3.2). The 2D TOCSY spectrum revealed correlations 
from this resonance to () 3.61, 3.23, 3.11, 2.31 and 1.56 ppm. A 
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second 1D TOCSY, using excitation at 8 3.90 (H32), was used to assign 
the sequence of resonances along the spin system (Fig 3.3.4). 
(c) 100 ms 
(b) 50 ms 
~H32 H31 
(a) 10 ms 
4.4 4.2 4.0 3.8 3.6 3.4 3.2 3.0 2.8 2.6 2.4 2.2 2.0 1.8 
Fig 3.3.4 1D TOCSY Spectrum of D-YTX, With Excitation At H32 
and Mixing Times of(a) 10 ms, (b) 50 ms and (c) 100 ms 
At a mixing time of 10 ms (Fig 3.3.4(a)), a strong correlation was 
observed to 8 3.11 and assigned as H31. At 50 ms (Fig 3. 3 .4(b)) an 
additional correlation was observed to 8 3.61, accordingly assigned as 
H30. At 100 ms (Fig 3.3.4(c)), further correlations were observed to 8 
2.31/1.56 (H29). No further correlations were observed from H32. 
The triplet at 8 2.73 was assigned as H27, by direct comparison with 
YTX (Fig 3.3.2). The 2D TOCSY spectrum showed correlations from 
this resonance to 8 3.61, 3.23, 3.11, 2.31, 1.83, 1.71, 1.57 and 1.01 
ppm. The sequence of resonances within the spin system were solved 
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by a third 1D TOCSY experiment, using excitation at 8 2.73 (H27) (Fig 
3.3.5) and various mixing times. 
(c) 100 ms 
(b) 25 ms 
(a) 10 ms H26 
Fig 3.3.5 1D TOCSY Spectrum of D-YTX, With Excitation At H27 
and Mixing Times of(a) 10 ms, (b) 25 ms and (c) 100 ms 
At a mixing time of 10 ms (Fig 3.3.5(a)), strong correlations were 
observed to 8 3.23 and 1.71 ppm, hence assigned as H28 and H26 
respectively. The experiment at 25 ms (Fig 3.3.5(b)), showed 
additional correlations to 8 1.57, 1.83 (H25) and 1.01 ppm, the doublet 
Me51. At 100 ms (Fig 3.3.5(c)), additional correlations were observed 
to 8 3.61 (H30) and 8 3.11 (H31). Collation of the above data assigned 
the complete spin system, H32-H25. 
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3.3.3 Conformations of Rings G-K In D-YTX 
Conformational elucidation for rings G-K of D-YTX was made by 
measurement of observed coupling constants. Estimation of dihedral 
angles, from coupling constants, was achieved by consideration of the 
Karplus equation. 81 
Analysis of the coupling constants between protons on rings G-K, was 
achieved by direct measurement of well resolved signals in the lH 
NMR spectra and by measurement of signals, resolved by lD TOCSY 
traces. In addition, various couplings were "removed" in lD TOCSY 
experiments, by the decoupling of selected resonances during the 
acquisition of data. This simplified some multiplets and allowed 
assessment of coupling patterns. The measurement of coupling 
constants could then be achieved both for the simplified multiplet and, 
by subtraction, the coupling removed. 
The conformation of ring K was proposed in the following manner: 
The resonance at 8 3.42 (H37) was well resolved in the lH NMR 
spectrum of D-YTX (Fig 3.3.2). The vicinal 3JHH couplings were 
measured as 8.9, 7.2 and 9.4 Hz. A lD TOCSY experiment was run 
with excitation at 8 2.49 (H38) and selective decoupling at 8 3.80 (H36) 
(Fig 3.3.6(a)), 3.42 (H37) (Fig 3.3.6(b)), 2.11 (H35) (Fig 3.3.6(c)) and 
1.57 (H35) (Fig 3.3.6(d)). 
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H36 
(c) 
(b) 
4.4 4.2 4.0 
H35ax 
decoupled 
2.4 2.2 2.0 1.8 ppm 
Fig 3.3.6 ID TOCSY Spectrum of D-YTX With Excitation At H38 
and Decoupling At (a) H36, (b) H37, (c), H35eq and (d) H35ax 
Decoupling at 8 3.80 (H36) (Fig 3.3.6(a)) collapsed 8 3.42 (H37) to a 
triplet (J = 7.9, 7.6), with the couplings assigned as 3fH37H38ax and 
3fH37H38eq· By subtraction, the coupling of 3fH37/H36 was shown as 
large and approximately 8.5 Hz. This corresponds most closely to a 
dihedral angle of ca. 180° and, consequently, a trans-linked ring 
junction at H36/H37. The approximately equal couplings, of ca. 8 Hz 
for both 3fH37H38ax and 3fH37H38eq, are not consistent with a chair 
conformation for ring K. In particular, the 3fH37H38eq coupling 
constant would be expected to be small due to the dihedral angle being 
close to 90° for these protons. A more plausible explanation would be 
if ring K adopted a twisted chair conformation as shown in Fig 3.3.7. 
Fig 3.3.7 Proposed Conformation of Ring K of D-YTX 
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The dihedral angles of the H37 /H38 protons are more clearly shown by 
the Newman projections (Fig 3.3.8) of both the chair (Fig 3.3.8(a)) and 
twisted chair (Fig 3.3.8(b)) conformations for ring K. The dihedral 
angle of H37/H38eq is close to 90° for the chair conformation, however 
is close to 0° for the twisted chair conformation. 
(a) 
/ l1arge 
0"1111 
H 
H 38cq 
53 
(b) 
I large 
H \ l1arge 
36 38ax / 
H:t~ 
3? 38eq 
H 
Fig 3.3.8 Newman Projections for (a) Chair and (b) Twisted Chair 
Conformations for Ring K of D- YTX 
Decoupling at 8 3.42 (H37) (Fig 3.3.6(b)) c llapsed 8 2.49 (H38) to a 
singlet, revealing the vicinal 3JH38H37 coupling of 7.3 Hz. 
The conformation of ring J was proposed a follows: 
Decoupling at 8 2.11 (one diastereotopic H35) (Fig 3.3.6(c)), gave rise 
to no significant changes in the appearance of multiplets 8 3.80 (H36) 
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and o 3.68 (H34). This showed small couplings from H36 and H34 too 
2.11, assigning this resonance as equatorial H35. This was supported 
by decoupling at the other H35 resonance (1.57 ppm) (Fig 3.3.6(d)), 
which led to the collapse of o 3.80 (H36) to a doublet and o 3.68 (H34) 
to a singlet, assigning o 1.57 as axial H35. The coupling seen in the 
doublet o 3.80 J = 8.0, could only be explained by a trans orientation 
from H37 to H36, further supporting the trans-linked ring junction at 
this position. The collapse of the multiplet o 3.68 (H34) to a singlet, 
revealed the coupling of 3JH34H35ax was 11.5 Hz and hence H34 as 
axial. The conformation best fitting the above data for ring J, is a 
chair conformation. 
The conformation of ring I was proposed as follows: 
A second 1D TOCSY experiment was run, using excitation at o 3.90 
(H32), with decoupling at o 3.61 (H30) (Fig 3.3.9). The decoupling led 
to the collapse of o 3.11 (H31) to a non resolvable doublet (3JH31H32 
ca. 1 Hz). This revealed a large 3JH30H31 coupling and, consequently, 
a trans ring junction between H30 and H31. This 3JH31H32 requires 
H32 to be in an equatorial orientation, with the hydroxyl group axial. 
The conformation best fitting the above data for ring I, is a chair 
conformation. 
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H32 
, H30 
f'. decoupled H31 
~~ J 
~ 
4.4 4.2 4.0 3.
1
8 3.
1
6 3.4 3.2 3.0 2.8 ppm 
Fig 3.3.9 JD TOCSY Spectrum of D-YTX, With Excitation At H32 
and Decoupling of H30 
The conformation of ring H was proposed in the following way: 
A 1D TOCSY experiment, using excitation at 8 2.73 (H27) and 
decoupling at 8 1.56 (one diastereotopic H29) (Fig 3.3.10), led to the 
collapse of 8 3.23 (H28) to a doublet, revealing large coupling of 
3 1H27H28 and, consequently, a trans ring junction between H27 and 
H28. The coupling from H28 to H29 was large and removed by 
decoupling of 8 1.56. This lead to the assignment of 8 1.56 as the axial 
proton at C29 and, consequently, 8 2.31 as equatorial H29. 
Again, the data best fits a chair conformation for ring H. 
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3.8 3.6 
Fig 3.3.10 
H27 H29ax 
H28 H29eq 
2.2 2.0 1.8 1.6 ppm 
1 D TOCSY Spectrum of D-YTX, With Excitation 
At H27 and Decoupling of H29ax 
· This implies that the three trans-linked nngs all have chair 
conformations, as shown in Fig 3.3.11. 
H 
Fig 3.3.11 
H I 
H Me 
52 
J 
H 
Proposed Conformations of Rings H-J of D-YTX 
The assignment of the conformation of ring G is more complex, as it is 
an 8 membered ring and the chemical shift values of the methylenes 
H24 and H25 are identical. The resonance at 8 2.73 (H27) showed two 
large couplings, J = 9.3, 8.8. One of the couplings was previously 
assigned as arising from the 3JH27H28 trans-ring junction. The other is 
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best explained by an approximate 180° orientation to 8 1.71 (H26), 
assigning H26 as pseudo-trans. No other useful data from ring G could 
be obtained from lD TOCSY experiments, due to the proximity of the 
chemical shifts of the key protons. 
The coupling constants, revealed by decoupled 1D TOCSY 
experiments, are summarised in Fig 3.3.12. These show large coupling 
(7-11Hz) and small coupling (1-2.5 Hz). 
G H I J K 
H 
, ........... 
, \ small coupling constants ( I - 2.5 Hz) 
' . n large coupling constants (7 - II Hz) 
Fig 3.3.12 Coupling Constants of Protons on Rings G-K 
The conformations of rings H-K were verified by selective NOE 
experiments on isolated resonances (Table 3.3.1). In addition, a 20 
NOESY experiment was used to examine enhancements over the whole 
chemical shift range and, in particular, between signals that were not 
well separated (Table 3.3.2). 
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Table 3.3.1 Selected Difference NOE Enhancements (%)for 
D-YTX 
From/To 
Me54 H53t (1.23) H43 (4.01) H42 (3.42) H40 (5.89) 
Me52 H37 (6.60) H32 (4.34) H31 (1.28) 
H53t H53° (4.39) H40 (2.86) 
H45 H5Y (2.00) H47 (*) H46 (4.62) H42 (5.14) 
H43 Me54 (0.38) H47 (*) 
H42 Me54 (0.41) H45 (2.57) H40 (1.78) H38 (0.76) H36 (0.81) 
H40 Me54 (0.72) H53 (1.27) H42 (1.74) 
H38 H55A (1.20) H53 (*) H43 (1.98) H42 (2.09) H37 (3.79) 
H32 Me52 (0.96) H31 (1.34) 
H27 H31 (1.41) 
* % enhancement unknown 
t H53 at() 4.87 ppm only 
0 H53 at() 5.09 ppm only 
H55 at() 5.01 ppm only 
A H55 at() 5.04 ppm only 
Selective irradiation at 8 1.20 (Me52), in an NOE experiment, 
enhanced signals at 8 3.11 (H31) and 3.42 ppm (H37) (Table 3.3.1), 
supporting an all axial arrangement for these protons and, 
consequently, chair conformations for rings I and J. Enhancement of 
the signal at 8 3.90 (H32) (Table 3.3.1), in the same experiment, 
showed further evidence for the placement of this proton as equatorial 
and the hydroxyl group as axial. A trace through the same resonance 
in a NOESY experiment, revealed an extra enhancement to 8 1.57 
(H35ax) (Table 3.3.2), further supporting the assignment of this proton 
as axial. 
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Table 3.3.2 2D NOESY Correlations for D-YTX 
From/To 
H55 H46 H45 
Me54 H53'f H43 H42 H40 H36 
H53t Me54 H53° H40 
Me52 H37 H3Y H32 H31 
Me51 H27 H26 H25A 
H47/H53° H53t H38 
H46 H47 H45 
H45 H55 H42 
H43 Me 54 H47 H42 
H42 Me54 H45 H43 H40 H38 H36 
H40 H53'f H42 
· H38 H37 
H37 Me52 H38 
H32 Me52 H31 H29 
H31 Me52 H32 H27 
H27 Me51 H31 
t H53 at () 4.87 ppm only 
0 H53 at() 5.09 ppm only 
H35 at() 1.57 ppm only 
A H25 at () 1.57 ppm only 
The enhancement of 8 3.11 (H31), by selective irradiation of 8 2.73 
(H27) (Table 3.3.1) in an NOE experiment, further supported the all 
chair conformation of rings H, I and J. Additionally, the NOESY 
spectrum showed correlations between 8 2.73 (H27) and 8 1.01 (Me51) 
(Table 3.3.2), supporting the placement of Me51 as equatorial in ring 
G. 
The orientation around C41 was solved by use of NOE and NOESY 
experiments. Selective irradiation at 8 1.35 (Me54), in an NOE 
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experiment, gave enhancements to 8 6.33 (H43), 5.72 (H42) and 3.94 
(H40) (Table 3.3.1) and a correlation to 8 3.85 (H36) (Table 3.3.2) was 
observed in the NOESY spectrum. Similarly, selective irradiation 
from 8 5. 72 (H42), in another NOE experiment, revealed 
enhancements to 8 3.94 (H40) and 3.85 (H36) (Table 3.3.1). These 
data indicated that Me54, H40 and the H42/H43 double bond all lie in 
one plane of the C41/C40 bond, with the hydroxyl group in the 
opposite (Fig 3.3.13). 
(\ Enhancement seen in both direction 
(\ Enhancetnent seen in direction shown 
Fig 3.3.13 Orientation around C41 of D-YTX as Described by 
NOE and NOESY Enhancements 
The recent publication of the relative stereochemi try of YTX by 
Sataki et al, 31 provided data complementary to that obtained in thi 
research. 
The all-trans conformation of rings G-K, proposed in this the is, was 
consistent with published data. Furthermore, the all-trans relationship 
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was shown to be present in all rings, a phenomena consistent with the 
brevetoxin backbone. 
However, one inconsistency arose from the comparison of observed 
and published data. A chair conformation for ring K is not in 
accordance with the apparent quartet observed for H37. The three 
large vicinal couplings (ca. 8Hz) of H37 are best explained by a twisted 
chair conformation proposed here. 
It was necessary to consider whether there was a conformational 
change upon desulfation. This was addressed by a trace through the 2D 
TOCSY spectrum of YTX at () 2.70 (H38) (Fig 3.3.14). This trace 
revealed the apparent quartet of H37, seen for D-YTX. Hence these 
data provided evidence for the twisted chair conformation of ring K in 
YTX. 
H37 
H36 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I l I I I I I I I I I I I I I I I I I I I I I I I 
3.8 3.6 3.4 3.2 3.0 ppm 
Fig 3.3.14 Trace Through 2D TOCSY Spectrum of YTX Revealing 
Resonances for H36 and H37 
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3.4 
3.4.1 
Design and Synthesis of YTX 
Haptens 
Design 
Y essotoxin (YTX, 19) contains two likely positions for the attachment 
of linker groups suitable for the synthesis of haptens. The sulfate 
groups provide indirect positions for attachment. Attachment may be 
achieved through the hydroxyl groups formed by desulfation or amino 
groups formed by aminolysis. The olefinic "tail" on YTX is amenable 
to cleavage by ozone. The product(s) formed provide useful linker 
sites at this end. 
YTX (19) 
Desulfation of YTX is an established procedure and had already been 
achieved as part of this research (Section 3.3.1). The linker group 
chosen was p-maleimidophenyl isocyanate (PMPI, 45). 
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0 
GN-o-N=C=O 
0 
(45) 
PMPI was selected as the linker group because the maleimide provides 
a linker for selective attachment to sulfhydryl (S-H) residues on 
proteins . 
. Substitution of the sulfate groups can be achieved with an appropriate 
· nucleophile. An amine provides an ideal nucleophile as the product 
formed is an amino group (Fig 3.4.1). Due to this amino group, 
coupling to the carboxylic acid terminus of a protein then becomes 
possible. 
RHN 
RHN 
\ 
; 
0 \ 
; 
Fig 3.4.1 Proposed Aminolysis of Sulfate Groups On YTX 
Ammonia was selected for aminolysis as the probable product would be 
either a mono or di primary amine. In addition, glycine provides a 
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mono/di carboxylic acid for linkage and was also selected for this 
reason. 
Ozonolysis is a commonly used procedure for cleavage of carbon-
carbon double bonds. 82 The product(s) formed are dictated by the 
work-up procedure. A reductive work-up typically yields ketones and 
aldehydes, whereas an oxidative work-up usually produces carboxylic 
acids. The likely aldehyde produced after reductive work-up (Fig 
3.4.2) can be conjugated in high yields to the amino terminus of a 
protein. 83 
Fig 3.4.2 Likely Product from Ozonolysis of YTX 
3.4.2 Syntheses 
PMPI 
Desulfation of YTX was carried out previously and is described in 
Section 3.3.1. The product formed, D-YTX (44) was reacted with 
PMPI, under anhydrous conditions, in a sealed glass NMR tube. 
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Analysis of the reaction progress was made by 1 H NMR spectroscopy, 
with particular examination of the emergence of signals around 4 ppm, 
which are indicative of protons adjacent to carbamate moieties. After 
24 hours, baseline resonances were observed in the region 4.2 - 4.4 
ppm. The intensities of these resonances increased slowly over time 
and after 167 hours no further apparent change was observed in the 
spectrum. 
D-YTX (44) 
The dichloromethane soluble products were purified on reverse phase 
C8 HPLC, using acetonitrile/water gradient elution. Eleven fractions 
were collected and those showing UV absorbance at above 250 nm 
were analysed by lH NMR spectroscopy. 
The NMR spectra all showed degradation of the olefinic side chain. 
Fraction 5 showed aromatic peaks consistent with one PMPI moiety. 
However, fractions 6, 7 and 8 all showed indiscernible multiples of 
these resonances. This gave evidence for the attachment of the PMPI 
linker at multiple hydroxyl groups. 
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The degraded olefinic side chain would probably provide significant 
effects for the recognition by an immunogen. Hence this degradation 
was considered disadvantageous for the success of these haptens in an 
Immunoassay. 
Aminolysis 
The reaction between YTX and 50% ammonia/MeOH was carried out 
at room temperature, in a sealed vial for 1 hour and all solvents 
removed. The 1 H NMR spectrum of the reaction product revealed that 
the resonances for H1 & H4 were still at 8 4.2. These data 
demonstrated that at least one sulfate group was still intact. However, 
the low sample mass prevented accurate integrals from being measured, 
hence not allowing the number of attached sulfate groups to be 
determined. 
Analysis of this sample by reverse phase C18 TLC (Thin Layer 
Chromatography) was undertaken. Spraying of these plates separately 
with Dragendorff's reagent and ninhydrin (Section 6.1.5) gave negative 
results. These data suggested that no amine group had been formed. 
It was postulated that the aminolysis was slow at room temperature, 
based on the requirement of high temperatures (120 °C) for the 
hydrolysis of YTX. The incorporation of heat into the aminolysis 
could not be accompanied by the use of ammonia, due to its low boiling 
point. Hence, glycine was used. 
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Glycine was reacted with YTX at 60 oc (64 hours). After removal of 
solvents the reaction mixture was analysed by lH NMR spectroscopy. 
The spectrum showed the presence of at least one sulfate group 
indicated by the resonance at o 4.2. The olefinic resonances of the 
molecule were diminished in intensity, giving evidence for degradation 
of the side chain. 
The failure of the PMPI and aminolysis syntheses was attributed largely 
to the instability of the olefinic side chain. The success of using 
different reagents or conditions to achieve a linker at the sulfate end of 
the molecule was low. 
Ozonolvsis 
' 
An initial reaction of ozone and YTX was undertaken. Analysis of the 
reaction mixture by 1 H NMR spectroscopy revealed the complete 
cleavage of the carbon-carbon double bonds in YTX. This revelation 
was due to the absence of the olefinic proton resonances. The absence 
of an aldehyde peak and the presence of new resonances around 5.1 
ppm was observed in the spectrum. In addition, a singlet at o 3.60 was 
suggestive of a methoxy group. These data indicated that the aldehyde 
formed ( 46) had undergone acetal formation with methanol to form 
the hemiacetal (47). This hemiacetal may have then undergone 
intramolecular acetal formation to form the acetal (48) (Fig 3.4.3). 
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H 
Fig 3.4.3 Proposed Formation of The Hemiacetal (47) and Cyclic 
Acetal ( 48) from The Ozonolysis Product ( 46) 
Attempts at formation of the desired aldehyde ( 46) from the proposed 
acetal ( 48) were made with acetic acid. This proved unsuccessful with 
complete loss of material. 
A second ozonolysis reaction was carried out on a "year old sample" of 
YTX. The reaction product formed was analysed by 1 H NMR 
spectroscopy. The spectrum did not show the expected resonances at 
around 5.1 ppm, suggesting that the hemiacetal/acetal had not been 
formed. The chance of the acetal proton coinciding with the HOD 
solvent peak was addressed. Consequently, the sample was analysed by 
mass spectrometry. 
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LRFABMS was performed on the sample. Negative ion FABMS and 
positive ion FABMS, with the addition of Csl was used. A molecular 
ion at mlz 1150 was postulated from these data. The negative ion 
F AB MS spectra afforded a peak at mlz 1127, corresponding to [M-N a]-
. This data was supported by the positive ion Csl F ABMS spectrum, 
which afforded a peak at m/z 1503, corresponding to [M-2Na+3Cs]+. 
The presence of doublets (2 mass units apart with a 1: 1 intensity ratio) 
of the highest mass peaks, was observed in all spectra, characteristic of 
the presence of bromine (Br) in the molecule. This data was supported 
by the loss of 80 mass units (HBr) from mlz 1503 in the Csl spectrum, 
with a corresponding removal of the bromine pattern. 
The incorporation of Br into the molecule was presumably a result of 
degradation over time. The YTX sample used for ozonolysis had been 
isolated 1 year previously. It was probable that the incorporation of Br 
over that time was due to a contaminant in the sample. The presence of 
Br rendered the molecule unsuitable for immuno-assay development. 
Consequently, the ozonolysis was repeated a third time on a newly 
isolated YTX sample. 
The product formed from the third ozonolysis of YTX was analysed by 
1 H NMR spectroscopy. The spectrum was similar to that of the second 
ozonolysis reaction, with no apparent acetal or aldehyde peaks 
observed. 
LRFABMS (with the addition of Csl) on this sample did not reveal a 
molecular ion for the compound. 
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Although not characterised, the third ozonolysis sample was sent to 
AgResearch, at Hamilton, New Zealand for direct conjugation to a 
protein. 
3.4.3 Results 
At the time of writing, the preparation of a protein conjugate with the 
ozonolysis product was being carried out at AgResearch. An 
immunisation schedule will involve inoculation of the conjugate into 
sheep and mice for the development of a competitive ELISA. 
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3.5 
3.5.1 
Development of a Large Scale 
Isolation Method for YTX 
Strategy 
The strategy for the large scale extraction and isolation of YTX from 
shellfish revolved around the unexpected chromatographic behaviour 
of the toxin on LH-20 gel. A compound the size of YTX (1186 Da) 
would be expected to elute off the LH-20 gel very early, however 
preliminary work on the initial isolation of YTX revealed that the 
majority of the toxin eluted very late (Scheme 2.2.2). The late elution 
of YTX, on LH-20 gel, is presumably a result of reversible absorption 
effects of the two terminal sulfate groups with the gel, hence retarding 
the toxin (KD > 1). 
The retardation of YTX on LH-20 was advantageous for quick isolation 
in two ways: first, much "unwanted" mass is removed from the YTX 
containing sample (95% is removed from fraCtion 2.19, Scheme 2.2.2), 
while the toxin is concentrated, predominantly, in the remaining mass. 
The second advantage is that loss of the toxin on the gel is less than for 
any other chromatographic phase examined. 
With the strategy centred on LH-20 gel permeation chromatography, it 
was essential that the remainder of the extraction and isolation 
procedure prepared the extract for this phase. The criteria for the 
protocol was; maximum extraction followed by efficient removal of 
unwanted mass, with concurrent minimal loss of toxin. 
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3.5.2 Extraction Methodology 
The aim of the extraction methodology for YTX was to develop a 
procedure that extracted the toxin yet gave a readily manageable 
extract. As mentioned in Section 2.2.1, the high lipid content of 
shellfish, which causes handling problems, can be controlled by the use 
of highly polar extraction solvent mixtures. The polarity of YTX is 
favourable to the use of polar extraction solvents. 
Freeze drying the mussels aided handling, while extraction with 70% 
methanol/water was effective in extracting minimal amounts of lipid 
material. However, the cytotoxicity of the extract was not as high as 
seen previously for other crude extractions. Re-extraction of a small 
amount of the shellfish, with methanol, revealed that substantial 
amounts of toxin had not been extracted by the first method. 
Extraction under reflux conditions was a method previously used by 
Ishida et al, for extraction of BTX-B1 from shellfish.76 Re-extraction 
of a small portion of the shellfish, by refluxing in methanol, afforded 
an extract with a 2-fold increased cytotoxicity, compared with that of 
the cold methanol extraction. 
The reflux extraction was established as a supenor method and 
accordingly applied on a larger scale. 
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3.5.3 Preliminary Isolation 
The extract from the initial 70% methanol/water extraction, was 
partitioned against petroleum ether, to remove unwanted, non-polar 
material. After removal of the methanol, the aqueous phase was 
partitioned against ethyl acetate. P388 assays of all partitions revealed 
that the total cytotoxicity was spread evenly among the ethyl acetate and 
water phases. For this reason, this particular partition sequence was 
deemed highly unsuccessful and eliminated from future protocols. 
The utilisation of reverse phase C18 chromatographic material, for 
removal of unwanted mass, was attempted. The results proved to be 
mixed. Separation was poor for samples containing predominantly 
lipid soluble material (eg. the ethyl acetate phase) (Fig 3.5.1), but 
improved for samples containing predominantly polar material ( eg. 
aqueous methanol partitions) (Fig 3.5.2). For the C18 phases used, 
there was always a loss of toxin (as demonstrated by diminishing of 
total cytotoxicity recovered off the columns), presumably by 
irreversible absorption onto the solid support. 
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Fig 3.5.1 Graph Showing Cytotoxicity and Mass of Fractions off 
C18 Reverse Phase Column 
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For samples of predominantly high lipid content, silica 
chromatographic material was tried as an alternative phase. The 
exploratory trial of silica was unsuccessful, due to "streaking" of the 
toxin. Almost every fraction contained amounts of the toxin. 
The elimination of the water vs ethyl acetate partition and the 
unsuitability of silica as a first solid-phase purification step, placed the 
emphasis back on C18 as the primary solid-phase purification process. 
The combination of large volumes of aqueous extracts and large 
amounts of C18 material (ca. 1 kg), created problems. 
Large volumes required large columns, which in turn led to increased 
difficulties in sample handling and consequently time required to 
complete the operation. The published isolation scheme for YTX 
utilised an n-butanol vs water partition, followed by primary solid 
phase chromatography on alumina material. 24 
Exploratory use of this method was promising. The total measurable 
amount of toxin was partitioned into the n-butanol phase, from which 
good separation and toxin recovery were exhibited by the alumina 
phase. This method was adopted as the primary isolation procedure for 
the further extraction/isolation of shellfish (Scheme 3.5.1). 
3.5.4 Final Purification Methodology 
The design of a "custom made" column, suitable for purification of 
large quantities of sample on LH-20 gel permeation chromatography, ' 
97 
Chapter Three - Yessotoxin 
was fundamental to the overall isolation. A column, of length 2 metres 
and internal diameter of 25 millimetres was of appropriate size to 
contain ca. 200 grams of LH-20 gel. This amount of gel was pertinent 
for processing large quantities of extract (a weight ratio of 50:1 
gel:sample, cf 1000:1 normally required). Being a gel filtration 
technique, the length of column was of major importance. Overloading 
of the column was tolerated due to the absorption effects, exhibited by 
YTX on the gel. Generally, use of this column removed 97-98% of 
unwanted mass from the YTX containing samples. 
With efficient concentration of the toxin by LH-20 gel permeation 
chromatography (Scheme 3.5.1), final purification could be achieved 
on a reverse phase C 18 lobar column. The C 18 lobar column proved 
successful in near completion of the purification. 
Early work had shown that diol phase was successful in isolations, 
however the low amount available and vulnerability of this phase, made 
it practical only as a final purification step. After the C18 lobar 
column, the diol phase proved successful in purifying YTX to an 
acceptable level of purity (Scheme 3.5.1). 
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(boiling H20 extraction) (MeOH reflux) 
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Scheme 3.5.1 Large Scale Isolation Scheme for YTX 
The yield of YTX purified by this protocol (fraction 3.F3, 1.6 mg, 
1.6xl0-5% yield, wet/weight) was lower than initially expected. 
However, the mussels extracted were from a different batch than those 
examined earlier. It is possible that the levels of YTX in the mussels 
were variable and were lower in the batch extracted on a large scale. 
THE LIBRARY 
UNIVERSITY OF CANTERBURY 
CHRISTCHURCH, N.Z. 
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3.6 Conclusions 
3.6.2 Spectroscopic Assignment of YTX 
Close NMR and MS data correlations between published24 and observed 
data for YTX proved the presence of this toxin in the shellfish. 
3.6.3 Stereochemical Assignment of YTX 
Partial stereochemical assignment of YTX was carried out on the 
desulfated derivative D-YTX (44) as part of this research. However, 
the relative31 and absolute32 stereochemistry was subsequently 
published by Professor Yasumoto's research group. 
The data obtained during this research suggested the published chair 
conformation of ring K31 was incorrect, with the likely conformation 
for this ring being a twist boat. 
3.6.4 Design and Synthesis of YTX Haptens 
Attempted synthesis of YTX haptens was carried out. The syntheses 
were largely unsuccessful, with the most promise shown by ozonolysis. 
The product of the ozonolysis reaction was sent to AgResearch at 
Ruakura, Hamilton for immunisation in sheep. At the time of writing 
this immunisation is in the early stages and so no results are available. 
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3.6.5 Development of a Large Scale Isolation 
Method for YTX 
A large scale isolation procedure for YTX has been developed. The 
method centres on the use of LH-20 gel permeation chromatography, a 
phase effective in rapid concentration of the toxin and successful in the 
quick removal of unwanted mass. The overall success of the method 
could not be accurately gauged due to the unknown YTX content in the 
mussels. 
Accurate evaluation of the success of the method (and hence possible 
improvements) can only be made after a quantitative, YTX-specific 
assay is implemented. 
A fluorescence HPLC assay, for the determination of YTX and 45-
hydroxy YTX in shellfish, has been developed by Professor 
Yasumoto's research group in Japan. The assay is not yet available for 
outside use, although with a reported detection limit of 1 ng it is very 
sensitive.79 
The assay has been used to determine low levels of YTX and 45-
hydroxy YTX in contaminated mussels, harvested in early 1993 from 
Coromandel peninsula. In addition, the assay has proven instrumental 
in the determination of YTX, as the major contaminant of shellfish at 
Wedge point, in the Marlborough Sounds (Fig 2.1.1). Levels of 7.5 
mg/kg shellfish have been reported in these shellfish. 
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Once the assay technique is revealed, accurate analysis of the success of 
the methodology, developed here, can be made. 
102 
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Investigation of Toxicity 
in Foveaux Strait Oysters 
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4. 1 Introduction 
On 14 January 1994, as part of the biotoxin monitoring program, the 
routine testing of shellfish using the mouse bioassay led to the 
discovery of a lipid soluble toxin in oysters, harvested from Foveaux 
Strait area. The initial levels of 39 mouse units (MU)/100 g shellfish, 
were above the regulatory limit of 20 MU/100 g. Over the following 
weeks the levels increased until, by 25 February, values greater than 
650 MU/100 g were observed. As a result, a large part of the 
Southland coast was closed. Over a period of two months, the toxicity 
spread up the East coast of the South Island, to reach northern 
Marlborough Sounds in early May (Fig 4.1.1).84 
~ Port Underwood 
(29th April) 
~ Akaroa (25th April) 
___ Timaru (15th April) 
~ Oamaru (11th March) 
-j- Dunedin (11th March) 
~ Tairei Mouth (lith March) 
Foveaux Stmit~ • / 
(!4th January) V -_Big Glory Bay (11th March) 
Fig 4.1.1 Map of New Zealand's South Island Showing the Location 
and Dates of the Detection of Toxic Shellfish. Large Arrows Indicate 
the Direction of the Sea Current 
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High algal counts of a Gymnodinium species of dinoflagellate were 
found in the vicinity of the toxic shellfish. 84 The spread of 
contamination up the East coast of the South Island was accompanied by 
the presence of these algae. Confirmation that this Gymnodinium sp. 
was responsible for the shellfish contamination was made after the 
establishment of the dinoflagellate in culture. The dinoflagellate shares 
many characteristics with Gymnodinium mikimotoi and was 
consequently named Gymnodinium cf mikimotoi, (Fig 4.1.2). 84 
n 
10.um 
Fig 4.1.2 Schematic Drawing of Ventral and Lateral Views of 
Gymnodinium ct mikimotoi 
ch = chloroplast, nu = nucleus 
The results from the mouse bioassay suggested NSP toxicity. Due to 
the NSP toxicity and the presence of the dinoflagellate G. cf. 
mikimotoi, brevetoxins (BTX) were assumed to be the cause of the 
toxicity. However, the observed symptoms of the mice were unlike 
those normally observed for BTX containing samples. The key 
observation was that, on dilution, these samples did not show the 
proportional reduction in toxicity, observed for B TX containing 
extracts. A gradual increase in death time was observed until a 
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"critical" dilution of ca 1:5 was reached where no mouse deaths 
occurred. 
An investigation of the toxicity in the oysters was undertaken as part of 
this research and is described in Section 4.2. At the time at which this 
work commenced, it was not known that on 21 February 1994, twenty 
kilograms of toxic oysters had been sent to Professor Yasumoto's 
research group at Tohoku University, Japan. This material had been 
sent by the Cawthron Institute for chemical analysis in order to 
determine the identity of the toxin which has been the subject of this 
present research. 84 
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4.2 Investigation of Toxicity 
Due to the slow turn around times of the mouse bioassay and 
difficulties in handling highly lipid soluble samples (Section 2.2) an 
alternative method of detecting toxicity was required. Again, the P388 
murine leukaemia assay (Appendix 1) was used. 
An exploratory test of the polarity of the cytotoxic component( s) was 
made by extracting the oysters with various solvents. Frozen oyster 
flesh was freeze dried and extracted twice with water and once with 
50% methanol/water, methanol, ethyl acetate, and dichloromethane. 
The P388 assay showed a low level of cytotoxicity in the water extract, 
however the vast majority appeared in the ethyl acetate and 
dichloromethane extracts (Scheme 4.2.1). These results suggested that 
the cytotoxin was a non-polar, lipid soluble compound. 
An elaborate P388 cytotoxicity directed isolation was carried out on the 
extracts. The isolation is summarised in Schemes 4.2.1, 4.2.2, 4.2.3 
and is detailed in Section 6.4. 
The extract was concentrated into three samples of high cytotoxicity: 
fractions 4.J3 (0.3 mg, P388 ICso value 230 ng/mL, Scheme 4.2.2), 
4.M10 (1.7 mg, P388 ICso value <487 ng/mL, Scheme 4.2.3) and 4.01 
(0.8 mg, P388 ICso value 310 ng/mL, Scheme 4.2.3). 
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frozen oysters ( 600 g) 
n freeze dried, crushed 
H20 H20 50%MeOH MeOH EtOAc 
I I I I I 
4.Al 4.A2 4.A3 4.A4 4.A5 
13.2 g 30.7 g 14.8 g 9.8 g 4.8 g 
476000 4360000 >1250000 830000 171000 
I I I I C18 
500 150 300 500 500 400 1000 aq. MeOH 
H20 30%MeOH60% 70% 80% MeOHMeOH/DCM I I I I I I I I 
4.Bl 4.B2 4.B3 4.B4 4.B5 4.B6 4.B7 4.Cl 
19.2 g 146 mg 193 mg 150 mg 102 mg 188 mg 347 mg 6520mg 
491000 > 1250000 987000 330000 23700 <9750 <9750 <9750 
(2) 
300 300 
50%MeOH70% 
I I 
4.El 4.E2 
4170 mg 45 mg 
> 1250000 72000 
(~) 
(6) (61) (>105) (>193) (>3f6) (133) 
4.D2 
250mg 
99700 
(25) 
300 
80% 
I 
4.E3 
66mg 
84000 
(8) 
pet. ether 
MeOH/H20 
4.Dl 
530mg ~ Cl8 4.H 
4oooo (Scheme 4.2.2) C18 
(135) I 
300 I 300 300 300 500 
90% MeOH MeOH/DCM 
I I I I I 
4.E4 4.E5 4.E6 4.E7 4.E8 
152mg 217mg 337mg 210mg 345mg 
64000 56000 126000 300000 125000 
(24) (39) (2j) (7) (28) 
DCM 
I 
4.A6 
1.9 g 
93000 
I 
pet. ether 
I 
4.C2 
6320mg 
229000 
(276) 
silica 
n 400 200 500 300 300 500 400 200 300 
Cl8 4.K PE 5%Et0Ac 10% 20% 50% EtOAc 50% MeOH I I I I I I I I I (Scheme 4.2.2) 4.Fl 4.F2 4.F3 4.F4 4.F5 4.F6 4.F7 4.F8 4.F9 
240 120 
2% EtOAc/PE 3% 
I I 
4.Gl 4.G2 
1 mg 26mg 
1466 mg 4 mg 198 mg 1880 mg 221 mg 1380 mg 314 mg 30 mg 
212000 >125000 55000 414000 145000 225000 28000 27000 
354mg 
137000 
(27) 
180 
4% 
I 
4.G3 
97mg 
(69) (36) (45) (15) (61) (113) (11) 
60 
5% 
I 
4.G4 
5mg 
I I I silica a.....~n,_.g 
60 
5% 
I 
4.G5 
1 mg 
100 150 100 .u. 
20% EtOAc MeOH 
I I I 
4.G6 4.G7 4.G8 
Cl8 4.L 
(Scheme 4.2.3) 
>125000>125000>125000 68000 >12500 
11 mg 
46500 
(2) 
46mg 
23000 
(20) 
I 
15mg 
4170 
(35) (1) 
I 
For Legend See Scheme 4.2.2 n 
Scheme 4.2.1 
Cl8 4.N 
(Scheme 4.2.3) 
Concentration of P388 Cytotoxicity in Foveaux 
Strait Oysters 
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C18 4.H 
(Scheme 4.2.1) 
I 
165 110 110 110 110 110 110 400 
25%NVW~~ __ ,50~%~ ___ 6T0~% ____ ~7rOo/<~o ____ ~80~%~ ___ 9TO~%--~M=erO=H~-=M~eOHillCM 
I I I I I I I I 
4.H1 4.H2 4.H3 4.H4 · 4.H5 4.H6 4.H7 4.H8 
78 mg 34mg 
>250000 >125000 
13 10 10 
50% IPE/PE 
I I I 
4.11 4.12 4.13 
20 mg 10 mg 35 mg 28 mg 69 mg 43 mg 
74000 64000 72000 21000 99000 3900 
(3) (2) (5) (13) (7) (110) 
10 
IPE 
I 
4.14 
10 10 10 
5%Me0H 
I I I 
4.15 4.16 4.17 
10 
10% 
I 
4.18 
10 
20% 
I 
4.19 
silica I 
10 
50% 
I 
4.110 
30 
MeOH 
I 
4.111 
4.2 mg 1.1 mg 0.7 mg 0.1 mg 0.2 mg 14.6 mg 4.5 mg 0.8 mg 0.7 mg 1.1 mg 11.3 mg 
>12500 890 570 250 1400 >62500 11000 >12500 >12500 >12500 55000 
- (12.4) (12.3) (4.0) (1.4) - (4.1) - - - (2.1) 
I I 
LH20 
I 
0.5 0.25 0.75 2.0 
I I I I 
4.J1 4.J2 4.J3 4.J4 
0.6 mg 0.5 mg 0.3 mg 0.5 mg 
>6250 >6250 230 >6250 
- - (13.0) - C18 4.K 
(Scheme 4.2.1) 
I 
240 160 160 160 160 160 160 500 
25% M/W 50% 60% 70% 80% 90% MeOH MeOH/DCM 
~~--~~--~~----~~--~l----~1--~l--~l 
4.K1 4.K2 4.K3 4.K4 4.K5 4.K6 4.K7 4.K8 
131 mg 22 mg 26 mg 34 mg 42 mg 96 mg 226 mg 122 mg 
>250000 70000 31000 37000 76000 44000 48000 48000 
(3) (8) (9) (6) (23) (47) (25) 
Legend 
aaa Elution volume (mL) 
bbb Elution Solvent Mix 
ccc Sample Code 
ddd Sample mass (mg) 
eee 1C50 (nglmL) 
(fff) P388 cytotoxicity= mass (mg)/IC50 (ng/mL) x 104 
Scheme 4.2.2 Concentration of P388 Cytotoxicity in Foveaux 
Strait Oysters 
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C18 4.L (Scheme 4.2.1) 
I 
105 70 70 70 70 70 70 300 
25% MeOH/H20 50% 60% 70% 80% 90% MeOH MeOH/DCM 
I 
4.Ll 
4.6mg 
>25000 
60 
50%DCM/PE 
4.Ml 
92.2mg 
28000 
(32.9) 
4.Nl 
5.5mg 
>25000 
I I I I I I I 
4.L2 4.L3 4.L4 4.L5 4.L6 4.L7 4.L8 
7.0mg 7.4mg 7.3 mg 9.0mg 23.0 mg 141.0 mg 121.0 mg 
>25000 14000 12000 13000 11000 23000 64000 
(5.3) (6.1) (6.9) (20.9) (61.3) (18.9) 
I 
dioll 
I 
40 40 40 40 40 40 40 40 80 
DCM 5%MeOH 25% 50% MeOH 
4.M2 4.M3 4.M4 4.M5 4.M6 4.M7 4.M8 4.M9 4.Ml0 
50.0 mg 23.3 mg 20.4 mg 12.3 mg 79.6 mg 5.0mg 4.6mg 2.2mg 1.7mg 
28000 17000 13000 18000 32000 39000 >125000 37000 <487 
(17.9) (13.7) (15.6) (6.8) (24.9) (1.3) (0.6) (>34.7) 
C18 4.N (Scheme 4.2.1) 
20 
50% 
4.N2 
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20 
60% 
4.N3 
1.2mg 
>25000 
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70% 
4.N4 
l.Omg 
20000 
(0.5) 
I 20 
80% 
4.N5 
0.2mg 
1400 
(1.4) 
LH20 
20 
90% 
4.N6 
1.7mg 
390 
(43.6) 
(50% MeOH/DCM) 
20 
MeOH 
4.N7 
11.2 mg 
7000 
(16.0) 
so 
MeOH/DCM 
4.N8 
21.5 mg 
51000 
(4.2) 
For Legend See Scheme 4.2.2 
I 
4.01 
0.8mg 
310 
(25.8) 
I 
4.02 
0.5 mg 
10000 
(0.5) 
Scheme 4.2.3 Concentration of P388 Cytotoxicity in Foveaux 
Strait Oysters 
Each fraction showed distinctly different chromatographic profiles. 
Fraction 4.J3 (Scheme 4.2.2) was extracted into water, eluted late off 
C18 reverse phase, eluted early off silica and late off LH-20, suggesting 
a small non-polar compound. Fraction 4.M10 (Scheme 4.2.3) was 
extracted in non polar solvents, partitioned into hexane, eluted late off 
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silica, streaked on reverse phase C18 and eluted very late off diol. This 
suggested a compound that is reasonably polar, but able to be extracted 
as a micelle in non-polar solvents, therefore likely to contain a non-
polar backbone. Fraction 4.01 (Scheme 4.2.3) was extracted in non 
polar solvents, partitioned into hexane, eluted early off an initial silica 
column, but late off a subsequent silica column. The bioactivity eluted 
with medium polarity solvents off reverse phase C18 and came off LH-
20 early. This suggested a compound with possible acid or basic 
functional groups, of moderate polarity and medium-large size. These 
significantly different chromatographic profiles suggested three 
separate compounds and NOT an artifact of the overlapping of the 
same compound into the three fractions. 
The 1 H NMR spectra of each cytotoxic fraction did not yield further 
evidence of structural type. This was a consequence resulting from the 
low mass of each fraction and complexity of the spectra. 
The three concentrated active samples were analysed in the mouse 
bioassay and in the neuroblastoma assay (N2A). None of the three 
samples gave rise to mouse deaths at the assayed concentrations. This 
suggested either the levels were too low and/or the cytotoxicity was not 
caused by the same compound causing NSP toxicity in mice. Although 
all three samples exhibited mild cytotoxicity towards the N2A cell line, 
no evidence of any B TX -like effect was observed. 
The results illustrated the necessity for the extraction of more oysters 
and closer initial monitoring by the mouse bioassay. 
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This second extraction of frozen oysters was achieved with methanol 
and 80% methanol/water. The extracts were combined and desalted on 
a large C 18 reverse phase column. The oysters were then re-extracted 
three times with dichloromethane and when combined with the desalted 
methanol extract, afforded a total lipid extract. 
An aliquot of this lipid extract was partitioned on diol phase, yielding 
sixteen fractions, designated 4.Pl - 4.P16. The P388/mouse bioassay 
results (Fig 4.2.1) showed clearly that the cytotoxicity and mouse 
toxicity were NOT caused by the same compound(s). 
100 
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Fig 4.2.1 Graph Showing P388 Cytotoxicity and Mouse Deaths of 
Fractions off a Dial Phase Column 
P388 cytotoxicity (u) = mass (mg)IICs o (nglmL) x Jo4 
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The emphasis of work shifted from that of P388 cytotoxicity directed 
isolation to mouse toxicity directed isolation. 
4.2.1 Isolation of Gymnodimine 
At this time it was revealed that Professor Yasumoto's research group, 
at Tohoku University in Japan, had performed a mouse toxicity 
directed isolation using an "in house" mouse bioassay. They had 
discovered the toxic component and tentatively named it 
"gymnodimine". The structure had not been solved, yet it was revealed 
that the toxin was a nitrogen containing macrocycle. 79 
Consequently, the use of Dragendorff's reagent85 for the staining of 
TLC analyses was adopted. Dragendorff's reagent is a TLC developing 
spray that is selective for nitrogen containing compounds. A positive 
response is a dark orange colour on a light orange background. 
When a TLC of fractions 4.P1 - 4.P16 was re-run and sprayed with 
Dragendorff's reagent, two orange spots could be detected. Fractions 
4.P9 - 4.P12 had an orange spot at Rf = 0.32 and fractions 4.P13 -
4.P14 had an orange spot at Rf = 0.27. The mouse toxicity in fraction 
4.P13 and mouse neurotoxic symptoms in 4.P14 appeared to 
correspond with the orange spot at Rf = 0.27 (Fig 4.2.2). 
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solvent front c::::::> 
solvent= 5 % methanol in dichloromethane 
Rf=0.32- ............ 
Rf=0.27-
zero point c::::::> 
4.P9 4.PIO 4.Pil 4.PI2 4.PI 3 4.Pl4 
Fig 4.2.2 Stylised Picture of TLC Chromatograph of Fractions 4.P9 
- 4.Pl4 
The nitrogen atom in the molecule allowed the use of weak cation 
exchange chromatography, such as CBA (CarBoxylic Acid) bonded 
silica phase, for quick purification. Fraction 4.P 13 was 
chromatographed on a CBA column and the fractions analysed by TLC, 
using Dragendorffs reagent. The fraction that eluted at 0.5% NH3 in 
methanol contained the orange spot. LREIMS (Low Resolution 
Electron Impact Mass Spectrometry) of this fraction gave a molecular 
ion at m/z 507.3, which is the correct mass for gymnodimine.79 
At this point further quantities of gymnodimine were required for 
structural elucidation and other work, including hapten design and 
syntheses (see Section 5.3). The low levels of gymnodimine in the 
oysters (ca. 1 mg per kg of shellfish tis ue) forced the development of a 
rapid, efficient and cost effective extraction/isolation procedure for 
gymnodimine. This work is detailed in Section 5.5 . 
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4.2.2 "Slow Acting" NSP Toxicity 
While searching extracts for gymnodimine, certain side fractions 
exhibited death times of up to 4.5 hours in the mouse bioassay. The 
long death times and symptoms of gasping, prostration and hind leg 
paralysis were not expected as for those caused by gymnodimine. 
A fraction demonstrating these long death times was passed through a 
diol phase column, fractions 4.Q1 - 4.Q4 collected (Scheme 4.2.4) and 
aliquots sent for mouse bioassay. 4.Q1 - 4.Q3 all had short 
"gymnodimine" death times, whereas 4.Q4 had a death time of around 
four hours. 
4.Q4 was further chromatographed on a C18 reverse phase column to 
give fractions 4.R1 - 4.R8 (Scheme 4.2.4) of which aliquots were sent 
for both mouse bioassay and N2A assay. 
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oysters (freeze dried) 
n extraction with MeOH/DCM pet. ether 
n 80% MeOHIH20 
n concentrate to H20 H20 
n EtOAc llg 
diol 
350 350 300 500 
50%DCM/PE 75% DCM MeOH 
4.Ql 4.Q2 4.Q3 4.Q4 
6310 mg 840mg 680mg 3190mg 
gymnodimine 
C18 
I 
200 200 200 200 200 200 200 200 
50% Me0H/H20 60% 70% 80% . 90% MeOH 50%DCM DCM 
I I I I I I 
4.Rl 4.R2 4.R3 4.R4 4.R5 4.R6 4.R7 4.R8 
775mg 632mg 152mg 149mg 320mg 269mg 204mg 104mg 
gymnodimine "BTX" 
For Legend See Scheme 4.2.2 
Scheme 4.2.4 Isolation Scheme for "Slow Acting" NSP Toxicity 
The results are summarised in Table 4.2.1. These demonstrate that the 
longer death times seen in 4.R6 and 4.R7 also correspond with BTX 
like activity. 
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Table 4.2.1 Table of Mouse Deaths and "BTX" Activity of 
Fractions off Cl8 Reverse Phase Column 
Fraction Mouse Deaths ng "BTX" in 1 mg 
(minutes) 
4.R1 <150 
4.R2 58 <150 
4.R3 9 <150 
4.R4 17 200 
4.R5 * <150 
4.R6 105 310 
4.R7 134 130 
4.R8 t <150 
* Sample lost in transit 
t death time 6 - 24 hours 
Once the dilution of gymnodimine was below the "critical threshold", 
extremely low (0.031 %) levels of BTX-like compound(s) were 
revealed. These levels were not picked up earlier due to a "masking 
effect" of mouse toxicity caused by gymnodimine. 
The low levels of "BTX" were well below the regulatory limit of 20 
!lgll 00 g shellfish, and supported the subsequent ELISA data of 
Garthwaite et al,74 demonstrating low levels of BTX in these shellfish. 
The low levels of BTX-like material did not warrant further 
investigation. 
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4.3 Conclusions 
Three samples of concentrated cytotoxicity (against P388) were isolated 
from oysters harvested from Foveaux Strait during the early 1994 
outbreak of NSP toxicity. The identification of the cytotoxic 
compounds in these samples was not able to be achieved due to the low 
mass amounts involved. These samples exhibited no measurable 
toxicity in the mouse bioassay and hence not considered a public health 
ISSUe. 
The toxin responsible for NSP toxicity in mice was isolated as part of 
this research, however the structure was published independently by 
Professor Yasumoto's research group, in Japan. The toxin was named 
gymnodimine. 79 
Low levels of "brevetoxin (BTX)-like" compounds was discovered 
from these shellfish. The levels were well below regulatory limits. 
Chapter Five 
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5. 1 Introduction 
Gymnodimine ( 40) was isolated from Foveaux Strait oysters, Tiostrea 
chilensis and identified as the biotoxin responsible for the acute NSP 
symptoms in mice. The gross structure of gymnodimine was published 
by Seki et al, 67 however structure elucidation studies were also carried 
out as part of this research and are described in Section 5 .2. 
The absolute stereochemistry of gymnodimine was elucidated by 
chemical modification and X-ray crystal structure analysis. In 
addition, examination of differences between solid state and solution 
state conformations of gymnodimine were carried out. This work is 
described in Section 5.3. 
0 0 
- ~ N 
0 
gymnodimine ( 40) 
Rodent feeding trials of gymnodimine revealed that it was not toxic 
orally 74 and hence, not considered a public health problem. The potent 
toxicity observed by injection of gymnodimine into mice presents a 
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problem for monitoring of other lipid soluble "human toxic" toxins, 
presently monitored by the mouse bioassay, eg. brevetoxins. 
In the routine monitoring of gymnodimine in shellfish samples by the 
mouse bioassay, two parallel extractions are undertaken; the New 
Zealand acetone extraction, 7 5 and the APHA ether extraction. 7 5 
Shellfish showing positive results in the acetone extraction method are 
assayed using the ether extraction method. Positive results in the ether 
method suggest toxin(s) other than gymnodimine present in the 
shellfish. As a result, the APHA ether extraction method is currently 
used to regulate against gymnodimine. Although this method is 
currently the chosen procedure for regulation against gymnodimine it 
has two problems associated with it. The first is that occasional "false 
positives" occur when high levels of gymnodimine are present in the 
shellfish. This leads to unnecessary closure of commercial shellfish 
beds. The second problem is that the APHA method does not screen 
for toxins of low lipid solubility, such as the brevetoxin conjugates, eg. 
BTX-B1 (41). 
Furthermore, acceptance of the mouse bioassay as a method of shellfish 
testing, is diminishing worldwide, for ethical reasons. Tolerance for 
the assay has ebbed to the point where some countries will soon no 
longer accept shellfish imports that have been tested on live animals. 86 
As a result, alternative methods of toxicity testing are being developed. 
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Me 
BTX-Bl (41) 
As part of the development of new toxin specific assays, research into 
two new assays for specific detection of gymnodimine in shellfish was 
undertaken. 
The synthetic modification of gymnodimine haptens, suitable for 
linkage to proteins, is the initial step for the development of a 
gymnodimine-specific ELISA. The further development of the ELISA 
for gymnodimine is a research objective of AgResearch at Ruakura, 
Hamilton, New Zealand. The design and synthesis of gymnodimine 
haptens suitable for an ELISA is described in Section 5.4. 
A chromatography/HPLC based assay for specific detection of 
gymnodimine in shellfish was another assay developed as part of this 
research and is described in Section 5.6. 
All the research described above required milligram quantities of pure 
gymnodimine. The low levels of the toxin in the shellfish required that 
an efficient large scale extraction and isolation procedure be developed 
to achieve sufficient quantities of the toxin. Such a method for the 
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large scale isolation of gymnodimine has been developed and ts 
described in Section 5.5. 
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5.2 Structure Elucidation of 
Gymnodimine 
5.2.1 Partial Structure Elucidation of 
Gymnodimine 
LREIMS on a pure sample of gymnodimine (40) revealed a molecular 
ion mlz 507.3. Subsequent accurate mass measurement, under high 
resolution conditions, afforded mlz 507.3343, corresponding to 
C32H45N04. 
Numerous NMR techniques were applied on the pure toxin to elucidate 
the connectivity and hence the structure. The methods employed were 
lH and 13C NMR, along with 2D COSY, HMQC and HMBC 
experiments. 
The lH NMR spectrum of gymnodimine (Fig 5.2.1), revealed four 
resonances in the region 8 5 - 7, each corresponding to 1 proton. In 
addition, signals in the region 8 3 - 4.2 accounted for a further six 
protons. The majority of the signals, however, lay in the region 8 1 -
2.5, suggesting a predominantly aliphatic compound. Four intense 
singlets in the region 8 1.5 - 2 were suggestive of vinyl methyl groups 
and an intense doublet at 8 1.07 indicated an extra aliphatic methyl 
group, attached to a methine. 
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The 13C NMR spectrum revealed clusters of peaks in the regions B 10 -
22 , B 29 - 38 and B 75 - 90. The chemical shifts of these clusters are 
indicative of methyl, methylene and ether-type carbon atoms 
respectively. Most signals in the region B 100 - 180 were not visible 
above the noise, due to the low amount of material. Carbon resonances 
in this region were detected in the HMQC and HMBC pectra. 
Based on the lD NMR data and 20 NMR techniques, three separate 
fragments could be postulated. 
..t\IV'VVV'VV" 
I 
Observed Correlation 
-
HMQC 
HMBC 
COSY 
..t\IV'VVV'VV" 
I 
Fig 5.2.2 Proposed Fragment 1 of Gymnodimine Obtained By NMR 
Experiments 
Fragment 1 (Fig 5.2.2) wa propo ed in the£ llowing manner: 
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A COSY experiment revealed vicinal coupling from the proton at 8 
6.89 to a resonance at 8 5.80 and long range allylic coupling to 8 1.94, 
one of the vinyl methyls. An HMQC experiment showed lJcH 
correlations of 8 6.89/146.8, 5.80/80.4 and 1.94/10.7, allowing 
assignment of these carbon chemical shifts. An HMBC experiment 
revealed 2JcH and 3JcH correlations from the vinyl methyl at 8 1.94 to 
carbon atoms at 8 130.2, 174.5 and 146.8. As the carbon chemical 
shift at 8 174.5 is indicative of an ester functionality, the vinyl methyl 
was placed on the quaternary carbon at 8 130.2. 
The proton/carbon chemical shifts at 8 5.80/80.4 are indicative of a 
methine ester carbon. HMBC correlations from this proton revealed 
resonances at 8 146.8, 132.5, 124.7 and 130.2. The resonances at 8 
124.7 and 132.5 were assigned as quaternary alkene carbon atoms (due 
to the absence of any lJcH correlations in the HMQC spectrum). One 
of these carbon atoms was evidently adjacent to the carbon at 8 80.4. 
Due to the presence of other unrelated oxygenated carbon atoms and 
the mass requirement of 4 oxygen atoms in the molecule, it was only 
possible to accomodate one ester functional group in the molecule. The 
carbon resonances at 8 174.5 and 80.4 were thus linked through a 
cyclic a,~-unsaturated y-lactone. The absence of an HMBC correlation 
from 8 5.80 to 8 174.5 was attributed to an unfavourable coupling 
optimisation for the experiment (lNXH = 8.3 Hz was used). 
The HMQC spectrum revealed the lJcH correlation of 8 1.67/16.8. 
These chemical shifts are indicative of a second vinyl methyl. The 
HMBC spectrum revealed three correlations from this methyl to carbon 
atoms at 8 132.5, 124.7 and 46.1. These data established that the 
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methyl, and the carbon at 8 46.1, were part of a tetra-substituted 
double bond. The attachment of the methyl group was assigned to 8 
132.5 based on chemical shift arguments. This assignment could not be 
made unequivocally, due to the absence of an HMBC correlation from 
8 6.89 to either of these olefinic carbon atoms. Again, the absence of a 
correlation was attributed to unfavourable coupling optimisation in the 
HMBC experiment. The resonance at 8 46.1 was shown by the HMQC 
spectrum to be a methine carbon, with the attached proton at 8 3.63 . 
No HMBC correlations were observed from this methine proton, 
preventing further extension of the fragment. 
Collation of the above data led to the proposal of Fragment 1, as shown 
in Fig 5.2.2. 
possible linkage c==> 
site to Fragment 1 
1.80 
Observed Correlation 
HMQC 
HMBC 
COSY 
Fig 5.2.3 Proposed Fragment 2 of Gymnodimine Obtained By NMR 
Experiments 
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Fragment 2 (Fig 5.2.3) was proposed as follows: 
The olefinic doublet positioned at 8 5.26 was coupled to a carbon at 8 
126.7, as shown by the HMQC spectrum. A long range COSY 
correlation from this proton was observed to a three proton resonance 
at 8 1.80, which had an HMQC correlation to 8 11.5. This identified 
the third vinyl methyl. The HMBC spectrum revealed 2JcH & 3JcH 
correlations from this methyl group to 8 139.6, 126.7 and 79.2. From 
the chemical shifts of the three carbon atoms, it was clear that the 
methyl was attached to the carbon at 8 139.6. 
The carbon resonance at 8 79.2 was shown to have a corresponding 
proton at 8 4.00. The chemical shift of this proton suggested an 
oxygenated carbon. The COSY spectrum showed a correlation from 8 
4.00 to two protons at 8 2.06/1.64. The HMQC spectrum revealed that 
these two protons were probably bonded to the same carbon at 8 31.7. 
These data were confirmed by an HMBC correlation from 8 4.00 to the 
carbon at 8 31.7. No other 2JcH or 3JcH correlations were observed 
from 8 4.00 in the HMBC spectrum. 
The doublet at 8 5.26 showed a strong COSY correlation to a proton at 
o 3.63. There is a methine proton at 8 3.63 at the terminus of 
fragment 1 (Fig 5.2.2). This suggested a link between the first 
fragment and the second fragment. This was discounted by the absence 
of any HMBC correlations to/from the 8 5.26/126.7 and 8 3.63/46.1 
positions. It was possible that the coupling observed from 8 5.26 was 
to a proton of identical resonance on another part of the molecule. 
This was supported by the integral. The peak at 8 3.63 is broad and 
integrates for three protons. Hence fragment 2 was treated 
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independently from fragment 1 until further structural information was 
obtained. 
Collation of the above data led to the proposal of fragment 2, as shown 
in Fig 5.2.3 . 
1.40 
H 
\ 
14.6 C 
H; I'H 
H 
1.5 1 
37.6 H~ \S 20.2 
H ---- C-H 
3.95 I \ 
H H 
1.07 
Observed Correlations 
-
HMQC 
HMBC 
COSY 
Fig 5.2.4 Proposed Fragment 3 of Gymnodimine Obtained By NMR 
Experiments 
Fragment 3 (Fig 5.2.4) was proposed in the following way: 
The proton resonances at () 4.08 and 3.95 are indicative of methine 
protons attached to ether type carbon atoms. Their respective carbon 
atoms were revealed by the HMQC spectrum as () 77.8 and () 89.5. 
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These oxygenated methines were shown to be attached via an ether 
linkage by the HMBC correlation from 8 3.95 to 8 77.8. 
The doublet methyl at 8 1.07 was shown to have a carbon resonance at 
8 20.2 by an HMQC experiment. HMBC correlations were observed 
from these methyl protons to carbon atoms at 8 89.5 and 8 37.6. The 
proton resonance on the carbon at 8 37.6 was established by the HMQC 
spectrum as 8 2.17. Attachment of the methyl on this carbon was 
confirmed by a COSY correlation between 8 1.07 and 8 2.17. In 
addition, a COSY correlation between 8 2.17 and 8 3.95 gave the 
connectivity between these two methines. 
The lack of a third HMBC correlation from the methyl 8 1.07, could 
best be explained by there being two virtually identical carbon 
resonances within three bonds of the methyl protons. A close 
inspection of the 13C NMR spectrum around this carbon chemical shift 
region, revealed resonances at 8 37.6 and 8 37.3. Analysis of the 
HMQC spectrum revealed the resonance at 8 37.3 had two protons 
attached at 8 1.55 and 8 1.48. 
The data above was best explained by a five membered ether ring. 
Further data in support of this was a COSY correlation between 8 4.08 
and 8 1.48. 
Vicinal COSY coupling between 8 4.08 and 8 1.13 suggested linkage of 
a methine group off the five membered ring at this position. However, 
the HMQC spectrum showed lJcH correlations from 8 1.13 and 
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another proton at o 1.40, to a single carbon atom at o 32.5. This 
established a methylene attachment to the five membered ether ring. 
The substitution at the o 3.95/89.5 position of the five membered ring 
required further analysis. HMBC correlations from o 3.95 were 
observed to carbon atoms at o 134.9, 123.6, 37.6 and 20.2. The carbon 
chemical shift at o 123.6 was characteristic of an olefin and its proton 
resonance established as o 5.00 by the HMQC spectrum. From 
chemical shift requirements, the carbon at o 134.9 was likely to be the 
linkage point of the fourth vinyl methyl. This was confirmed by 
HMBC correlations from the fourth vinyl methyl proton at o 1.51 to 
carbon atoms at o 134.9, 123.6 and 89.5. The key 3JcH correlation of 
o 1.51/89.5 indicated that the double bond was directly attached to the 
ether ring. 
No further correlations, which would expand Fragment 3, could be 
obtained from the available data. Collation of the above data led to the 
proposal of Fragment 3 (Fig 5.2.4). 
While this work was in progress, the gross structure of gymnodimine 
was published by Seki et al. 67 The partial fragments described above 
were compared with the published structure of gymnodimine. The 
fragments showed very close correlation to the published structure (Fig 
5.2.5). 
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The parts of the molecule not assigned here were predominantly 
methylene groups. From the NMR data obtained, it was not feasible to 
assign these signals on the small amount of material available. This was 
largely due to the complex coupling, broadness of peaks and the close 
chemical shifts of methylene protons. Hence, weak correlations and 
extensive overlap of methylene signals were observed. To resolve this 
a larger sample was required. 
5.2.2 Complete Structural Assignment of 
Gymnodimine 
Various significant differences were identified between the observed 
and published NMR data, presumably as a direct result of the different 
solvents used in acquisition of NMR spectra. The spectra in Section 
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5.2.1 were run in CDC13, with a trace amount of triethylamine (TEA), 
whereas published data was obtained from NMR spectra run in d5-
pyridine. On procurement of more toxin, the complete structural 
assignment was achieved by the combination of a direct comparison 
with literature NMR data and the use of the 1D and 2D NMR 
techniques, as outlined in Section 5.2.1. In addition, 2D TOCSY 
experiments were used to detect proton/proton couplings throughout 
entire spin systems. 
Furthermore, the addition of trifluoroacetic acid (TF A) to the sample, 
produced significant salient changes in the NMR spectra of the toxin 
(Fig 5.2.6). 
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(a) 
7 6 5 4 3 2 1 ppm 
(b) 
7 6 5 4 3 2 1 ppm 
Fig 5.2.6 Proton NMR Spectra for (a) Free-Base and (b) Acidified 
Gymnodimine 
It was postulated that a pH dependant imine/enamine tautomerism may 
be occurring in the molecule. The possibility of an imine/enamine 
tautomerism had also been suggested by Seki et al. 67 
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The complete NMR assignment of both forms of gymnodimine was 
necessary for future stereochemical/conformational analysis of the 
toxin. This would be achieved by a combination of NOE and 
molecular modelling techniques. 
On application of the NMR techniques, described above, full 
assignment of the free base form and near complete assignment of the 
salt form of gymnodimine was achieved (Table 5.2.1). 
The significant differences between the chemical shift data for the 
published and observed data, of the free-base form of gymnodimine, 
are for atoms in proximity to the hydroxyl and imine functional groups 
(Fig 5.2.7). These data suggest pH dependent conformational changes 
in the molecule, and so providing a rationale for conformational 
modelling of gymnodimine. 
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Table 5.2.1 13 C and 1 H NMR Assignments for Gymnodimine As 
Published (Pb),+ Free Base (Fb)¥ and Salt Form (Sf)oo 
# Pb Pb Fb Fb Sf Sf 
13C lH 13C lH 13C lH 
1 174.9 174.5 170.9 
2 129.8 130.2 130.9 
3 148.4 7.09 146.8 6.89 146.2 6.89 
4 80.9 5.90 80.4 5.80 79.8 5.80 
5 124.8 124.7 125.6 
6 133.7 132.5 131.4 
7 46.2 3.56 46.1 3.63 46.0 3.78 
8 126.1 5.32 126.7 5.26 123.7 5.22 
9 141.1 139.6 142.6 
10 79.4 4.33 79.2 4.00 78.2 4.03 
11 32.9 2.53 31.7 2.06 2.05 
2.00 1.64 
12 35.0 1.42 32.5 1.40 
1.13 
.13 78.0 4.12 77.8 4.08 77.7 4.09 
14 38.9 1.76 37.3 1.55 37.3 1.54 
1.46 1.48 
15 37.7 2.15 37.6 2.17 37.6 2.29 
16 89.4 4.08 89.5 3.95 89.6 3.97 
17 133.9 134.9 142.6 
18 125.9 5.42 123.6 5.00 116.7 4.75 
19 22.4 2.73 21.8 2.48 3.05 
2.04 2.05 3.01 
20 31.4 2.55 31.0 2.49 3.05 
2.46 2.49 2.36 
21 171.4 174.0 
22 41.3 41.6 
23 33.6 1.67 33.6 1.75 
1.32 1.51 
24 19.6 2.01 19.2 2.06 
1.55 1.53 
25 10.6 1.95 10.7 1.94 10.7 1.96 
26 16.8 1.65 16.8 1.67 16.4 1.71 
27 10.9 2.05 11.2 1.80 11.5 1.86 
28 20.2 1.01 20.2 1.07 19.9 1.09 
29 14.5 1.53 14.6 1.51 14.5 1.54 
30 26.3 1.79 26.2 1.94 
1.34 1.47 
31 20.9 1.47 20.4 1.52 1.85 
32 50.1 3.66 49.6 3.55 46.0 3.78 
3.39 3.40 3.78 
:j: Spectra mn in d5-pyridine on 500 MHz machine 
¥ Spectra mn in CDCI3 with trace of triethylamine at 75/300 MHz (13ct1H) 
00 Spectra mn in CDCI3 with trace of trifluoroacetic acid at 7 5/300 MHz ( 13ct 1 H) 
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Fig 5.2.7 (a) 13C and (b) lH NMR Chemical Shift Differences 
Between Published ( Pb) and Free-Base ( Fb) Data for Gymnodimine 
The suggested enamine form of gymnodimine (Fig 5.2.8) would be 
characterised by an extra olefinic hydrogen atom. The lack of extra 
138 
Chapter Five - Gymnodimine 
olefinic resonances 1n the proton NMR spectrum of acidified 
gymnodimine (Fig 5.2.6(b)), gives strong evidence that the 
imine/enamine tautomerism is not a predominant process in 
gymnodimine. The changes observed in the NMR spectra, as a result 
of decreased pH, is evidently caused by the formation of an iminium 
lOll. 
0 0 
0 0 
- ~ N 
v 
imine 
enamine 
H 
'/ 
- NH 
v 
Fig 5.2.8 Postulated pH Dependant Imine/Enamine Tautomerism of 
Gymnodimine ( Seki et al) 
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The differences between the NMR spectral data of the free-base and salt 
forms of gymnodimine are shown clearly in Fig 5.2.9. 
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Fig 5.2.9 13C (a) and iH (b) NMR Chemical Shift Differences 
Between Free-Base (Fb) and Salt-Form (Sf) Data for Gymnodimine 
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5.3 
5.3.1 
Absolute Stereochemistry 
Gymnodimine 
Possible Methods 
of 
The proposed strategy for the elucidation of the absolute 
stereochemistry of gymnodimine (40) consisted of two possible 
methods. 
14 
11 
25 10 28 
26 9 29 
Q,,, ,,, 
16 
8 ~ 27 
0 
gymnodimine (nno) 
First Approach 
The first approach involved a three step procedure: initially NOB and 
NOESY experiments would give data on approximate proton-proton 
distances. By using the approximate distance information, in 
conjunction with a molecular dynamics program, such as the ConGen 
procedure, 87 relative stereochemical data could be obtained. The 
absolute stereochemistry could then be elucidated by attachment of 
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anisotropic shift reagents, such as the (R) and (S) enantiomers of 
MTPA (49)(50) or similar analogues, to the hydroxyl group in 
gymnodimine. 
F3C ''''''OMe C02H 
F3C ''''''C02H 
OMe 
(R)-MTPA (49) (S)-MTPA (50) 
·Two inherent problems were associated with this method of 
stereochemical analysis. These were: measurement of proton-proton 
distance approximations by NOB and NOESY experiments is vital to 
the success of this method. Slow conformational changes in the 
molecule caused broadening of the proton NMR signals, especially for 
methylene protons, making some distance assignments impractical. 
Furthermore, the stereogenic carbons C4 and C22 are remote from 
others in the molecule. The remoteness of these centres would be 
likely to cause difficulties in obtaining distance information, by NOB 
arguments. These considerations are a contributing factor to the 
unlikely success of this approach. 
The second major problem involved the attachment of a anisotropic 
shift reagent to the hydroxyl group. Exploratory work revealed that 
the hydroxyl group was not amenable to acylation reactions, 
presumably as a result of steric hindrance. In addition, while 
attempting to acylate the hydroxyl group it was observed that the 
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gymnodimine itself was degrading. This degradation of the molecule 
was attributed to the instability of the imine. 
The use of such empirical methods, using the like of MTP A, can also 
occasionally give erroneous results. One such example is sipholenol A 
(51). 88 Unreliable results were obtained by this method. This arose as 
a consequence of steric hindrance around the secondary alcohol, 
leading to significant conformational changes associated with the 
MTP A ester. As a consequence, the predictive power of the Mosher 
method was lost. 
sipholenol A (51) 
Further research concluded that care must be taken in applying 
Mosher's method to secondary alcohols with the OH group located in a 
crowded environment. 89 
Second Approach 
The second strategy was to elucidate the stereochemistry by single X-
ray crystallography. For X-ray analysis to be successful a single 
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crystal must be grown. The growth of crystals suitable for X-ray 
analysis is often the limiting step in this approach. With gymnodimine, 
suitable crystals were not available as it was a non-crystalline 
compound. Furthermore, with no heavy atom in the molecule only the 
relative not the absolute configuration could be obtained. 
The enhancement of the crystallinity of a compound can often be 
accomplished by the attachment of a highly crystalline auxiliary. 
Specifically, the crystalline auxiliaries should contain either a 
stereogenic carbon atom of known chirality, or a heavy atom. The 
incorporation of a known stereogenic carbon atom will give conclusive 
proof of absolute stereochemistry, whereas the anomalous scattering of 
X-rays, on the heavy atom, serves as another method of absolute 
stereochemical elucidation. 
Crystal quality is usually the major complication for elucidation of a 
structure by X-ray crystallography. Poor crystal traits invariably lead 
to erroneous refinement models and consequently, ambiguous 
structural elucidation. Nevertheless, clarification of the 
stereochemistry is unambiguous when the refinement of the structure is 
acceptable. 
The second strategy, using X-ray analysis, was chosen due to a higher 
probability of success. 
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5.3.2 Strategy 
Preliminary work revealed the instability of gymnodimine to acid 
chlorides, presumably due to the high reactivity of the imine. 
Conversion of the imine to the more stable amine was seen as a way to 
circumvent this problem. However, formation of the amine by 
reduction adds a new stereogenic centre at C21. This creates an 
additional complication but it does generate a position where selective 
addition of a chiral auxiliary can occur. 
Two critical factors must be addressed before reducing the imine to the 
amine. Firstly, the reduction needs to be stereoselective with respect to 
the formation of the new stereogenic centre. Secondly, the reduction 
must effect only the imine group and not lead to the reduction of the 
other labile groups present in the molecule. 
The selection of NaCNBH3 fulfilled both these criteria. The cyano 
group increases selectivity for the imine as well as aiding in providing 
a highly stereoselective reduction. 
5.3.3 Reduction of Gymnodimine 
Reduction of gymnodimine with N aCNBH3 afforded the amine, 
hereafter referred to as gymnodamine (52). 
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28 
0 
gymnodamine (52) 
. 5.3.4 Spectroscopic 
Gymnodamine 
Assignment of 
LREIMS on gymnodamine revealed a molecular ion mlz 509.3, two 
mass units higher than gymnodimine. Subsequent measurement of the 
molecular ion, under high resolution conditions, afforded mlz 
509.3495, which corresponded to C32H47N04. 
NMR experiments employed to assign the structure of gymnodamine 
included lH, 13C COSY, TOCSY, HMQC, and HMBC. The low 
amount of material available resulted in poor data quality for the 13C 
based experiments, hence not allowing full NMR assignment of the 
structure. 
The lH NMR spectrum of gymnodamine (Fig 5.3.1) showed little 
difference to that of free-base gymnodimine (Fig 5.2.e(a)). Prominent 
chemical shift changes (Fig 5.3.1) were exhibited by H18 (8 0.45, 
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downfield), H32 (8 0.75/0.80, upfield) and H7 (8 0.71, upfield). 
Furthermore, coalescence of Me26 and Me29 to 8 1.60 was observed. 
The new proton resonance exhibited by H21 was inferred by chemical 
shift arguments, at 8 3.65. However, conclusive proof of this 
assignment was obtained by a TOCSY correlation from 8 5.45 (H18) to 
8 3.65. 
Experimental data for gymnodamine are contained in Section 6.5.3. 
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5.3.5 Formation of Crystalline Derivatives of 
Gymnodamine 
The potential of each of three auxiliaries, to form a crystalline product, 
was explored. The three compounds examined were p-bromobenzoyl 
chloride (PBBC, 53), p-bromobenzene sulfonyl chloride (BsCl, 54) 
and (1 S)-( + )-camphorsulfonyl chloride (CSCl, 55) 
Br Br 
O==S= 0 0.::::- 0 S.::::-Cl I c{ o Cl 
PBBC BsCl CSCl 
(53) (54) (55) 
Reaction of PBBC (53) with gymnodamine was achieved under 
anhydrous conditions. The reaction mixture was purified on diol 
HPLC, with one product only obtained. LRFABMS gave two 
molecular ions, mlz 692.3/694.3 (1: 1 intensity), showing the 
characteristic bromine pattern. This isotope pattern confirmed the 
attachment of just one p-bromobenzoyl group. 
The proton NMR spectrum of the product showed two doublets, at 8 
7.5217.19, arising from the aromatic protons. This too served to 
confirm the attachment of the p-bromobenzoyl group. The H10 proton 
resonance was still at 8 3.94, giving evidence for the absence of an 
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ester at this position and consequently, attachment of the auxiliary as 
the amide (56). 
0 0 
- N 
0 
Br 
p-bromobenzamide (56) 
The reaction between BsCl (54) and gymnodamine was carried out 
under anhydrous conditions. The organic soluble material from this 
reaction was analysed by proton NMR spectroscopy. The spectrum 
showed a proton resonance at 8 4.90, indicative of an ester functional 
group and suggestive of attachment of this crystalline auxiliary at both 
amine and hydroxyl groups. Subsequent purification on amino and diol 
cartridges afforded one product. A proton NMR spectrum of this 
product revealed the absence of the signal at 8 4.90, that had been seen 
in the reaction mix. Aromatic signals in the NMR spectrum verified 
the attachment of the p-bromosulfonyl group. LRFABMS was 
attempted on this fraction, however the molecular ion was not 
observed. 
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The reaction between (1 S)-( + )-camphorsulfonyl chloride (CSCl, 55) 
and gymnodamine was carried out under anhydrous conditions. The 
organic soluble material was purified on an amino cartridge and then 
analysed by proton NMR spectroscopy. The diastereotopic protons of 
CSCl were shifted upfield by around 0.8 ppm, suggesting successful 
coupling. Further purification on a diol cartridge was unsuccessful. 
No product could be discerned from any fraction off this cartridge. 
Evaluation of the three auxiliaries employed revealed that PBBC had 
been the most successful. The reaction/purification procedure was the 
simplest and the product formed was able to be identified conclusively. 
Furthermore, this material showed potential crystallinity, appearing as 
a white amorphous solid. 
The PBBC/gymnodamine reaction was repeated on a second batch of 
gymnodamine (8.0 mg). The organic soluble material was purified on 
diol HPLC, providing the pure p-bromobenzamide derivative (56), at a 
yield of 4.0 mg (37% ). 
5.3.6 Crystal Structure of p-Bromobenzamide 
(56) 
Recrystallisation of the amide (56) was successfully achieved from a 
50% CH2Cl2/benzene solvent mix, affording irregular shaped, 
transparent crystals. A single crystal, suitable for X-ray structure 
analysis, was separated from the bulk sample. 
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The data were collected using a Siemens P4 diffractometer. The 
structure of (56) was solved by direct methods (SHELXS-96). Of the 
4064 reflections obtained, 4007 were unique (Rint = 0.0221). These 
reflections were used in the full-matrix, least-squares refinement 
(SHELXL-96), after being corrected for absorption by using the psi-
scan method. Three check reflections were measured every 97 
reflections throughout the data collection. All hydrogens were inserted 
in calculated positions. Significant residual electron density was 
attributed to a benzene molecule, co-crystallised in the solid state. The 
absolute configuration was determined from the anomalous scattering 
of the bromine atom. Final conventional R factors were calculated for 
the absolute structure [/>20'(1)] R1 = 0.0360, wRz = 0.0376 and for the 
inverse structure, R1 = 0.0574. 
The perspective drawing of the refined crystal structure (Fig 5.3.2) 
shows all stereocentres precisely, from which the assignment of 4S, 7S, 
lOS, 13R, 15R, 16R, 21S, 22R could be made unequivocally. From 
this it follows that the absolute stereochemistry of gymnodimine is 4S, 
7 S, lOS, 13R, 15R, 16R, 22R. 
An ORD experiment on a sample of gymnodirnine revealed that it had 
the same sign of rotation to that published by Seki et al. 67 These data 
confirmed the absolute stereochemistry elucidated here applies also for 
the published toxin. 
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Fig 5.3.2 Perspective Drawing of Crystal Structure of (56) 
The asymmetric unit cell was found to contain four independent 
molecules. Inter-molecular hydrogen bonding from the hydroxyl 
proton was observed to carbonyl oxygen atoms in the lactone and 
amide functional groups. Fig 5.3.3 shows the packing orientation in 
the crystal lattice. 
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Fig 5.3.3 Packing Diagram of Crystal Structure (56) 
[Hydrogen atoms omitted for clarity] 
Crystallographic data are listed in Appendix 2. 
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5.3.7 NMR Spectral 
Bromobenzamide 
Assignment 
(56) 
of p-
LRFABMS gave molecular ions at mlz 692.3/694.3 ([M+H]+, as 
observed for the initial sample. Subsequent HRFABMS on the 692 ion, 
afforded an accurate mass of 692.2971, corresponding adequately to a 
molecular formula of C39H5oOsNBr. 
Numerous NMR techniques were utilised to gtve chemical shift 
assignments for (56). These NMR experiments included lH, 13C, 
COSY, TOCSY, HMQC and HMBC. 
The proton NMR spectrum of (56) (Fig 5.3.4) showed doubling of 
various peaks (in a ratio of approximately 3:1), attributed to two amide 
conformations. For ease of assignment, only signals belonging to the 
major amide conformation are reported. The majority of proton and 
carbon resonances were congruent with those observed for the amine 
(52) and so were assigned by direct comparison. 
The proton and carbon resonances of the p-bromobenzoyl group were 
assigned in the following manner: 
An HMQC experiment gave lJcH correlations for the aromatic 
doublets of o 7.52/131.8 and o 7.19/128.0. 2JcH and 3JcH correlations 
were observed from o 7.19 (H3 "/H7") to o 170.0 (C1 "), 135.6 (C2") 
and 123.5 (C5"), in the HMBC spectrum, providing full chemical shift 
assignment of this moiety. 
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The most notable changes in chemical shifts from the parent amine 
(52) were observed for atoms in proximity to the amide moiety. A 
new proton resonance at 8 4.50 (Fig 5.3.4) was assigned as H21 by 
chemical shift arguments. A lJcH correlation was observed from this 
proton to a carbon atom at 8 58.5. The TOCSY spectrum showed 
correlations from this proton to 8 5.38 (H18), confirming this 
assignment as H21. 
The spin system of H18-H21 was able to be assigned by a lD TOCSY 
experiment, using excitation at 8 5.38 (Hl8) and various mixing times. 
The proton resonances unravelled by the lD TOCSY, showed lJcH 
correlations to respective carbon atoms. 
The isolated resonance at 8 3.47 (Fig 5.3.4) showed geminal coupling 
to 8 2.97 in the COSY spectrum. These resonances were assigned as 
the H32 methylene protons. This was supported by the HMQC 
spectrum which correlated both these proton resonances to 8 42.3. 
Accurate chemical shift assignments could not be made for positions 
23/24, as chemical shift resolution of these methylenes could not be 
achieved. 
Collation of the NMR data gave an almost complete chemical shift 
assignment for the amide structure (Fig 5.3.5). 
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5.3.8 Conformational Studies on Gymnodimine 
and p-bromobenzamide (56) 
p-bromobenzamide (56) 
An analysis of proton-proton distances for the amide (56) in solution 
was achieved by a series of NOB experiments. The results from these 
selected enhancements (Fig 5.3.6) were compared with the 
proton/proton distances measured from the crystal structure of (56). 
These data provided arguments for conformational difference between 
the solid and solution states. The differences were particularly 
highlighted by two significant enhancements observed between protons 
with proton-proton distances greater than 3 A in the solid state (Fig 
5.3.6).90 
The differences between the conformations for the solid and solution 
states of (56) highlighted the necessity for modelling studies on this 
compound. 
The cartesian coordinates from the X-ray structure of the amide (56) 
were loaded into the Chem3D91 application and served as the basis for 
initial studies. 
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Fig 5.3.6 Selected NOE's for Amide (56) 
Geometry minimisation of (56), with the program Spartan,92 was 
achieved using the semi-empirical AMI model.93 The optimised 
structure produced by this minimisation is named GM-1 (Appendix 
Four). Analysis of the inter-proton distances of GM-1 revealed further 
anomalies with the NOE data. The proton-proton distances, already 
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0 • 
over 3 A for the crystal structure, mcreased even further, after 
minimisation. Furthermore, inter-proton distances of H8/Me26 and 
H13/Me28, initially at 2.835 A and 2.870 A respectively, increased to 
3.052 A and 3.400 A, following minimisation. These data suggested 
that the energy minimum found by the modelling program was a local 
minimum, and that other low energy conformations of the amide were 
likely. 
As a conformational picture of gymnodimine in solution, as opposed to 
the amide (56), was the desired result of this research, further 
conformational searching, or global minimisation techniques, were not 
employed for (56). The study of the conformation of gymnodimine 
was initiated by collection of inter-proton distance approximations in 
solution. 
Gymnodimine 
Analysis of proton-proton distances of gymnodimine, in solution, was 
achieved by selective NOE experiments. 
The observed NOE enhancements for gymnodimine were compared 
with the proton-proton distances acquired from the minimised amide 
structure GM-1. These data revealed that six of the observed NOB's 
were outside the 3 A threshold (Fig 5.3.7). In addition, three of these 
• 0 
showed very large proton-proton distances: H15/Me29 (3.902 A), 
H16/H18 (3.729 A) and H18/Me27 (4.029 A). 
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The molecular shape of the amide is significantly different to that of 
gymnodimine and hence does not provide an accurate model for 
conformational study. Consequently, a minimisation of gymnodimine 
was carried out using the coordinates of GM-1 as a starting point. 
rr., 
Cl) 
u 
c: o<t; o<: C!:S 
.... 
rr., ("f") ("f") 
..... Q v 1\ 
c: 
0 c ..-. .... 0 / .... I fr ' Cl) -
.... 
Vl ~ Q 
N ~ -0 
Fig 5.3.7 Selected NOE's for Gymnodimine 
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Gymnodimine was created in Spartan by modification of the GM-1 
structure. This was achieved by removal of the p-bromobenzoyl group 
and re-formation of the imine bond. Geometry minimisation of this 
structure, again using the AM1 model, gave a new optimised structure, 
GM-2 (Appendix Four). The heat of formation of GM-2 was 
calculated as -142.7 kcallmol. 
Measurement of proton-proton distances of GM-2 revealed closing of 
some of the unfavourable distances. Those distances still over the 3 A 
threshold included: H7/H8 (3.113 A), H8/H30eq (3.040 A), H13/Me28 
0 0 0 (3.497 A), H15/Me29 (3.737 A), H16/H18 (3.744 A) and H18/Me27 
. 0 (3.897 A). 
Constrained molecular modelling was employed as the next step. 
0 
Constraining of the six conflicting inter-proton distances to 2.5 A was 
achieved. The distance of 2.5 A was chosen as an arbitrary distance to 
attempt to "force" a conformational change of GM-2 to a global 
m1mmum. A geometry minimisation of GM-2 was employed, with 
these constraints, again using the AM1 model. The optimised structure 
produced by this minimisation is named GM-3 (Appendix Four). The 
heat of formation of GM-3 was calculated as 3.7 kcal/mol higher than 
GM-2. 
To attempt to create a non-constrained minimised model the constraints 
applied to GM-3 were removed. After removal of the distance 
constraints in GM-3, another AM1 geometry minimisation was carried 
out. The model produced by these calculations was assigned as GM-3a 
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(Appendix Four). The heat of formation of GM-3a was calculated as 
4.7 kcal/mollower than GM-3 and 1 kcal/mollower than GM-2. 
Measurement of inter-proton distances of GM-3a revealed that 
minimisation with constraints had succeed in closing three of the 
0 
conflicting distances observed in GM-2: H8/H30eq (1.922 A), 
0 0 • 
H15/Me29 (2.566 A) and H18/Me27 (2.507 A). However, the mter-
proton distances of H7/H8 (3.115 A), H13/Me28 (3.606 A) and 
H16/H18 (3.471 A) were still unfavourable. 
The above data and calculations suggest that gymnodimine may contain 
several conformers with similar energy levels. This would then 
account for the broadness of many proton signals in the 1 H NMR 
spectrum, as these conformations may be interchanging on a time-scale 
similar to that of the NMR observations. The conformational 
flexibility of the molecule presents difficulties in the analysis and 
interpretation of NOE data, due to averaging of the proton resonances 
in the NMR spectrum. 
Analysis of the preferred (lowest energy) conformations of 
gymnodimine would require much effort and time and comprises a 
separate topic in itself. Conformational searching on a molecule the 
size of gymnodimine would not guarantee a satisfactory result due to 
the many variables involved. Furthermore, for a molecule with the 
conformational flexibility of gymnodimine, the information gleaned 
from such a study would not in itself provide much further useful 
information on the conformations adopted by the molecule. 
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5.4 Design and Synthesis of 
Gymnodimine Haptens 
5.4.1 Design 
Three likely positions for attachment of a linker to gymnodimine ( 40) 
were considered possible (Fig 5.4.1). 
position A~ 
HO 
0 [) 0 
position B - ""' N u ~ position C 
Fig 5.4.1 Proposed Linkage Positions for Hapten Synthesis of 
Gymnodimine 
The hydroxyl group at position A (Fig 5.4.1) provided the most 
obvious linker point. However, previous attempts at derivatisation of 
this hydroxyl (Section 5.3.1) proved unsuccessful. The failure of the 
acylation was attributed to a probable steric hindrance around the 
hydroxyl group. Furthermore, degradation of the toxin suggested 
lability of the imine to standard acylation methods. 
Position B required the openmg of the butenolide (Fig 5.4 .1) . 
Butenolides are not normally amenable to opening under standard 
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conditions, although reagents such as (CH3)2AlNH294 and (CH3)3Sii95 
have been reported in the literature. However, the lability of the 
imine, suggests that success with these reagents would be unlikely. 
The imine (Fig 5.4.1) does not itself offer a direct position for 
attachment of a linker group. Fortunately, previous work revealed the 
ability to stereoselectively reduce the imine to the more stable amine 
(Section 5.3). The greater nucelophilicity of the amine over the 
hydroxyl group provides a regiospecific point of attachment at position 
C . Hence the amine provided a unique opportunity for linker 
attachment at position C and was judged the approach most likely to 
succeed. 
Linker groups examined for attachment were succinic semialdehyde 
(57) , succinic anhydride (58) and p-maleimidophenyl isocyanate 
(PMPI, 45) . 
0 
H 
Jl /'-._ .OH 1\ / "-/ I( 0~~0 
0 
(57) (58) 
0 
~N-o-N=C= O 
0 
(45) 
Both succinic semialdehyde and succinic anhydride provide linkers of 
identical chain lengths, although offer different linkage chemistries to 
the toxin. PMPI provides alternative linkage and conjugation 
chemistry to the first two linkers. The maleimide moiety of PMPI 
supplies selectivity for protein conjugation by binding to sulfhydryl (S-
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H) residues in those proteins via Michael addition to the maleimide 
group. 
5.4.2 Syntheses 
The reaction between gymnodamine (52) and succinic semialdehyde 
(57), in the presence of NaCNBH3 was carried out under anhydrous 
conditions. After work-up, the reaction mixture was chromatographed 
on a reverse phase C 18 column. The desired gymnodamine-amine 
linker (59) was isolated (64% yield). 
0 
,, 
- '''N 
0''2 
3' 
HO 0 
(59) 
LRFABMS on (59) afforded a molecular ion mlz, 596.2 [M+H]+. 
Subsequent measurement of the molecular ion, under high resolution 
conditions, afforded mlz 596.3965, corresponding to a molecular 
formula of C36H53N06. 
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The lH NMR spectrum of (59) contained an extra triplet at o 2.91. A 
1D TOCSY experiment, using excitation at this resonance, established 
that this resonance was part of the spin system H1'-H3', and confirmed 
the H2' and H3' resonances. These signals showed good chemical shift 
agreement with a model compound (60)(Fig 5.4.2) . 
. ,,
'N ON H ~ 1' 1' 2.85 H 
H 2' H 
2.40 2.15 
1.65 H H 
0 HO 0 
(59) (60) 
Fig 5.4.2 Proton Chemical Shifts for HI '-H3' Spin System of 
Gymnodamine-Amine Linker (59) and Model Compound (60) 
Experimental data for (59) and (60) are contained in Section 6.5.4. 
The reaction between gymnodamine and succinic anhydride (58) was 
performed under anhydrous conditions. After work-up, the reaction 
mixture was purified by reverse phase C 18 HPLC. The desired 
gymnodamine-amide linker (61) was isolated (21% yield). Recovery 
of gymnodamine (35% of starting mass) from the HPLC column 
revealed that the reaction had not reached completion. 
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0 
,,,,, 
- N 0 v 1'2' 
3' 
HO 0 
(61) 
LRFABMS on (61) afforded a molecular ion of mlz 61Q.2 [M+H]+. 
Subsequent measurement of the molecular ion, under high resolution 
conditions, afforded mlz 610.3741, corresponding to a molecular 
formula of C36Hs1N07. 
The lH NMR spectrum of (61) revealed an increased broadening of the 
majority of signals over those observed in the spectrum of 
gymnodamine. This suggested conformational changes between the 
cis/trans amide forms. A broad peak at o 2.58, equivalent to four 
protons, was at the correct chemical shift for the H2'/H3' protons. This 
was confirmed by synthesis of the model compound (62). Proton 
signals belonging to H2'/H3' of (62) were identified, in the lH NMR 
spectrum, at o 2.64/2.52 (Fig 5.4.3). Attachment of the linker at the 
amine, and not the hydroxyl group, was proven by an NOE experiment 
on (61). Selective irradiation at o 5.22 (H7), revealed an enhancement 
at o 3.96 (H10). This is the typical and expected chemical shift for this 
proton in this series. 
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(62) 
H 
2.64/2.52 
H 
0 
Fig 5.4.3 lH NMR Chemical Shift Positions of H2' and H3' of(62) 
Experimental data for (61) and (62) are contained in Section 6.5.4. 
· The reaction between PMPI ( 45) and gymnodamine was performed in 
a sealed glass NMR tube, under anhydrous conditions. Progress of the 
reaction was monitored by 1 H NMR at regular intervals. After 98 
hours, disappearance of the signals, for the phenyl protons on PMPI, 
signalled the completion of the reaction. Upon work-up, the reaction 
mixture was purified by reverse phase C18 HPLC. Two maleimide 
linker compounds were isolated. The major product (0.5 mg, 23% 
yield) was the gymnodamine-urea maleimide linker (63), while the 
minor product (0.25 mg, 9% yield) was the gymnodamine-di-
urea/carbamate maleimide linker (64). 
LRFABMS on (63) produced a molecular ion m/z, 724.4 [M+H]+. 
Subsequent measurement of the molecular ion, under high resolution 
conditions, afforded mlz 724.3990, which corresponded satisfactorily 
to a molecular formula of C43H53N307. 
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The lH NMR spectrum of (63) revealed a 2H singlet at 8 6.82. This 
was due to the symmetric maleimide protons. In addition, the doublets 
at 8 7.43 (J = 8.3) and 8 7.23 (partially obscured by CHC13 solvent 
peak), were assigned as the phenyl protons. 
ON" 9" 
4" "'\: 10" 
30::' ~ N 11" 
2" \ / S" 0 
// 6" 
O~NH 7, 
0 
0 0 
:: '''''NyO 
01'1 0 
NH 0 
(63) (64) 9' 10' 
The 1 H NMR spectrum of ( 64) revealed doubling of the male imide 
proton singlet (8 6.82/6.83), indicative of a di-linked product. 
Furthermore, an extra proton resonance at 8 5.45 was distinctive of a 
downfield shift of H10, due to a carbamate moiety at this position. 
LRFABMS was attempted on this sample, however the expected 
molecular ion was not observed. 
Experimental data for (63) and (64) are contained in Section 6.5.4. 
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5.4.3 Results 
The carboxylic acid haptens (59) and (61) were selected for 
developmental study. The similarity of each linker provided the type 
of molecules necessary for further progress. The maleimide linker 
(63) was not chosen, due to the size of the linker group. The success 
of the maleimide linker could be hampered by recognition of the linker 
itself, which can lead to possible cross reactivity in the assay. 
Further evidence for the unlikely success of the PMPI linker (63) was 
obtained from the minimised model of this molecule, GM-4 (Appendix 
4). AM1 minimisation could not be carried out as the limit for AM1 
semi-empirical minimisation is 100 atoms.92 The Sybyl force field was 
used. The model GM-4 (Appendix 4) clearly shows the maleimide 
linker folded back and close in space to the butenolide. This linker 
would deliver the toxin close in space to the conjugated protein and 
consequently reduce the chance of recognition of the toxin. 
In addition, modelling studies were carried out on the haptens (59) and 
(61), using an AM1 force field and Spartan application.92 The models 
produced were: gymnodamine-amine linker, GM-5 (Appendix 4) and 
gymnodamine-amide linker, GM-6 (Appendix 4). 
The models GM-5 and GM-6 (Appendix 4) show complementary 
conformations, with the carboxylic acid linker arms well removed 
from the body of the toxin. 
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Haptens (59) and (61) were sent to AgResearch for ELISA 
development. The subsequent results discussed in this section are those 
obtained by AgResearch. 
A gymnodimine antisera was raised against a sample of gymnodamine 
(supplied by Professor Yasumoto, Japan) conjugated to a glycoprotein 
via a Schiffs base. The antisera was raised by inoculation of the 
conjugate into sheep. 
Gymnodimine haptens (59) and (61) were conjugated separately to 
ovalbumin (OVA) to achieve two separate protein conjugates. These 
were tested as plate coaters for the selectivity of the gymnodimine 
antisera. 
The results (Fig 5.4.4) revealed selective binding to both conjugates. 
The binding was equivalent for each conjugate. These data reveal that 
neither the linkage sites or the proteins are recognised by the antibody. 
This is because a different protein was used to elicit the immune 
response from the one used as the plate coater. In addition, the amine 
and amide linkage chemistry of the haptens is significantly different to 
expect varying binding potentials if these were recognised. 
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Fig 5.4.4 ELISA Results for (a) (59)-0VA Conjugate and (b) (61)-
0VA Conjugate 
The indirect ELISA (Appendix 1) was used to assay authentic samples 
of gymnodimine and gymnodamine (prepared at Canterbury). 
Competition for the gymnodimine antisera was not observed for either 
toxin. These data suggest the antisera raised originally was not suitable 
for an ELISA. Consequently, at the time of writing, re-immunisation 
has been initiated at AgResearch, using the OVA conjugates prepared 
from (59) and (61). 
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5.5 
5.5.1 
Development of a Large Scale 
Isolation Scheme for Gymnodimine 
Introduction 
Gymnodimine ( 40) is a contaminant of shellfish due to accumulation of 
the toxin after filter feeding on the dinoflagellate, Gymnodinium cf. 
mikimotoi. Being a contaminant, the level of gymnodimine in shellfish 
is very low. 
0 
gymnodimine (40) 
The shellfish extracted during the preliminary investigation, yielded 
less than 1 mg of purified gymnodimine per kg of shellfish tissue, or 
alternatively, a yield less than 1 x 10-4% (wet weight). These low 
yields require the extraction qf large quantities of shellfish to obtain 
even modest supplies of gymnodimine. 
These problems are compounded further when the high lipid content of 
oysters and the lipid solubility of gymnodimine are addressed. 
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Purification of gymnodimine in the presence of the high amount of 
lipids is a complex exercise, especially when large scale work is being 
contemplated. 
5.5.2 Development of Protocol 
The preliminary work revolved around following a more "classical" 
approach to toxin isolation, as shown in Scheme 5.5.1. The oysters 
were freeze dried, to make handling of large quantities easier, then 
extracted with dichloromethane and aqueous methanol. An aqueous 
methanol vs hexane solvent partition removed abundant, non polar 
material, including triglycerides and steroids. Concentration of the 
aqueous methanol phase to water, followed by solvent partition against 
ethyl acetate, yielded the organic extract, 5.A(Et0Ac). 
5.A(hex) 
oysters (freeze dried) 
hexane 
n extraction with MeOH/DCM 
n 80% MeOH!H20 
5.A(M/W) 
n concentrate to H20 
n EtOAc 
5.A(Et0Ac) 
Scheme 5.5.1 Preliminary Extraction/Solvent Partition Scheme of 
F oveaux Strait Oysters 
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Mouse bioassays of the partitions gave some surpns1ng results. 
Gymnodimine is a lipid soluble toxin, however fraction 
5.A(H20)(Scheme 5.5.1) showed death times of 7.5 minutes, with 
typical gymnodimine symptoms, at approximately 80 MU/g of sample. 
Fraction 5.A(Et0Ac)(Scheme 5.5.1) showed varying death times of 7 
minutes, 4.5 hours, and 6 - 22 hours for three different mice. The 
short death times were characteristic of gymnodimine, whereas the 
long death times were subsequently found to be caused by low levels· of 
B TX -like material. 
These results suggested that gymnodimine was reasonably water 
soluble. The pH of fraction 5.A(H20)(Scheme 5.5.1) was checked and 
found to be 4.5. It is likely that formation of an iminium ion occurs at 
this acidic pH, hence making gymnodimine (more) water soluble. 
Fraction 5.A(H20)(Scheme 5.5.1) was adjusted to pH 8.5 with NaHC03 
and again partitioned with ethyl acetate. This ethyl acetate partition 
was analysed by TLC. On spraying with Dragendorff's reagent, 85 an 
orange spot was clearly visible at the same Rt as the reference material. 
Gymnodimine was subsequently purified from this fraction (Section 
6.5.5). 
The water solubility of gymnodimine in acidic conditions was 
advantageous for its purification, yet some material still appeared in the 
ethyl acetate phase. The use of dichloromethane, instead of ethyl 
acetate, was a likely alternative that needed to be examined. 
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. Extraction of a new batch of frozen oysters with methanol (at an 
effective concentration of 80% methanol/water) was used, followed by 
a dichloromethane vs acidic water solvent partition. The aqueous layer 
was made alkaline with NaHC03 and partitioned against ethyl acetate, 
as shown in Scheme 5.5.2. 
5.B(DCM) 
5.B(H20) 
n CBA cartridge 
5.C2 
oysters (frozen) 
DCM 
n extraction with MeOH 
n cone. to water 
n acidic water 
n pH raised to 8.5 
n EtOAc 
5.B(Et0Ac) 
n CBA cartridge 
5.D2 
Scheme 5.5.2 Second Extraction/Solvent Partition Scheme of 
F oveaux Strait Oysters 
Analysis of fraction 5.B(Et0Ac) by TLC showed the absence of an 
orange spot of gymnodimine when sprayed with Dragendorffs reagent. 
Sub-samples of 5.B(Et0Ac) and 5.B(DCM) were run through CBA 
cartridges and the 2% ammonia/methanol eluents analysed by TLC 
(Scheme 5.5.2). On spraying with Dragendorffs reagent, fraction 
5.C2 showed a distinct orange spot, however fraction 5.D2 did not. 
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This work suggested that the entire detectable amount of gymnodimine 
had partitioned in the dichloromethane phase and was in fraction 
5.B(DCM). This was unexpected, as dichloromethane is a less polar 
solvent than ethyl acetate. However, the superior solvating properties 
of dichloromethane over ethyl acetate are exhibited. 
This led to a search for a suitable alternative to ethyl acetate and 
dichloromethane. 
The low solubility of gymnodimine in ether was demonstrated by the 
APHA ether extraction96 procedure. With this knowledge, fraction 
5 .B (DCM) was dried and partitioned between ether and acidic water at 
pH 4.5. The acidic water phase was then made to pH 8.5 with NaHC03 
and partitioned against ethyl acetate, as summarised in Scheme 5.5.3. 
5.B(DCM) 
ether 
n 5.E(ether) acidic water 
H20/0H- n pH raised to 8.5 
5.E(H20) n EtOAc 
5.E(Et0Ac) 
Scheme 5.5.3 Improved Solvent Partition Scheme of Foveaux 
Strait Oysters 
Fractions 5.E(ether) and 5.E(Et0Ac) were both analysed by TLC with 
Dragendorff's reagent. Fraction 5.E(ether) showed no sign of any 
gymnodimine, however fraction 5 .E(EtOAc) showed an intense orange 
spot at the correct Rt. This suggested that use of the acidic water vs 
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ether solvent partition gave the necessary differentiation to concentrate 
gymnodimine by solvent partitioning techniques. 
Fraction 5.E(Et0Ac) was chromatographed further on CBA, (Scheme 
5.5.4) from which gymnodimine was eluted in fraction 5.F3. Analysis 
of 5 .F3 by TLC and 1 H NMR spectroscopy showed it to be of high 
purity. This was supported by analytical C18 reverse phase HPLC (Fig 
5.5.1) on this fraction which revealed gymnodimine as the major 
component. 
Fraction 5.F3 was subsequently chromatographed by Cl8 reverse phase 
HPLC (Scheme 5.5.4) to afford pure gymnodimine. 
5.E(Et0Ac) 
n 
CBAcolumn 
0.1% AcOH/90% MeOH/H20 MeOH 
5.Fl 5.F2 5.F3 
C18 hplc 
gymnodimine 
Scheme 5.5.4 Purification of Gymnodimine 
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Fig 5.5.1 HPLC Chromatogram of Fraction 5.F3 (Scheme 5.5.4) 
This new method enabled gymnodimine to be extracted and purified 
from 5 kg of oysters in just 1 week. The yield was 1 mg/kg of frozen 
shellfish tissue. The major advantage of this method is that by utilising 
the solvent partitions after extraction, the mass can be reduced 
substantially before any solid phase chromatography is required. The 
extract from 5 kg of shellfish tissue was concentrated to just 200 mg 
using these solvent partitions. 
The protocol was subsequently modified to include the more polar 
extraction solvent of 60% methanol/39% water/1% acetic acid for 
freeze dried oysters and 80% methanol/19% water/1% acetic acid for 
frozen oysters. The acetic acid was added to ensure acidic extraction 
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conditions and the difference in extraction solvents is due to water 
already present in the frozen shellfish. In addition, the preliminary 
solvent partition of dichloromethane vs acidic water was changed to 
dichloromethane vs alkaline water. The situation was complicated 
when the solution was saturated with NaHC03 to ensure alkaline 
conditions. Occasionally, emulsions formed between the two 
immiscible solvents. The protocol was modified again to include 
ammonia and NaHC03. The acidic solution was made neutral with 
ammonia, with sufficient NaHC03 added to ensure pH 8.5, but not 
saturation. This solved the problem of emulsions. 
The modified protocol was used on a 2 kg batch of freeze dried oysters 
(10 kg frozen). The extraction and solvent partitions are summarised 
in Scheme 5.5.5. 
5.G(basel) 
5.G(ether) 
5.G(base2) 
oysters (freeze dried) 
ether 
n extraction with 
"J 60% MeOH/39% H2011% AcOH 
n concentrate to H20 
"J pH 8.5 
n DCM 
5.G(DCM) 
n DCM removed 
n H20/H+ 
5.G(acid) 
n pH 8.5 
n EtOAc 
5.G(Et0Ac) 
Scheme 5.5.5 Modified Extraction/Preliminary Isolation Protocol 
for Gymnodimine 
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The protocol was very successful as gymnodimine was observed by 
TLC in fraction 5.G(DCM). The major advantage from using 
extraction solvents of high polarity, was that the weight of the final 
fraction 5.G(Et0Ac), was only 230 mg. 
The concentrating of gymnodimine completely into fraction 
5.G(Et0Ac), could be shown by HPLC analysis of fractions 
5.G(basel), 5.G(ether) and 5.G(base2). A gradient acetonitrile/water 
elution was used on an analytical C 18 reverse phase HPLC column. 
Analysis of each fraction, by comparison with authentic gymnodimine, 
was made using both UV max and retention time. The results established 
unambiguously that there was no gymnodimine in these three side 
fractions. 
5.5.3 Final Purification of Gymnodimine 
The high proportion of gymnodimine in fraction 5.G(Et0Ac)(Scheme 
5.5.5) provided the opportunity to use alternative methods of 
chromatography to CBA for the final purification stages. Preliminary 
results demonstrated that gymnodimine showed different characteristics 
on the dial phase, depending on whether it was in the free base or salt 
forms. 
Fraction 5.G(Et0Ac)(230 mg)(Scheme 5.5.5) was chromatographed on 
dial phase with gymnodimine eluting in one fraction at 80% 
dichloromethane/petroleum ether, at a weight of 48 mg. TLC analysis 
of this fraction revealed that gymnodimine was the most polar 
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compound in the mixture. The fraction was acidified with acetic acid 
and the protonation of gymnodimine checked by 1 H NMR 
spectroscopy. The 1 H NMR spectrum showed full protonation, with a 
shift of o 5.0 to o 4.7 ppm (Fig 5.2.6). 
The sample was then re-run through diol phase. This, however, was 
unsuccessful in removing impurities and was consequently eliminated. 
LH-20 gel permeation chromatography had already been attempted on 
an earlier sample as an alternative mild method. This again proved 
unsuccessful, with gymnodimine "streaking11 on the column and 
appearing in nearly every fraction collected. 
Attempts at using different HPLC phases were also variable in success. 
Cyano phase HPLC was unsuccessful using normal phase solvents of 
isopropanol/hexane, but did give good separation with reverse phase 
solvents such as methanol and water. However, the separation was 
associated with loss of material. The UV max for gymnodimine is at just 
215 nm, precluding the use of dichloromethane on diol phase HPLC. 
Diol phase HPLC was still attempted but using isopropanol/hexane 
mixtures. However, separation was unsuccessful. 
C 18 reverse phase HPLC was used using trifluoroacetic acid (TFA) and 
triethylamine (TEA) as polar modifiers in the water. Both modifiers 
were successful with 100% purity achieved. However, the suitability of 
this method was questioned as some loss of material occurred. 
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These results all demonstrated that no matter what phase was used for 
HPLC it was accompanied by some loss of material. . Hence, 
preparative HPLC should only be used when absolutely necessary. 
Repeating the protocol in Scheme 5.5.5 on a further 5 kg of frozen 
oysters yielded an extract of 298 mg (ethyl acetate phase). By 
chromatographing this fraction on diol phase, collecting smaller 
fractions and lowering elution strength, it was possible to concentrate 
all the gymnodimine with just one contaminant. 
The contaminant was established to be a fatty acid by 1 H NMR 
spectroscopy. This was successfully removed by passing the mixture 
through an amino phase column. This method resulted in the highest 
yield of pure gymnodimine (8.4 mg, 1.68xl0-4 yield, wet weight) when 
compared to previous methods. 
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5.6 
5.6.1 
Development of a Chromatography 
Based Assay for Gymnodimine 
Introduction 
The extremely efficient methodology that the large scale isolation of 
gymnodimine (40)(Section 5.5) was based on was modified to develop 
an assay specific to this toxin. The methods used in developing the 
assay were TLC, HPLC, and NMR spectroscopy. Incorporation of 
these techniques provided specific methods of detection. 
The assay requires several chromatographic steps of extractions and 
solvent partitions to achieve a partially purified extract suitable for 
analysis. Oysters known to contain gymnodimine were used in the 
assay set-up. 
5.6.2 Methodology 
The extraction/isolation methodology used for the assay is virtually 
equivalent to that used for the large scale extraction. The procedure 
has been modified to accommodate analyses for both shellfish and 
algae. The procedure is detailed in Section 6.5.6. The algae analysed 
were Gymnodinium cf mikimotoi, cultured by Dr Lincoln Mackenzie 
at the Cawthron Institute in Nelson. 
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5.6.3 Results 
Thin Layer Chromatography Analysis 
As a consequence of the nitrogen atom present in gymnodimine a 
characteristic orange colour is formed when it is sprayed with 
Dragendorff's reagent. In addition, comparisons of compound 
retention (Rr), are particularly useful and can be achieved by eluting 
against an authentic sample of gymnodimine. These particular features 
provide a very powerful tool for qualitative analysis. 
Resolution and colour clarity were the major criteria for the selection 
of the chromatographic phase for analysis. Of the many phases 
examined, silica gave the best results. The best solvent conditions were 
achieved by elution with 7.5% methanol/CH2Cl2 (1% AcOH). 
Variations in pH of elution solvent created marked differences in Rr 
values. Inclusion of acetic acid in the developing solvent ensured 
uniform pH elution conditions. 
TLC proved successful in identifying gymnodimine in both the shellfish 
and algae (Fig 5.6.1). 
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Solvent Front ~ 
(a) (b) (c) 
Fig 5.6.1 Silica TLC Chromatograph of (a) Authentic 
Gymnodimine, (b) Shellfish Test Sample and (c) Algae Test Sample 
[Elution solvent= 7.5% methanol/CH2Cl2 ( 1% AcOH)] 
[Dragendorff Spray} 
High Peiformance Liquid Chromatography Analysis 
HPLC provided a highly specific analytical tool once the correct 
conditions had been achieved. Accurate analy is could be accomplished 
by comparisons of retention times, UV chromophore and peak shape 
with an authentic sample of gymnodimine. 
The conditions were optimised by use of a reverse phase C 18 column 
with a gradient elution of acetonitrile and water. Trifluoroacetic acid 
(TFA) was added to the water as an acidic polar modifier. The 
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gradient scheme (Fig 5.6.2) minimised problems of peak broadening 
and co-eluting peaks, which were the problems observed with isocratic 
elution schemes. 
Legend 
A = acetonitrile 
B = water (0.05% trifluoroacetic acid) 
(i) = 5 minutes 
( ii) = 20 minutes 
(iii) = 5 minutes 
(i) 
(ij/ 
20% AlB- 20% AlB 
(iij/ 
60% AlB 
100%A 
Fig 5.6.2 Gradient Elution Scheme Used for HPLC Analysis 
Results obtained on test samples analysed by the gradient HPLC are 
shown in Fig 5.6.3. 
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Fig 5.6.3 HPLC Chromatograph of (a) Authentic Gymnodimine, 
(b) Shellfish Test Sample and (c) Algae Test Sample 
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Proton NMR Analysis 
The signals exhibited by the lactone protons in the 1 H NMR spectrum 
of gymnodimine, are well isolated and characteristic to the compound. 
Proton NMR provided a complementary analytical method to TLC and 
HPLC. 
Comparisons of the test samples with that of authentic gymnodimine, 
were made using lH NMR spectroscopy. The spectra (in CDCb) 
revealed the characteristic lactone peaks for the samples tested (Fig 
5. 6.4). The slight difference in chemical shifts for the shellfish test 
sample (Fig 5.6.4(b)) are due to 10% CD30D added to aid in 
solubility. 
~ 
(a) L 
(b) 
(c) L 
iilljiillj lii(lllljiillj iiljli ijlilijlllljiliijlllij iiljli'ljiilljli fjilllj 
7.0 6.9 6.8 6.7 6.6 6.5 6.4 6.3 6.2 6.1 6.0 5.9 5.8 5.7 5.6 ppm 
Fig 5.6.4 Proton NMR Spectra of (a) Gymnodimine, (b) Shellfish 
Test Sample and (c) Algae Test Sample, Showing Lactone Resonances 
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5.7 Conclusions 
5.7.2 Structure Elucidation of Gymnodimine 
Structural elucidation of gymnodimine (40) was first achieved by 
Professor Yasumoto's research group.67 However, parallel elucidation 
was carried out as part of this research. The NMR data contained in 
Section 5.2 established that the postulated pH dependent imine/enamine 
tautomerism67 was not a contributing process. The salient changes 
observed in the NMR spectra, on addition of acid, were attributed to 
formation of an iminium ion. 
5.7.3 Absolute 
Gymnodimine 
Stereochemistry of 
The absolute stereochemistry of gymnodimine was solved by X-ray 
crystallography on the crystalline p-bromobenzamide derivative (56). 
The measurement of observed NOB's for (56) and gymnodimine 
provided information on conformational differences between the solid 
and solution phase structure of gymnodimine. Constrained molecular 
modelling suggested the presence of many low energy conformers of 
gymnodimine. 
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5.7.4 Design and Syntheses of Gymnodimine 
Hap tens 
The design and syntheses of three haptens for the development of an 
ELISA for gymnodimine were carried out. The haptens (59) and (61) 
were tested for selective binding against a gymnodimine antisera. Both 
haptens revealed binding in ELISA, however gymnodimine and 
gymnodamine (52) exhibited no competition. 
5.7.5 Development of a Large Scale Isolation 
Scheme for Gymnodimine 
An efficient extraction/isolation scheme was devised for gymnodimine 
from oysters. This scheme overcomes many of the problems 
encountered with large scale isolation procedures, particularly handling 
difficulties using bulky extracts and large column sizes and expending 
much valuable time. 
Furthermore, the use of the mouse bioassay is not needed during the 
isolation process as gymnodimine can be tracked by the use of TLC 
(with Dragendorff development), HPLC, or lH NMR spectroscopy. 
The low levels of toxin in the isolation means contaminants are usually 
needed to be removed by HPLC. In doing so some material is 
invariably lost. The use of HPLC was avoided in most cases by 
efficient use of diol and amino phase columns, resulting in increased 
yield of toxin. 
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5.7.6 Development of a Chromatography Based 
Assay for Gymnodimine 
A chromatography/HPLC based technique has been developed for the 
specific detection of gymnodimine in shellfish and algae. The 
advantages of the assay are that it takes just a few hours from 
shellfish/algae to a result and gives a definitive answer. 
The assay is only intended as a "back-up" assay to the mouse bioassay 
and requires further development to reach a quantitative level. In 
addition, any future gymnodimine analogues discovered need to be 
incorporated into the assay. 
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6.1 General Methods 
6.1.1 Nuclear Magnetic Resonance 
Proton detected NMR spectra were recorded on a Varian Unity 300 
spectrometer at 23 °C, operating at 300 MHz. Carbon detected NMR 
spectra were recorded on a Varian XL300 spectrometer at 23°C, 
operating at 7 5 MHz. Other NMR experiments described in this thesis 
viz. lD-TOCSY, 2D-TOCSY, COSY, NOE, NOESY and the reverse-
detected HMQC and HMBC experiments were all recorded on the Unity 
spectrometer, at 300 MHz. This instrument was fitted with a Nalorac 
Z.spec MID300 3 mm Indirect Detection Probe. Chemical shifts in this 
thesis were described in parts per million (ppm), on the 8 scale, and were 
referenced to the appropriate solvent peaks: CDCb referenced to CHCb 
at OH 7.25 ppm (lH) and CHCl3 at oc 77.0 ppm (13C); CD30D 
referenced to CHD20D at OH 3.30 ppm (lH) and CD30D at 8c 49.3 
ppm (13C); D20 referenced to HOD at OH 4.70 ppm (lH). lH NMR 
spectra were recorded using an acquisition time (AT) of 2 s, except for 
those run in CD30D, which ran suppression of the HOD solvent peak, 
under the following conditions; relaxation delay (Dl) =1 s, decoupler 
power = 4, steady state = 4, decoupler mode = 'ynn'. 13C NMR spectra 
were recorded using an acquisition time of 0.5 s. All difference NOE 
experiments were recorded on undegassed solutions, with AT = 1 s and 
an irradiation time of 2 s. The decoupler was offset 10,000 Hz for the 
control experiment. Percentage enhancements reported in this thesis 
represent the observed increase in the intensity of a specific resonance 
relative to the corresponding signal in the control spectrum. NOESY 
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experiments were run using an AT= 0.46 s, D1 = 0.60 sand a mixing 
time of 0.30 s. COSY experiments were recorded using an acquisition 
time of 0.24 s and a relaxation delay of 1 s. 2D-TOCSY spectra were 
recorded using an acquisition time of 0.50 s, a relaxation delay of 0.60 s 
and a mixing time of 80 ms. 1D-TOCSY spectra were recorded using an 
acquisition time of 2 s, a relaxation delay of 1 s and mixing times as 
indicated in the discussion. HMQC experiments were recorded with an 
acquisition time of 0.2 s, a relaxation delay of 0.4 s and Jx-H=130 Hz. 
HMBC experiments were recorded with an acquisition time of 0.21 s, a 
relaxation delay of 0.3 s, J =140Hz and JNxH= 8.3 Hz. 
6.1.2 Mass Spectrometry 
Mass Spectrometry at Canterbury University was performed on a Kratos 
MS80 Mass Spectrometer operated at 4 kV. FAB was performed with 
an Ion Tech ZN11FN ion gun using Xe as the reagent gas, operating at 8 
kV and 2 rnA with either NOBA (m-nitrobenzyl alcohol), m-b (magic 
bullet, 50% thioerythritol/thiothreitol), or glycerol as matrix. 
Some samples were analysed at other institutions hence the place where 
the samples were run are stated as follows: (Canterbury) Bruce Clark, 
(Chemistry Department, University of Canterbury, Christchurch, New 
Zealand); (NIH) sent to Lewis Pannell (NIDDK, NIH, U.S.A.); (ESR) 
sent to Dr Porter (Institute of Environmental and Scientific Research, 
Gracefield Research Centre, Lower Hutt, New Zealand). 
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6.1.3 High Performance Liquid Chromatography 
Analytical HPLC was performed on a Philips PU4100 Liquid 
Chromatograph equipped with a Philips PU4120 Diode Array Detector 
interfaced to a PC General486 computer running Philips PU6003 Diode 
Array Detector System Software (V3.0) and a Hewlett Packard 7475A 
Plotter. HzO was purified using a MilliQ deionising system. MeOH 
(J.T. Baker, HPLC reagent grade) and acetonitrile (BDH, HiPerSolv) 
solvents were used undistilled. All other solvents were of technical 
grade and were purified and re-distilled before use. Hexane was 
prepared from petroleum ether (10 L, b.pt. 60-70oC), nitrated with a 
mixture of c. HN03 (1 L) and c. HzS04 (1 L) for two days. After this 
time, the nitrating mixture was removed and the organic layer washed 
with HzO (20 L), and dried over CaClz overnight. The resulting solution 
was filtered through activated alumina (Laporate, 100 mesh) and 
distilled. All solvents (with the exception of MilliQ water) were filtered 
through a Millipore filter apparatus, equipped with a Rainin Nylon-66 
filter (0.45 J.Lm) prior to use. All samples were filtered through a syringe 
filter (Alltech, 0.45 J.Lm) prior to injection. 
The analytical reverse phase C18 column used was a Microsorb-MV, 
86200-C5, 5 J.Lm, 100 A, 250 x 4.6 mm, Rainin Instrument Company Inc, 
USA. The analytical reverse phase C8 column used was an 
Econosphere, 5 J.Lm, 250 x 4.6 mm, Alltech/Applied Science, USA. The 
analytical diol column used was a LiChrospher® 5 J.Lm, 100 A, 250 x 4.6 
mm, E. Merck, Darmstadt, Federal Republic of Germany. 
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Medium pressure column chromatography was performed on a Lobar 
chromatography setup, with a variable speed electric pump, to achieve a 
typical flow rate of 10 mL/min. The C 18 lobar column used was a 
Lichroprep® RP-18, 40-63 J..lm, 310 x 25 mm, E. Merck, Darmstadt, 
Federal Republic of Germany. 
6.1.4 Column Chromatography 
All column chromatography was performed with glass columns of stated 
dimensions. 11Flash11 columns were run under N2 gas (oxygen free) 
pressure (0.5 kPa). Solvents used were all commercial grade, distilled 
once in glass distillation apparatus, except methanol (MeOH), which was 
distilled twice. 
Octadecyl (C18) reverse-phase packing used for preparative and flash 
column chromatography was prepared from silica gel (Davisil, 35-70 
Jlm) using a solution of octadecyltrichlorosilane (2 % vlv, EGA-Chemie) 
in carbon tetrachloride.97 The silica gel was stirred gently with a teflon-
coated magnetic follower overnight before washing with carbon 
tetrachloride (x 2). Unreacted chloride groups were removed by 
washing with dry MeOH. A carbon tetrachloride solution of 
trimethylchlorosilane (2 % vlv, Aldrich) was used to end-cap any 
unreacted hydroxyl groups. The reverse-phase material was finally 
washed with dichloromethane (CH2Cl2) (x 2) and MeOH (x 2) to 
remove the reagents. The C18 reverse-phase material was extensively 
washed with MeOH immediately before use. Small scale preparative 
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C18 reverse-phase column chromatography was performed using Alltech 
disposable cartridges (200 mg). 
Bakerbond diol (Bb)(40 ~m APD) or Merck diol (Mk)(40 ~m APD) 
packing material was used for diol column chromatography. Small scale 
preparative diol column chromatography was performed using Alltech 
disposable cartridges (200 mg). 
Bakerbond CBA ( 40 ~m APD) packing material was used for carboxylic 
acid (CBA) column chromatography. Small scale preparative CBA 
column chromatography was performed using 500 mg CBA BondElut 
cartridges. 
Amino column chromatography was performed using Bakerbond amino 
(40 ~m APD) packing material. On a smaller scale amino BondElut 
disposable cartridges (200 mg) were used. 
Alumina column chromatography was performed ustng activated 
alumina (Type H, 100-200 Mesh, Laporte). 
Pre-swollen Sephadex LH-20 (Pharmacia Biotech AB) was used for gel 
permeation chromatography. 
Celite filtration and coating was performed using diatomaceous earth 
(Celite Corporation). 
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6.1.5 Thin Layer Chromatography 
The silica analytical TLC described in this thesis was performed using 
Merck silica gel60 F254 aluminium-backed sheets, 0.2 mm in thickness. 
DIOL analytical TLC was performed using Merck F254 glass-backed 
plates of 0.2 mm thickness. Whatman MKC 18p TLC plates of 0.2 mm 
thickness were used for analytical C18 TLC. Amino analytical TLC was 
performed on Merck F254 glass-backed plates of 0.2 mm thickness. All 
TLC plates were visualised initially, under short-wave (A 254 nm) light 
and subsequently, with phosphomolybdic acid in ethanol spray (10 % 
phosphomolybdic acid in ethanol wlv). TLC plates containing 
gymnodimine and derivatives were visualised with Dragendorff's 
reagent. 85 C 18 reverse phase TLC plates containing yessotoxin were 
visualised with c. H2S04 in ethanol (1:1). Other TLC plates were 
visualised with ninhydrin in acetone ( 10% wlv) 
6.1.6 Dry Solvents 
Dichloromethane was dried initially over calcium chloride then distilled 
from calcium hydride. Dry 1 ,4-dioxane was achieved by distillation 
over calcium hydride. Dry pyridine was attained by reflux over 
potassium hydroxide pellets, followed by distillation with careful 
exclusion of moisture. Dry methanol was distilled from magnesium 
metal and iodine. All dry solvents were distilled immediately prior to 
use. 
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6.2 Work Described In Chapter Two 
6.2. 1 Collection 
New Zealand green-lipped mussels (Perna canaliculus) were harvested 
commercially from the Coromandel area on 8 January 1993. 
6.2.2 Total Lipid Extract 
Mussel viscera ( 6 kg) were prepared for analysis by Environmental 
Science and Research (ESR), in Lower Hutt, New Zealand, by the 
following method: 
(1) 100 g of shucked and drained shellfish were blended with 
redistilled acetone (300 mL) (20 seconds), and filtered through 
Whatman 541 filter paper. 
(2) The residue was further extracted with acetone (200 mL), filtered 
and the acetone extracts combined in a r.b. flask (1000 mL). 
(3) The acetone was removed by rotary evaporation. 
(4) The resultant aqueous/lipid mixture was acidified with HCl (1 M) 
to pH 2.5 (using narrow band pH paper) and poured into a 
separatory funnel (500 mL) and the residue in the RB flask washed 
in with three portions using redistilled DCM (3 x 100 mL). 
(5) The separatory funnel was gently shaken and the lower DCM layer 
run off through muffled anhydrous Na2S04 (10 g), prewetted with 
DCM in a glass funnel, into aRB flask (250 mL). 
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(6) The aqueous layer was further extracted with DCM (80 rnL) and 
the DCM extracts combined. The NazS04 was washed with DCM 
(20 rnL) making a total of 200 rnL of DCM extract. 
The total extract from 6 kg shellfish (described in step ( 6)) was sent as a 
DCM solution (180 mL) to Canterbury University. The extract was 
coded ES1-127. 
An aliquot (500 J.LL) of ES1-127 was dried thoroughly, in vacuo, until a 
constant weight (264 mg) was achieved. P388 assay (100 mg/rnL, 75% 
MeOH/DCM) gave an ICso value of 56.2 J.LglmL. 
A second aliquot (10 mL) of ES1-127 was dried thoroughly, in vacuo 
and partitioned between 80% MeOH/HzO (3 x 500 mL) and PE (3 x 500 
mL). Solvents were removed, in vacuo, to afford the aqueous methanol 
phase (1.13 g) and the PE phase (4.12 g). P388 assays gave an ICso 
value of 14.1 J.Lg/mL (100 mg/mL assay concentration, 75% 
MeOH/DCM) for the aq. MeOH phase, and an ICso value of>1,250,000 
J.Lg/rnL (100 mg/mL assay concentration, 75% MeOH/DCM) for the PE 
phase. 
Aliquots (5%) of each phase were sent for mouse bioassays (ESR). 
Results were: aq. MeOH phase, 112 mouse deaths in 137 min (32 
mg/mouse, i.p.); PE phase, 0/2 mouse deaths (53 mg/mouse, i.p.). 
The remaining aq. MeOH extract (1.07 g) was dissolved in DCM (10 
mL) and celite (1.1 g) added. The solvent was removed, in vacuo and 
the resulting solid loaded onto the head of a column (30 mm i.d.), 
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packed with C18 phase material (100 g), equilibrated to 50% 
MeOHIH20. A step gradient elution was run, under "flash" conditions, 
starting at 50% MeOH/H20, through MeOH, finishing with 50% 
DCM/MeOH. Fractions 2.A1 - 2.A10 (200 mL fractions) were 
collected, with a resulting mass recovery of 99%. Fraction weights and 
corresponding P388 ICso values were recorded as follows (x mg, y 
ng/mL); 2.A1 (17.0, >125,000), 2.A2 (6.8, >125,000), 2.A3 (8.0, <975), 
2.A4 (16.5, <975), 2.A5 (30.0, 1,584), 2.A6 (20.5, 31,622), 2.A7 (50.0, 
39,810), 2.A8 (85.5, 39,810), 2.A9 (37.0, 44,668) and 2.A10 (789.0, 
89,125). 
An aliquot of 2.A4 (4.5 mg; equivalent to 10 g of crude extract) was sent 
for mouse bioassays (ESR). Results were: 3/3 mouse deaths, all 3 in 20 
minutes. 
Fractions 2.A3 and 2.A4 were combined (20 mg), solvents removed, in 
vacuo and sample re-dissolved in DCM (1 mL). The solution was 
pipetted onto the head of a column (20 mm i.d.), containing LH-20 (10 
g), pre-swelled in DCM (2 hr). Fractions collected were: 2.B 1 - 2.B5 
(DCM; 4, 6, 5, 5, 10 mL fractions), 2.B6 - 2.B7 (50% MeOH/DCM; 10, 
10 mL fractions) and 2.B8 (MeOH; 30 mL). There was a 91% mass 
recovery. Fraction weights and corresponding P388 ICso values were 
recorded as follows (x mg, y ng/mL); 2.B 1 (0.2, 4, 626), 2.B2 (1.0, 
>12,500), 2.B3 (1.3, >12,500), 2.B4 (1.1, >12,500), 2.B5 (0.4, 
>12,500), 2.B6 (0.2, >12,500), 2.B7 (7.0, 665) and 2.B1 (7.0, 1,600). 
Fractions 2.B7 and 2.B8 were combined (14.0 mg), solvents evaporated, 
in vacuo and sample dissolved in 10% MeOH/DCM (1 mL). The 
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solution was pipetted onto a column (10 mm i.d.), packed with LH-20 (5 
g), pre-swelled in 10% MeOH/DCM (2 hr). Nine fractions were 
collected; 1 - 5 (10% MeOH/DCM; 23, 3, 5, 7, 7 mL fractions), 6 - 8 
(50% MeOH/DCM; 10, 10, 4 mL fractions) and 9 (MeOH; 20 mL). 
There was 91% mass recovery. Fraction weights and corresponding 
P388 ICso values were recorded as follows (x mg, y ng/mL); 1 (1.1, 
>12,500), 2 (0.5, >12,500), 3 (1.3, >12,500), 4 (1.7, >1,614), 5 (1.0, 
3,453), 6 (0.5, 4,626), 7 (0.8, 6,197), 8 (1.9, 1,170) and 9 (3.9, 1,436). 
Alternative Extraction Method 
Preliminary Work 
Frozen mussel viscera (102 g) were lyophilised (2 days). The dried 
material (28.65 g) was crushed to afford a coarse powder and extracted 
with H20 (2 x 100 mL), MeOH (2 x 100 mL), EtOAc (2 x 100 mL) and 
DCM (2 x 100 mL), to afford 4 separate extracts. Extract weights and 
corresponding P388 ICso values were recorded as follows (x g, y 
~g/mL); H20 extract (8.40, >1,250), MeOH extract (2.09, >1,250), 
EtOAc extract (0.90, 316) and DCM extract (0.12, 224). Aliquots of 
each extract was sent for mouse bioassay (ESR). The results were: H20 
extract, 2/2 mouse deaths, 10 min (1 g/mouse), MeOH extract, 1/2 
mouse deaths, 27 min (250 mg/mouse), EtOAc extract, 0/2 mouse deaths 
(100 mg/mouse) and DCM extract 0/2 mouse deaths (55 mg/mouse). 
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Method. 
Frozen mussel viscera (1.9 kg) were lyophilised (4 days). The dried 
shellfish ( 430 g) were crushed to afford a coarse powder and placed in a 
beaker (5 L). H20 (2.5 L) was added and the mixture stirred (5 min). 
The resulting pulp was divided equally into two beakers (5 L), H20 (2.5 
L/beaker) was added and mixtures stirred (10 min). Each mixture was 
left to settle (3 hr). The supernatant was siphoned off and filtered 
through cotton wool. The mussel "paste" was then stirred with H20 (2.5 
L/beaker) and left to settle overnight. The supernatant was siphoned off, 
filtered through cotton wool and combined with the first H20 extract (9 
L, total). The mussel "paste" was then combined and MeOH (2.5 L) 
added, to achieve an effective concentration of 40% MeOHIH20. The 
mixture was subsequently blended (5 min) and filtered through a bed of 
celite, to afford the 40% MeOHIH20 extract (3.5 L). The macerated 
mussel residue was then blended with 70% MeOHIH20 (4 L, 5 min) and 
filtered, to afford the 70% MeOH/H20 extract (4.0 L). 
Small aliquots (0.1% volume) of each were dried, in vacuo, for 
estimation of extract weights and submitted for P388 assays. Estimated 
extract weights and corresponding P388 ICso values were recorded as 
follows (x g, y J.!g/mL); H20 extract (131.0, 391), 40% MeOH/H20 
extract (10.5, 146) and 70% MeOH/H20 extract (6.8, 558). 
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Scheme 2.2.1 
(Elution solvents and volumes not referred to in text are recorded in scheme) 
All three extracts were combined and concentrated, in vacuo, to a HzO 
extract (3.5 L). The aqueous solution was partitioned against PE (3.5 L) 
and the H20 layer then removed of residual PE, in vacuo. The aqueous 
extract (3.25 L) was subsequently poured onto the head of a column (170 
mm i.d.), containing C18 phase material (1 kg) that had been 
equilibrated to HzO. Column elution was achieved under vacuum. 
Once the aqueous extract had been absorbed the column was eluted with 
HzO (3 L) followed by 80% MeOHIH20 (4 L) and MeOH (4 L). 
The aq. methanol elutions were combined, dried in vacuo and re-
dissolved in 30% MeOHIH20 (20 mL). The solution was pipetted onto 
the head of a column (40 mm i.d.), containing C18 phase material 
equilibrated to 30% MeOH/HzO. Step gradient elution of the column 
was achieved under "flash" conditions to afford fractions 2.Cl- 2.C6. 
Fractions 2.C2- 2.C4 were combined (650 mg), coated onto celite (1.3 
g) and dried, in vacuo. The dried residue was subsequently packed onto 
the head of a column (15 mm i.d.), containing diol phase material (12 g) 
and equilibrated to DCM. Step gradient elution afforded fractions 2.Dl -
2.Dl0, with 75% mass recovery. 
Fraction 2.D8 (60 mg, ICso <975 ng/mL) was dissolved in MeOH (1 
mL) and pipetted onto the head of a column (20 mm i.d.), containing 
LH-20 (50 g), pre-swelled in MeOH (1 hr). The column was run with a 
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flow rate of 2.5 mL/min. Fractions 2.E1 - 2.E10 were collected, with a 
100% mass recovery. 
Fraction 2.D9 (127 mg, ICso <975 ng/mL) was dissolved in MeOH (2 
mL) and pipetted onto the head of a column (40 mm i.d.), packed with 
LH-20 (110 g), pre-swelled in MeOH (2 hr). The column was eluted at 
2.5 mL/min, from which fractions 2.F1 - 2.F10 were collected, with a 
100% mass recovery. 
An aliquot of fraction 2.D1 (5 mg) was dissolved in DCM (200 !-LL) and 
pipetted onto the head of a column (5 mm i.d.), containing amino phase 
material (500 mg), equilibrated to DCM. Elution was carried out with 
DCM (3 mL), MeOH (3 mL) and 1% TFA/MeOH (3 mL). Fraction 
weights and corresponding P388 ICso values were recorded as follows 
(x mg, y ng/mL); DCM fraction (1.7, 429), MeOH fraction (0.8, 4, 791) 
and 1% TFA/MeOH fraction (2.7, >12,500). 
The remainder of fraction 2.D1 (91 mg) was dissolved in 5% 
MeOH/DCM (l mL) and pipetted onto the head of a column (10 mm 
i.d.), containing amino phase material (2.7 g), equilibrated to 5% 
MeOH/DCM. Elution was carried out with 5% MeOH/DCM (15 mL), 
MeOH (15 mL) and 1% TFA/MeOH (15 mL). Fraction weights and 
corresponding P388 ICso values were recorded as follows (x nig, y 
ng/mL); 5% MeOH/DCM fraction (17.8, 22,261), MeOH fraction (4.7, 
>25,000) and 1% TFA/MeOH fraction (83.0, >25,000): 
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6.2.3 Isolation of Cytotoxic Compound 
Frozen mussel viscera (6.5 kg) were lyophilised. The dried shellfish (1.3 
kg) were crushed to a coarse powder, split into portions (100 g) and 
extracted separately using the following protocol: 
(1) Crushed dried mussels were divided into equal portions (100 g). 
(2) The powder was stirred with H2 0 (250 mL, 60 min) and 
centrifuged (5 min). The supernatant was removed and kept. The 
solid residue was re-stirred with H20 (250 mL, 30 min), 
centrifuged again and the supernatant removed. The process was 
repeated two more times. Extractions were combined as the total 
H20 extract. 
(3) The centrifuge pellet was stirred with 70% MeOHIH20 (250 mL, 
60 min) and filtered. The filter cake was then stirred with 70% 
MeOHIH20 (250 mL, 30 min) and filtered again. Both extractions 
were combined as the total aq. MeOH extract. 
(4) The total H20 and aq. MeOH extracts were combined and shaken 
gently with PE (250 mL) in a separating funnel (2 L). This was 
left to separate overnight then the lower aq. methanol layer was 
run off. This layer was re-extract twice more with PE (2 x 250 
mL) in an identical fashion as above. 
(5) All aq. methanol extracts were combined as total aq. methanol 
extract. 
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Scheme 2.2.2 
(Elution solvents and volumes not referred to in text are recorded in scheme) 
The total aq. MeOH extract, described in (5) (20 L), was concentrated, in 
vacuo, to H20 (2.5 L). The resulting solution was poured through a 
funnel onto the head of a column (170 mm i.d.), packed with C18 phase 
material (1 kg), equilibrated to H20. Step gradient elution, under 
vacuum, afforded fractions 2.H1 - 2.H7. 
Fraction 2.H5 (1.2 g, ICso <975 ng/mL) was coated onto celite (2.4 g) 
and the solvents removed, in vacuo. The resulting residue was dry 
packed onto the head of a column (25 mm i.d.), filled with diol phase 
material (55 g), equilibrated to DCM. A step gradient elution was run, 
affording fractions 2.11- 2.111, with an 87% mass recovery. 
Fractions 2.15 - 2.I7 were combined (150 mg) and solvents evaporated, 
in vacuo. The resulting residue was dissolved in MeOH (3 mL), filtered 
through an HPLC filter (0.45 ~) and concentrated to 1 mL, under N2 
flow. The solution was then pipetted onto the head of a column (25 mm 
i.d.), filled with LH-20 phase material (75 g), pre-swelled in MeOH (1 
hr). Elution at 2 drops/sec, afforded fractions 2.J1 - 2.17, with a mass 
recovery of 98%. 
Fraction 2.19 (248 mg, ICso 262 ng/mL) was dissolved in MeOH (3 
mL), filtered through an HPLC filter (0.45 ~)and concentrated to 1 mL, 
under N2 flow. The solution was then pipetted onto the head of a 
column (25 mm i.d.), filled with LH-20 phase material (75 g), pre-
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swelled in MeOH (1 hr). Elution with MeOH, at 2 drops/sec, afforded 
fractions 2.K1- 2.K7, with amass recovery of70%. 
Fractions 2.K6 and 2.K7 were combined (9.4 mg, ICso <<19.5 ng/mL), 
the solvents removed, under Nz flow and the solid residue dissolved in 
50% MeOH/DCM (1 mL). The resulting solution was then pipetted onto 
the head of a column (10 mm i.d.), filled with LH-20 phase material (10 
g), pre-swelled in 50% MeOH/DCM (2 hr). Elution with 50% 
MeOH/DCM, at 1 drop/sec, afforded fractions 2.L1- 2.L7, with a 100% 
mass recovery. 
211 
Chapter Six - Experimental 
6.3 Work Described In Chapter Three 
6.3.2 Spectroscopic Assignment of YTX 
YTX: Negative ion LRFABMS (NOBA) (Canterbury); [M-Na]- 1163.5. 
Positive ion HRFABMS (m-b, Csl) (NIH); [M-2Na+3Cs]+ 1539.1680, 
CssHsoOz1SzCs3 requires 1539.1787. 
6.3.3 Stereochemical Assignment of YTX 
Desulfation of YTX 
A YTX containing sample of unknown purity was used for the reaction. 
The YTX containing sample (30 mg) was dissolved in 50% 1,4-
dioxane/pyridine (3 mL) and transferred into a pear-shaped flask (4 mL). 
The solution was refluxed at 120 oc (3 hr). The solvents were removed, 
in vacuo and the residue dried thoroughly, under high vacuum (5 hr). 
The reaction mixture was dissolved in 70% MeOH/HzO(l% AcOH) (1 
mL) and pipetted onto the head of a column (5 mm i.d.), containing C18 
sorbent (3 g), equilibrated to the same solvent. Step gradient elution was 
achieved with 70% MeOH/Hz0(1% AcOH) through to MeOH (15 
mL/fraction). Five fractions were taken. 
The fraction eluting at 90% MeOH/HzO(l% AcOH) was dried in vacuo. 
This sample (2.4 mg) was dissolved in MeOH (500 J.LL) and pipetted 
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onto a cartridge containing amino phase material (200 mg), equilibrated 
to MeOH. The cartridge was eluted twice with MeOH (2, 3 mL) and 
once 1% TFA/MeOH (4 mL) and 5% TFA/MeOH (5 mL). The first 
fraction eluted off the cartridge was D-YTX ( 44) (0.8 mg). 
D-YTX (44): LRFABMS (NOBA) (Canterbury); [M-H20+H]+ 965.5. 
HRFABMS (NOBA) (Canterbury); [M-H20+H]+ 965.5619, CssHs1014 
requires 965.5626. 
6.3.4 Design and Synthesis of YTX Haptens 
Synthesis 
PMPI Attachment 
PMPI + D-YTX (44): D-YTX (0.8 mg) was transferred to a glass NMR 
tube (CH2Ch, 150 JlL). The end of the tube was sealed with a supa-seal 
and the solvent removed under high vacuum. The sample was then 
further dried under the high vacuum (4 hr). PMPI (1.7 mg) was 
dissolved in CDC13 (283JlL) from a newly opened ampoule. An aliquot 
of this solution (150 JlL) was removed, by syringe, and injected through 
the supa-seal, into the NMR tube. The top of the tube was sealed further 
with parafilm. The reaction was left (23 °C, 167 hr). 
The reaction solution was transferred from the NMR tube into a vial (7 
mL) and residue washed in with DCM (2 x 100 JlL). H20 (100 JlL) and 
ACN (1 mL) were added to the solution and all solvents removed, under 
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N2 flow. The residue was then dissolved in DCM (l mL). This solution 
was filtered through an HPLC filter (0.45 Jlm) and the filter washed with 
a further three times with DCM (3 x 1 mL). The solid residue was 
further dried under high vacuum. The HPLC filter was washed with 
EtOAc (2 mL) and ACN (2 mL) into a new vial (7 mL). 
The DCM soluble material was transferred into a new vial (2 mL) in 
DCM and the solvent removed, under N2 flow. The solid residue was 
dissolved in ACN (30 JlL) and an aliquot (15 JlL) injected onto a reverse 
phase C8 HPLC column. The column had been equilibrated to 40% 
ACNIH20. Eleven fractions were collected during gradient elution from 
40% ACN/H20 to 60% ACN/H20 over 20 minutes, running at 1 
mL/min. Chromatography was repeated on the other half of the sample. 
All corresponding fractions were combined. Fraction retention times 
and weights were recorded as follows (x min, y mg): 1 (0-3, 0.1), 2 (3-4, 
0.6), 3 (4-5.5, 0.1), 4 (5.5-7.5, 0.1), 5 (7.5-11, 0.1), 6 (11-13, 0.3), 7 (13-
15, 0.4), 8 (15-16.5, 0.4), 9 (16.5-17.5, 0.2), 10 (17.5-18.5, 0.1), 11 
(18.5-20, 1.0). 
Aminolysis 
YTX +Ammonia: Fraction 3.F4 (0.5 mg) was transferred, in MeOH (l 
mL), into a vial (7 mL) and the solvent removed under N2 flow. 50% 
MeOH/NH3 (28% ammonia) (1 mL) was added to the vial the vial was 
sealed with a lid and the reaction stirred (l hr). Solvents were removed 
under N2 flow and residue dried thoroughly under high vacuum (2 hr). 
Reverse phase C18 TLC plates were developed using 80% MeOHIH20. 
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YTX + Glycine: The fraction from the previous reaction was 
transferred, in MeOH (1 mL), to a pear shaped flask (5 mL). The 
solvent was removed under N2 flow. Glycine (5.6 mg) was dissolved in 
50% MeOH/H20 (5.6 mL) and an aliquot (300 J.LL) added to the flask. 
A reflux condenser was attached and the flask was stirred (60 °C, 64 hr). 
Solvents were removed, under N2 flow and the solid residue dried 
thoroughly under high vacuum (3 hr). 
Ozonolvsis 
Initial Ozonolysis: Fraction 2.L6 (Scheme 2.2.2)(100 J.Lg) was 
.transferred, in MeOH (2 mL), into a vial (7 mL). A dry ice/acetone bath 
(-78 °C) was set-up and the vial immersed into it. Ozone was bubbled 
through (12 min). Ozone conditions: internal pressure= 8 psi, outlet= 
0.7 psi, power= 100 W. The vial was removed from the bath and N2 
gas was bubbled through (2 min). Me2S (200 J.LL) was added and the 
vial agitated. Solvents were removed, under N2 flow and the residue 
dried thoroughly, under high vacuum. 
Second Ozonolysis: Fraction 2.L6 (Scheme 2.2.2)(1 mg) was 
transferred, in MeOH (2 mL), into a vial (7 mL). A dry ice/acetone bath 
( -78 °C) was set-up and the vial immersed into it. Ozone was bubbled 
through (12 min). Ozone conditions: internal pressure= 8 psi, outlet= 
0.7 psi, power= 100 W. The vial was removed from the bath and N2 
gas was bubbled through (2 min). Me2S (200 J.LL) was added and the 
vial agitated. Solvents were removed, under N2 flow and the residue 
dried thoroughly, under high vacuum. 
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LRFABMS (NIH): Negative ion (NOBA) mlz 1129, 1127, 1047.4, 945, 
815. (m-b) mlz 1129, 1127, 1047, 945, 815. Positive ion (m-b) mlz 
1505, 1503, 1423. 
Third Ozonolysis: Fraction 3.F3 (Scheme 3.5.1)(1 mg) was transferred, 
in MeOH (2 mL), into a vial (7 mL). A dry ice/acetone bath (-78 °C) 
was set-up and the vial immersed into it. Ozone was bubbled through 
(12 min). Ozone conditions: internal pressure= 8 psi, outlet= 0.7 psi, 
power = 100 W. The vial was removed from the bath and N 2 gas was 
bubbled through (2 min). Me2S (200 ~L) was added and the vial 
agitated. Solvents were removed, under N2 flow and the residue dried 
thoroughly, under high vacuum. 
6.3.5 Development of a Large Scale Isolation 
Method for YTX 
Extraction Methodology 
Mussel viscera (25 kg) were freeze dried in an industrial scale freeze 
drier, situated at Industrial Research Limited (IRL), at Gracefield 
Research Centre, Wellington. The dried mussel tissue (5 kg) was 
divided into five equal portions. The following extraction methodology 
was carried out: 
(1) Freeze dried, powdered mussels (1 kg) were blended with 70% 
MeOH/H20 (3 L) and filtered through a bed of celite. This 
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process was repeated with 70% MeOH/H20 (2 L) and all extracts 
combined. 
(2) Partially extracted mussels (500 g) were blended with MeOH (250 
mL) and filtered through a bed of celite. This process was 
repeated once more. P388 ICso value = 45,027 ng/mL. 
(3) Partially extracted mussels (500 g) were placed in a r.b. flask (3 
L). MeOH (500 mL) was added and the mixture refluxed (30 
min). The mixture was left to cool (60 °C) and filtered through a 
bed of celite. The celite was then washed with MeOH (100 mL). 
P388 ICso value 23,851 ng/mL. 
The remainder of the partially extracted mussels was divided into four 
portions. Each portion was placed in a r.b. flask (10 L) and MeOH (4 L) 
added. The mixture was refluxed (30 min). After cooling (60 °C) the 
mixture was filtered through a bed of celite. The filtrate was further 
cooled ( 4 °C) and the supernatant poured off. All four extractions were 
combined. P388 ICso value 16,346 ng/mL. 
Preliminary Isolation 
The aq. MeOH extract from (1) was washed twice with PE (2 x 1 L). 
The aq. MeOH partitions were combined and concentrated to H20, in 
vacuo. The resulting aqueous extract was divided into three equal 
portions and each diluted with water to achieve a volume of 2.5 L. Each 
portion was then partitioned three times against EtOAc (3 x 1 L). All 
partitions were dried in vacuo. P388 ICso values were: PE phase, ICso 
value 22,649 ng/mL, H20 phase ICso value 189,026 ng/mL, EtOAc 
phase ICso value 14,552 ng/mL. 
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The EtOAc phase material ( 40 g) was dissolved in 50% MeOH/DCM 
(100 mL) and celite (80 g) added. The solvents were removed in vacuo. 
The resulting solid residue was applied to the head of a column (1 00 mm 
i.d.), containing C18 material (1 kg), equilibrated to 50% MeOH/H20. 
Step gradient elution of 50% MeOH/H20 to MeOH (2 L/fraction), 
followed by a 50% MeOH/DCM strip (3 L), afforded seven fractions. A 
91% mass recovery and 80% recovery of cytotoxicity was achieved. 
The extract obtained by refluxing the mussels in MeOH (3) was 
concentrated to H20, in vacuo. The resulting aqueous solution (1 L) was 
made to 75% MeOHIH20 (4 L) by the addition of methanol (3 L). This 
solution was partitioned three times against PE (3 x 1 L). P388 ICso 
values were: aq. MeOH phase ICso value 14,981 ng/mL, PE phase ICso 
value 71,721 ng/mL. 
The aq. MeOH phase was concentrated to approximately 50% 
MeOH/H20 (2.5 L) and poured onto the head of a column (80 mm i.d.), 
containing C18 material (250 g), equilibrated to 50% MeOH/H20. Step 
gradient elution through to MeOH (1 L/fraction), followed by 50% 
DCM/MeOH (1 L), afforded 6 fractions. 
An aliquot of the PE phase (1 g) was dried thoroughly under high 
vacuum. The residue was dissolved in 75% DCM/PE (2 mL) and 
pipetted onto the head of a column (15 mm i.d.), containing silica gel (10 
g), equilibrated to 75% DCM/PE. Elution with 75% DCM/PE (30 mL), 
DCM (10 mL), followed by a step gradient from 10% MeOH/DCM to 
MeOH (20 mL/fraction), afforded 6 fractions. Fraction weights and 
corresponding P388 ICso values were recorded as follows (x mg, y 
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ng/mL); 75% DCM/PE fraction (218.0, 11,925), DCM fraction (4.0, . 
25,390), 10% MeOH fraction (2.6, 20,716), 20% MeOH fraction (281.0, 
31,118), 50% MeOH fraction (46.0, 45,407) and MeOH fraction (33.0, 
>62,500). 
An aliquot (25 mL) of the crude extract obtained by reflux extraction 
was concentrated to H20 (5 mL) and more H20 (5 mL) added. The 
resulting aqueous solution was partitioned against n-butanol (10 mL) and 
the phases were left to separate. Fraction weights and corresponding 
P388 ICso values were recorded as follows (x mg, y ng/mL); n-butanol 
phase (12.0, 1,803) and H20 phase (38.4, >62,500). 
Then-butanol phase (12.0 mg) was dissolved in 50% MeOH/DCM (500 
J.LL) and pipetted onto a column (5 mm i.d.), filled with alumina (600 
mg), equilibrated to 50% MeOH/DCM. The column was washed with 
50% MeOH/DCM (2.5 mL) and 2% NH3/50%MeOH/H20 (4 mL). 
Fraction weights and corresponding P388 ICso values were recorded as 
follows (x mg, y ng/mL); 50% MeOH/DCM fraction (2.8, 37,048) and 
H20 phase (8.0, 10,017). 
Scheme 3.5.1 
(Elution solvents and volumes not referred to in text are recorded in scheme) 
Lyophilised mussel viscera (2 kg) were crushed to afford a coarse 
powder and placed inside a cheese cloth. The ends of the cheese cloth 
were tied with string. The cheese cloth/mussels was placed in a large 
steel vessel (20 L) and H20 added (10 L). The water was heated (100 
°C) with an open flame and left to cool (60 °C). The cheese cloth was 
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removed and hand squeezed to remove excess H20. The remaining 
water in the steel vessel was decanted into a flask (10 L). The resulting 
aqueous extract (7 .5 L) was covered with a layer (2 em) of n-butanol to 
prevent microbial growth. 
The mussels were removed from the cheese cloth and transferred into a 
r.b. flask (10 L). MeOH (6 L) was added and the mixture refluxed (30 
min). The mixture was left to cool (60 °C) and filtered through a bed of 
celite to afford the first MeOH extract. 
The solid residue was transferred back to the same r.b. flask and MeOH 
(4 L) added. The mixture was refluxed (30 min), left to cool (60 °C) and 
was then filtered through the same bed of celite as above, to afford the 
second MeOH extract. 
The aqueous extract was divided into three equal volumes and each 
partitioned twice against n-butanol (2 x 2.5 L). Combination of all then-
butanol phases, followed by removal of solvent, in vacuo, afforded the 
first n-butanol partition. 
The first MeOH extract was concentrated, in vacuo, to H20 and further 
H20 added (1 L). The resulting aqueous solution was partitioned three 
times with n-butanol (2, 1, 1 L). All the n-butanol phases were 
combined and the solvent removed, in vacuo, to afford the second n-
butanol partition. 
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The second MeOH extract was concentrated, in vacuo (2.5 L) and water 
added (500 mL). The resulting solution was partitioned twice against PE 
(2 X 1 L). 
The aq. MeOH phase was subsequently concentrated, in vacuo, to HzO 
(1 L) and further HzO added (2 L). The resulting aqueous solution was 
partitioned twice against n-butanol (2, 1.5 L). The n-butanol phase was 
added to the second butanol partition and solvent removed, in vacuo. 
The first n-butanol partition (58 g) was dissolved in 50% DCM/.M:eOH 
(200 mL) and pipetted onto the head of a column (80 mm i.d.), 
containing alumina (25 em), dry packed. The column was washed with 
50% DCM/.M:eOH (2 L) and 2.5% NH3 in 50% MeOH/HzO (2 L). The 
aq. MeOH fraction was dried, in vacuo to afford the first alumina 
fraction. 
The second n-butanol partition ( 44 g) was dissolved in 50% 
DCM/.M:eOH (200 mL) and pipetted onto the head of a column (80 mm 
i.d.), containing alumina (23 em), dry packed. The column was washed 
with 50% DCM/.M:eOH (2 L) and 2.5% NH3 in 50% MeOH/HzO (2 L). 
The aq. MeOH fraction was dried, in vacuo to afford the second alumina 
fraction. 
The first alumina fraction (6 g) was dissolved in MeOH (10 mL) and 
pipetted onto the head of a column (25 mm i.d.) containing LH-20 (1.7 
m), pre-swelled in MeOH (15 hr). Elution afforded fractions 3.Al to 
3.A5. 
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The second alumina fraction (11 g) was dissolved in MeOH (20 mL) and 
divided into two equal portions. Each was treated separately. The first 
was pipetted onto the head of a column (25 mm i.d.) containing LH-20 
(1.7 m), pre-swelled in MeOH (15 hr). Elution afforded fractions 3.B1 
to 3.B5. The second was pipetted onto the head of a column (25 mm 
i.d.) containing LH-20 (1.7 m), pre-swelled in MeOH (15 hr). Elution 
afforded fractions 3.C1 to 3.C5. 
Fractions 3.A5, 3.B5 and 3.C5 were combined and solvent removed, in 
vacuo. The resulting residue (358 mg) was dissolved in MeOH (1 mL) 
and pipetted onto the head of a column (10 mm i.d.), containing LH-20 
(75 g), pre-swelled in MeOH (15 hr). Elution afforded fractions 3.D1 to 
3.D11. 
Fractions 3.D6 to 3.D8 were combined and solvent removed in vacuo. 
The resulting residue (130 mg) was dissolved in 60% MeOH/H20 (2 
mL) and injected onto a C 18 lobar column, equilibrated to 60% 
MeOH/H2 0 and running at 5 mL/min. Elution was run at 60% 
MeOH/H20 for 39 minutes (195 mL), affording fractions 3.El to 3.E5. 
The column was finally washed with MeOH (250 mL) to afford fraction 
3.E6. 
Fraction 3.E6 was dried, in vacuo and the resulting residue (5.0 mg) 
dissolved in 10% MeOH/DCM (500 f-LL). An aliquot (100 f-LL) was 
pipetted onto the head of a cartridge containing diol phase material (100 
mg), equilibrated to 10% MeOH/DCM. Step gradient elution from 10% 
MeOH/DCM to 50% MeOH/DCM achieved fractions 3.F1 to 3.F4. The 
remaining solution ( 400 f-LL) was purified, as above, on 4 separate 
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identical diol cartridges. Combination of all relevant fractions afforded 
YTX in fraction 3.F3 (1.6 mg, 1.6xl0-5% yield, w/w). 
223 
Chapter Six - Experimental 
6.4 Work Described In Chapter Four 
6.4.1 Collection 
Commercial oysters (Tiostrea chilensis) were harvested around Foveaux 
Strait area. Analysis by mouse bioassay showed; >306 MU/100 g oyster 
flesh, in the acetone extract and 23 MU/100 g oyster flesh, in the ether 
extract. 
6.4.2 Investigation of Toxicity 
Scheme 4.2.1 
(Elution solvents and volumes not referred to in text are recorded in scheme) 
Frozen oysters (600 g) were lyophilised (2 days). The dried oysters were 
crushed to form a coarse powder (129 g). The powder was washed with 
a succession of solvents (2 x 750 mL, 30 min each) and filtered, keeping 
each extract separate. 
Fractions 4.Al and 4.A2 were combined (43.9 g) and concentrated, in 
vacuo, to H20 (30- 40 mL). The solution was then pipetted onto the 
head of a column (100 mm i.d.), containing C18 phase material (100 g), 
equilibrated to H20. Elution was achieved, under vacuum, to afford 
fractions 4.Bl- 4.B7, with a mass recovery of 46%. 
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Fractions 4.A4 and 4.A6 were combined (14.5 g) and the solvents 
removed, in vacuo. The solid residue was then partitioned between 80% 
MeOH/I-120 (3 x 500 mL) and PE (3 x 500 mL) to afford fractions 4.C1 
and4.C2. 
Fractions 4.B4 - 4.B7 were combined (787 mg) and the solvents 
removed, in vacuo. The solid residue was then partitioned between 80% 
MeOH/HzO (3 x 200 mL) and PE (3 x 200 mL) to afford fractions 4.D1 
and4.D2. 
Fraction 4.C1 (6.5 g, ICso 491 Jlg/mL) was dried, in vacuo and dissolved 
in 50% MeOH/HzO (15 mL). This solution was subsequently pipetted 
onto the head of a column (40 mm i.d.), packed with C18 phase material 
(1 00 g), equilibrated to 50% MeOH/HzO. Step gradient elution was 
achieved under "flash" conditions to afford fractions 4.E1 - 4.E8, with a 
85% mass recovery. 
Fraction 4.C2 (6.3 g, ICso 229 Jlg/mL) was dried, in vacuo and dissolved 
in PE (15 mL). The resulting solution was pipetted onto the head of a 
column (40 mm i.d.), containing silica (lOOg), equilibrated toPE. Step 
gradient elution afforded fractions 4.F1 - 4.F9, with a 93% mass 
recovery. 
Fraction 4.F3 (198 mg, ICso 56 Jlg/mL) was dried, in vacuo and 
dissolved in PE (5 mL). This solution was pipetted onto the head of a 
column (20 mm i.d.), filled with silica (25 g), equilibrated toPE. Step 
gradient elution afforded fractions 4.G1 - 4.G8, with a 100% mass 
recovery. 
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Scheme 4.2.2 
(Elution solvents and volumes not referred to in text are recorded in scheme) 
Fraction 4.D1 (530 mg, ICso 39 Jlg/mL, Scheme 4.2.1) was coated onto 
celite (1 g) and dried, in vacuo. The solid residue was dry packed onto 
the head of a column (25 mm i.d.), filled with C18 phase material (55 g), 
equilibrated to 25% MeOH/H20. Step gradient elution was achieved 
under "flash" conditions to afford fractions 4.Hl - 4.H8, with a mass 
recovery of 60%. 
Fraction 4.H8 (43 mg, ICso 3.9 jlg/mL) was coated onto celite (80 mg) 
and the solvents removed, in vacuo. The resulting residue was dry 
packed onto the head of a column (10 mm i.d.), containing silica (5 g), 
equilibrated to 50% IPE/PE. Step gradient elution yielded fractions 4.I1 
- 4.!11, with a 92% mass recovery. 
Fractions 4.E2- 4.E6 (Scheme 4.2.1) were combined (817 mg), coated 
onto celite (1.6 g) and solvents removed, in vacuo. The solid was 
subsequently dry packed onto the head of a column (40 mm i.d.), 
containing C18 phase material (80 g), equilibrated to 25% MeOH/H20. 
Step gradient elution was achieved under "flash" conditions to afford 
fractions 4.K1 - 4.K8. 
Scheme 4.2.3 
(Elution solvents and volumes not referred to in text are recorded in scheme) 
Fractions 4.F7 and 4.F8 (Scheme 4.2.1) were combined (344 mg), coated 
onto celite (680 mg) and the solvents removed, in vacuo. The resulting 
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solid residue was dry packed onto the head of a column (25 mm i.d.), 
containing C18 phase material (35 g), equilibrated to 25% MeOH/HzO. 
Step gradient elution was achieved under "flash" conditions to afford 
fractions 4.Ll - 4.L8. 
Fractions 4.L3- 4.L8 were combined (308 mg), coated onto celite (600 
mg) and the solvents removed, in vacuo. The dry residue was packed 
onto the head of a column (20 mm i.d.), containing diol phase material 
(12 g), equilibrated to 50% DCM/PE. Step gradient elution afforded 
fractions 4.Ml - 4.M10. 
Fractions 4.07 and 4.08 were combined (61 mg), coated onto celite 
(120 mg) and the solvents removed, in vacuo. The resulting solid 
residue was dry packed onto the head of a column (20 mm i.d.), 
containing Cl8 phase material (10 g), equilibrated to 25% MeOH/HzO. 
Step gradient elution was achieved under "flash" conditions to afford 
fractions 4.N1 - 4.N8. 
Fraction 4.N6 (1.7 mg) was dried, in vacuo and dissolved in 50% 
MeOH/DCM (100 ~-tL). This solution was pipetted onto the head of a 
column (5 mm i.d.), containing LH-20 (2 g), pre-swelled in 50% 
MeOH/DCM (1 hr). Elution with 50% MeOH/DCM afforded fractions 
4.01 and 4.02 (Scheme 4.2.3). 
Mouse Bioassay Results 
Fraction 4.J3: 20 ~-tg/mouse, 0/1 mice died, MLD > 1.0 mg/kg. 
Fraction 4.Nl0: 28~-tg/mouse, 0/2 mice died, MLD >1.4 mg/kg. 
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Fraction 4.01: 28 !-Lg/mouse, 0/2 mice died, MLD > 1.4 mg/kg. 
Second Extraction 
Frozen oysters (1 kg) were thawed in MeOH (4 L), blended (5 min) and 
filtered through a bed of celite. The extraction was repeated with 80% 
MeOHIH20 (2 L) and the filtrates combined to afford the aqueous 
MeOH extract. The macerated oysters were subsequently extracted with 
DCM (2 x 2 L) and, after filtration, afforded the DCM extract. The aq. 
MeOH extract was concentrated, in vacuo, to water (1 L). This solution 
was poured through a funnel onto the head of a column (100 mm i.d.), 
containing C18 phase material (100 g), equilibrated to H20. The solvent 
was eluted through and the column washed with H20 (300 mL). This 
fraction was discarded. The column was subsequently eluted with 
MeOH (500 mL) and DCM (500 mL). These washings were combined 
with the DCM extract to afford the total organic extract. 
A subsample (2 g) of the total organic extract was dissolved in PE (5 
mL), to which DCM (5 drops) was added to aid in solubility. This 
solution was pipetted onto the head of a column (25 mm), containing 
diol phase material (40 g), equilibrated toPE. Subsequent step gradient 
elution afforded fractions 4.P1- 4.P16 (Fig 4.2.1). 
Isolation of Gymnodimine 
Fraction 4.P13 (Fig 4.2.1) was dried, in vacuo and dissolved in MeOH 
(250 !!L). This solution was pipetted onto the head of a column (5 mm 
i.d.), containing carboxylic acid phase material (3.5 em long), 
228 
Chapter Six - Experimental 
equilibrated to MeOH. Elution was achieved with MeOH (3 mL), 0.5% 
NH3/MeOH (8 mL) and 2% NH3/MeOH (4 mL). 
"Slow Acting" NSP Toxicity 
Scheme 4.2.4 
(Elution solvents and volumes not referred to in text are recorded in scheme) 
The EtOAc partition (11 g) was dried, in vacuo and dissolved in 50% 
DCM/PE (10 mL). This solution was pipetted onto the head of a column 
(25 mm i.d.), containing diol (75 g), equilibrated to 50% DCM/PE. Step 
gradient elution afforded fractions 4.Ql- 4.Q4. 
Fraction 4.Q4 (3.19 g) was dried, in vacuo, coated onto celite (6 g) and 
wetted with 50% MeOHIH20 (10 mL). This material was then added as 
a slurry onto the head of a column (25 mm i.d.), containing C18 phase 
material (100 g), equilibrated to 50% MeOH/H20. Step gradient elution 
afforded fractions 4.R1 - 4.R8. 
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6.5 Work Described In Chapter Five 
6.5.2 Structure Elucidation of Gym nodi mine 
Gymnodimine (40): [apsD = -4.7° (c 7.5x1Q-3, MeOH). LREIMS 
(Canterbury) mlz 507.3. HREIMS (ESR) mlz 507.3343. C32H45N04 
requires 507.3348. Mouse lethality, MLD = 625-835 J..Lg!kg (i.p.). 
6.5.3 
Strategy 
Absolute 
Gymnodimine 
Stereochemistry of 
Preparation of PBBC: p-bromobenzoic acid (2 mg) was refluxed with 
redistilled SOCb (100 !J,L) (1 hr). The SOCb was evaporated under N2 
flow and the solid residue dried under high vacuum (15 min). 
PBBC + gymnodimine: The solid residue above was dissolved in dry 
DCM (1 mL) and an aliquot (500 J..LL) transferred to a reacti-vial (3 mL), 
containing a magnetic flea. Pyridine (2 !J,L) was added, followed by 
gymnodimine (500 ~J,g) in dry DCM (1 mL). The reacti-vial was sealed 
and the reaction stirred, under anhydrous conditions (1 hr). The solvents 
were removed, under high vacuum and the solid re-dissolved in 50% 
MeOH/DCM (2 mL). 
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Reduction of Gymnodimine 
Gymnodimine (6.0 mg) was transferred into a r.b. flask (5 mL), in 
MeOH (2 mL). The solvent was removed under N2 flow. NaCNBH3 
(4.0 mg) was dissolved in MeOH (3.2 mL) and an aliquot (1.2 mL) 
added to the r.b. flask. Acetic acid (5 J.LL) was added and the solution 
stirred (2 hr). The flask contents were transferred into a vial (7 mL) and 
residues washed in with 50% MeOH/DCM (2 x 1 mL). Solvents were 
removed, under N 2 flow and the residue dried under high vacuum (30 
min). The solid material was dissolved in dry DCM (1 mL) then filtered 
through an HP_LC filter (0.45 J.Lm) into a new vial (7 mL). The filter was 
subsequently washed with dry DCM (3 x 1 mL) into the same viaL The 
filter was finally washed with MeOH (5 mL) into a second new vial (7 
mL). Solvents were removed, under N2 flow and the sample dried 
thoroughly under high vacuum (3 hr). 
The DCM soluble material (4.5 mg) was pure gymnodamine. The 
MeOH soluble material was dissolved in 20% MeOH/H20(l% AcOH) 
(100 J.LL) and pipetted onto the head of a cartridge containing C18 phase 
material (100 mg), equilibrated to the same solvent. The cartridge was 
washed with 20% MeOH/H20(1% AcOH) (1.5 mL) and the eluent 
discarded. The cartridge was subsequently washed with MeOH (1.5 
mL). The solvents were removed, under N2 flow and the residue dried 
under high vacuum (3 hr). The combined weights of this material (1.1 
mg) and DCM soluble material (4.5 mg), gave a yield of 93% for the 
reduction. 
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Gymnodamine (52): LREIMS (Canterbury), mlz 509; HREIMS; 
(Canterbury), m/z 509.3495. C32H47N04 requires 509.3505. Mouse 
lethality, MLD = > 4,040 j..lg/kg (i.p.). NMR data: 
8c (CDCb) 174.9 (C1), 146.7 (C3), 138.2 (C9), 135.2 (C17), 132.8 
(C5), 130.3 (C8), 130.0 (C2), 125.9 (C6), 124.8 (C18), 88.8 (C16), 81.2 
(C4), 79.8 (C10), 78.5 (C13), 47.5 (C7), 41.0 (C32), 39.3 (C14), 35.7 
(C15), 34.0 (C12), 20.7 (Me28), 16.7 (Me26), 14.9 (Me29), 11.0 
(Me27), 10.0 (Me25). 
OH (CDCb) 6.85 (lH, brs, H3), 5.75 (lH, brs, H4), 5.45 (1H, t J = 6.8, 
6.9, H18), 5.35 (lH, d J = 11.2, H8), 4.17 (1H, brq J unresovled, H13), 
4.00 (1H, obs., H10), 3.97 (1H, brs, H16), 3.65 (lH, d J = 10.3, H21), 
2.92 (1H, d J = 11.3, H7), 2.76 (lH, m, H32), 2.66 (lH, m, H32), 1.94 
(3H, s, Me25), 1.75 (3H, s, Me27), 1.60 (6H, s, Me26, Me29), 1.09 (3H, 
d J = 7 .4, Me28). 
Formation of Crystalline Derivatives of Gymnodamine 
PBBC + Gymnodamine: gymnodamine (1.0 mg) was transferred to a 
reacti-vial (2 mL), in MeOH (1 mL). The solvent was removed, under 
N2 flow. A lid and septum were placed on the reacti-vial and the sample 
dried thoroughly, under high vacuum (5 hr). PBBC (9.2 mg) was 
dissolved in dry DCM (1 mL). DMAP (7 .2 mg) was dissolved in dry 
DCM (1.44 mL). Hunig's base (37.5 j..lL) was diluted with dry DCM (5 
mL). Aliquots of DMAP solution (10 j..lL), PBBC solution (100 j..lL) and 
Hunig's base solution (100 j..lL) were combined and dry DCM added (90 
JlL). The resulting solution was then injected through the septum of the 
reacti-vial containing gymnodamine, in an ice bath. The reaction was 
stirred, under anhydrous conditions, at ooc (15 min). The reaction 
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mixture was then diluted with DCM (2 mL) and washed with aqueous 
citric acid (10% v/w, 2 mL) and H20 (2 x 2 mL). The organic phase 
was dried over Na2S04 (1 g) and washed with DCM (2 x 1 mL), to 
afford the reaction product (1.2 mg). 
The reaction product (1.2 mg) was dissolved in DCM (100 J.!L) and 
pipetted onto the head of a cartridge containing diol phase material (200 
mg), equilibrated to DCM. Elution with DCM (2 mL) and 10% 
MeOH/DCM (3 mL), afforded 2 fractions. The 10% MeOH/DCM 
fraction (0.9 mg) was dissolved in DCM (75 J.!L). Aliquots (15 J.!L) were 
injected into an analytical diol HPLC column (5 separate runs), 
equilibrated to 1.5% MeOH/DCM and running at 1 mL/min. The peak 
eluting at Rt = 200 s was the amide (56) (0.7 mg, 51% yield). 
p-bromobenzamide (56): LRFABMS (NOBA) (Canterbury); [M+H]+ 
692.3/694.3. melting point 251-253 °C. 
BsCl + Gymnodamine: gymnodamine (1 mg) was transferred into a 
reacti-vial (1 mL) in MeOH (500 J.!L) and solvent removed under N2 
flow. The reacti-vial was sealed and dried thoroughly under high 
vacuum (5 hr). BsCl (32 mg) was dissolved in dry pyridine (2.13 mL) 
and an aliquot (100 J.!L) injected into the reacti-vial. Hunig's base (5 J.!L) 
was added and the reaction stirred (24 hr), under anhydrous conditions. 
Pyridine was removed, under N2 flow and the residue dried thoroughly 
under high vacuum. The material was transferred into a new vial (7 mL) 
with MeOH (2 mL), DCM (2 mL) and H20 (1 mL). All solvents were 
removed under N2 flow and the residue dried thoroughly under high 
vacuum. The solid material was dissolved in dry DCM (1 mL) and 
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filtered through an HPLC filter (0.45 J..Lm) into a new vial (7 mL). The 
filter was then washed with dry DCM (3 x 1 mL) into the same vial. The 
filter was finally washed with MeOH (5 mL) into a second new vial (7 
mL). Solvents were removed under N2 flow and the sample dried 
thoroughly under high vacuum (3 hr). 
The DCM soluble material (3.8 mg) was dissolved in MeOH (100 J..LL) 
and pipetted onto the head of a cartridge containing amino phase 
material (200 mg), prepared by washing with 2% NH3/MeOH (6 mL) 
and equilibrated to MeOH (10 mL). The cartridge was washed with 
MeOH (1 mL) to afford the reaction product (0.9 mg). 
The reaction product (0.9 mg) was dissolved in 50% DCM/PE (200 J!L) 
and pipetted onto the head of a cartridge containing diol phase material 
(1 00 mg), equilibrated to the same solvent mixture. The cartridge was 
subsequently washed with 50% DCM/PE ( 400, 200 J..LL), 80% DCM/PE 
(2 x 200 IlL), DCM (2 x 400 J..LL) and MeOH (1 mL). Seven fractions 
were collected. The first fraction eluting at 80% DCM/PE (0.5 mg) was 
the reaction product. 
CSCl + Gymnodamine: gymnodamine (500 !lg) was transferred into a 
reacti-vial (1 mL) in MeOH (500 IlL) and solvent removed under N2 
flow. The reacti-vial was sealed with a septum and dried thoroughly 
under high vacuum (5 hr). CSCl (11.4 mg) was dissolved in dry 
pyridine (1.52 mL) and an aliquot (100 IlL) injected into the reacti-vial. 
Hunig's base (5 IlL) was injected and the reaction stirred (24 hr). 
Solvents were removed under N2 flow and sample dried under high 
vacuum (3 hr). The residue was transferred into a new vial (7 mL) with 
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MeOH (2 mL), DCM (2 mL) and H20 (1 mL). All solvents were 
removed under N 2 flow and the sample dried thoroughly under high 
vacuum. The solid material was dissolved in dry DCM (1 mL) and 
filtered through an HPLC filter (0.45 ~m) into a new vial (7 mL). The 
filter was then washed with dry DCM (3 x 1 mL) into the same vial. The 
filter was finally washed with MeOH (5 mL) into a second new vial (7 
rnL). Solvents were removed under N2 flow and the sample dried 
thoroughly under high vacuum (3 hr). 
The DCM soluble material (1.8 mg) was dissolved in MeOH (100 J..LL) 
and pipetted onto the head of a cartridge containing amino phase 
material (200 mg), prepared by washing with 2% NH3/MeOH (6 mL) 
and equilibrated to MeOH (10 mL). The cartridge was washed with 
MeOH (1 mL) to afford the reaction product (0.4 mg). 
The reaction product (0.4 mg) was dissolved in 50% DCM/PE (200 J..LL) 
and pipetted onto the head of a cartridge containing diol phase material 
(1 00 mg), equilibrated to the same solvent mixture. The cartridge was 
subsequently washed with 50% DCM/PE ( 400, 200 J..LL), 80% DCM/PE 
(2 x 200 J.1L), DCM (2 x 400 J..LL) and MeOH (1 mL). Seven fractions 
were collected. 
Second Reduction of Gymnodamine: gymnodimine (8.0 mg) was 
transferred into a r.b. flask (5 rnL) in MeOH (2 mL) and solvent 
removed under N2 flow. NaCNBH3 (6.8 mg) was dissolved in MeOH 
(3.4 mL) and an aliquot (1 rnL) added to the r.b. flask. AcOH (5 J..LL) 
was added and the reaction stirred (4.5 hr). All solvents were removed 
under N2 flow and residue dried thoroughly under high vacuum (2 hr). 
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The sample was dissolved in dry DCM (1 mL) and filtered through an 
HPLC filter (0.45 ~m). The r.b. flask was subsequently washed with dry 
DCM (4 x 1 mL) and passed through the filter. The DCM soluble 
material was pure gymnodamine (8.0 mg, 100% yield). 
PBBC + Gymnodamine: gymnodamine (8.0 mg), was transferred into a 
reacti-vial (4 mL) in MeOH (2 mL). Solvent was removed under N2 
flow, the reacti-vial was sealed and the sample dried thoroughly under 
high vacuum (3 hr). PBBC (23.0 mg), freshly recrystallised from PE, 
was dissolved in dry DCM (2.61 mL). DMAP (3.6 mg) was dissolved in 
dry DCM (7 .35 mL). Aliquots of PBBC and DMAP solutions (500 ~L) 
were injected into the reacti-vial, in an ice bath (0 °C). Hunig's base 
(3.47 J.LL) was injected and the solution stirred at 0 °C (30 min). H20 
(100 ~L) was added, solvents removed under N2 flow and residue dried 
thoroughly, under high vacuum. The reaction material was dissolved in 
DCM (2 mL) and washed with aqueous citric acid (10% v/w, 2 mL) and 
H20 (2 x 1 mL). The DCM phase was dried over Na2S04 (2 g). 
The DCM soluble material was re-dissolved in DCM (150 JlL) and 
chromatographed in ten replicate runs (15 ~Leach) through an analytical 
diol HPLC column, equilibrated to DCM (1 mL/min). After each run 
the column was washed with 5% MeOH/DCM (5 mL) and re-
equilibrated to DCM (10 mL). Six fractions were collected. The peak 
eluting at Rt = 350 s, was pure p-bromobenzamide (56) (4 mg, 37% 
yield). 
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C1ystal Structure ofp-Bromobenzamide (56) 
Recrystallisation of (56): Material transferred into a Craigie tube (5 mm 
i.d.) in DCM (500 ~L) and solvent removed under high vacuum (1 hr). 
The sample was dissolved in DCM (100 ~L) and benzene (100 ~L) 
added. The tube was partially sealed with a glass rod and kept at 0 oc 
(10 days). The resulting crystalline solid was removed, covered with 
H20 and two crystals separated from the bulk material with a needle. 
NMR Assignment ofp-Bromobenzamide (56) 
p-bromobenzamide (56): LRFABMS (NOBA) (Canterbury); [M+H]+ 
692.1/694.1; HRFABMS (NOBA) (Canterbury); [M+H]+ 692.2971, 
C39H51NOsBr requires 692.2951. 
6.5.4 Hapten Design and Synthesis of 
Gymnodimine 
Svnthesis 
. 
Gymnodamine +Succinic Semialdehyde: gymnodamine (2.0 mg) was 
transferred into a vial (7 mL) in MeOH (500 ~L). Solvent was removed 
under N2 flow and the sample dried thoroughly under high vacuum (5 
hr). Succinic semialdehyde (2.0 mg) was dried thoroughly under high 
vacuum and dry MeOH (100 ~L) added. NaCNBH3 (6.3 mg) was 
dissolved in dry MeOH (2.1 mL). The succinic semialdehyde solution 
was added to the reaction vial followed by an aliquot (100 ~L) of the 
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NaCNBH3 solution, AcOH (1 ~L) and dry MeOH (1.8 mL). Finally, a 
magnetic flea and five molecular sieves (type 4A) were added to the vial. 
The vial was sealed with a lid and parafilm and the reaction stirred (3 
days). The vial contents were filtered through celite (1 g) and washed 
with MeOH (5 mL). The eluent was subsequently passed through an 
HPLC filter (0.45 ~m) and the filter washed with MeOH (2 mL). The 
solvent was removed under N2 flow and the residue dried under high 
vacuum. 
The residue was dissolved in 20% MeOHIH20(l% AcOH) (100 ~L) and 
pipetted onto the head of a column (5 mm i.d.), containing C18 material 
(4 em), equilibrated to 20% MeOHIH20(l% AcOH). The column was 
washed with a succession of solvents from 20%-70% MeOH/H20(1% 
AcOH), with five fractions collected (1.5 mL/fraction). The fraction 
eluting at 70% MeOHIH20(l% AcOH) was the gymnodamine-amine 
linker (59)(1.5 mg, 64% yield). 
Gymnodamine-amine linker (59): HRFABMS (NOBA) (Canterbury); 
[M+H]+ 596.3965, C36Hs4N06 requires 596.3951. NMR data: 
OH (CD30D) 7.12 (lH, brs, H3), 5.85 (lH, brs, H4), 5.60 (lH, brs, H18), 
5.34 (lH, d J = 11.2, H8), 4.16 (1H, brq J unresolved, H13), 4.05 (lH, 
brs, H16), 3.97 (1H, d J = 10.2, H10), 2.91 (2H, brt, 12.2, 9.7, H1'), 2.40 
(2H, obs, H3'), 1.93 (3H, s, Me25), 1.70 (3H, s, Me27), 1.65 (2H, obs, 
H2'), 1.58 (6H, s, Me26, Me29), 1.11 (3H, d J = 6.9, Me28). 
Piperidine + Succinic Semialdehyde: succinic semialdehyde (1.5 mg) 
was dried thoroughly, in a vial (7 mL), under high vacuum (3 hr). 
NaCNBH3 (3.7 mg) was dissolved in dry MeOH (3.27 mL) and an 
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aliquot (1 mL) was added to the reaction vial. Piperidine (7 .4 )lL) was 
added, the vial was sealed with a lid and parafilm and the reaction stirred 
(41 hr). Solvent was removed under N2 flow and residue dried 
thoroughly under high vacuum (4 hr). The reaction product was (60). 
Compound (60): NMR data: 
8H (D20) 3.02 (4H, t, J = 5.4, 5.8, H1/H5), 2.85 (2H, t, J = 7.4, 8.3, 
H1'), 2.15 (2H, t, J = 6.9, 7.3, H3'), 1.78 (2H, dt, J = 7.3, 7.8, 7.4, 7.3, 
H2'), 1.65 (4H, m, H2/H4), 1.50 (2H, m, H3). 
Gymnodamine + Succinic Anhydride: gymnodamine (2.0 mg) was 
transferred into a reacti-vial (1 mL), in MeOH (500 JlL). The solvent 
was removed under N2 flow, the reacti-vial was sealed and the residue 
dried thoroughly under high vacuum (3 hr). DMAP (4.8 mg) was 
dissolved in dry pyridine (8.42 mL) and succinic anhydride (7.2 mg) was 
also dissolved in dry pyridine (1.53 mL). Aliquots (83 )lL) of each 
solution were injected into the reacti-vial and the reaction stirred (17 hr). 
Pyridine was removed under N2 flow. The solid residue was 
subsequently washed into a vial (2 mL) three times with MeOH (3 x 500 
)lL). Solvent was removed under N2 flow and the residue dried 
thoroughly under high vacuum (3 hr). 
This sample was dissolved in MeOH (60 )lL). Aliquots (15 )lL) were 
chromatographed, in four replicate runs, on an analytical reverse phase 
Cl8 HPLC column, equilibrated to 60% MeOHIH20(0.05% TFA) (1 
mL/min). The fraction eluting at Rt = 5.0 min was gymnodamine, while 
the fraction eluting at Rt = 10.2 min was the gymnodamine-amide linker 
(61). 
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gymnodamine-amide linker (61): HRFABMS (NOBA) (Canterbury); 
[M+H]+ 610.3741, C36H52N07 requires 610.3744. NMR data: 
OH (CD30D) 7.12 (1H, brs, H3), 5.85 (1H, brs, H4), 5.45 (lH, brm, 
H18), 5.21 (lH, d J = 10.8, H8), 4.42 (1H, brd J = 10.8, H21), 4.15 (1H, 
brm, H13), 3.91 (1H, brs, H16), 3.80 (lH, brd J = 14.6, H10), 3.03 (2H, 
brt J unresolved), 2.97 (lH, brd J = 10.3, H7), 2.58 (4H, brm, H2'/H3'), 
1.89 (3H, s, Me25), 1.76 (3H, s, Me27), 1.66 (6H, s, Me26/Me29), 1.07 
(3H, d J = 6.8, Me28). 
Piperidine + Succinic Anhydride: DMAP (4.8 mg) was dissolved in dry 
pyridine (8.42 mL) and succinic anhydride (7.2 mg) was dissolved in dry 
pyridine (1.53 mL). Aliquots (100 J.tL) of each were injected into a dry 
reacti-vial (1 mL), followed by piperidine (0.385 J.t,L). The reaction was 
stirred under anhydrous conditions (17 hr). Pyridine was removed under 
N2 flow and the residue dried thoroughly under high vacuum (3 hr). The 
reaction product was (62). 
Compound (62): NMR data: 
OH (CD30D) 3.51 (4H, q, J = 5.3, 5.4, 5.4, H1/H5), 2.64 (2H, t, J = 6.8, 
6.4, H2' or H3'), 2.52 (2H, t, J = 6.3, 6.1, H2' or H3'), 1.65 (4H, m, 
H2/H4), 1.52 (2H, m, H3). 
Gymnodamine + PMPI: gymnodamine (1.5 mg) was transferred into an 
NMR tube in DCM (150 J.t,L) and a supa-seal placed on the end of the 
tube. Solvent was removed under high vacuum (5 hr). PMPI (1.2 mg) 
was dissolved in 0.1% d5-pyridine/CDC13 (260 IlL). An aliquot (150 
IlL) was removed and injected into the NMR tube. Parafilm was applied 
around the supa-seal to minimise moisture influx. The reaction was 
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monitored by lH NMR at t (hr) = 0.5, 1.5, 3.5, 7, 25 and 98. The 
material was transferred from the NMR tube into a vial (7 rnL) and the 
tube washed with DCM (250 JlL) and EtOAc (250 JlL). The solvents 
were evaporated under N2 flow. The solid residue was dissolved in 
DCM (500 JlL) and passed through an HPLC filter (0.45 Jlm) into a new 
vial (2 mL). The filter was washed twice more with DCM (2 x 500 JlL). 
The filter was finally washed with EtOAc (1 rnL) and ACN (1 mL) into 
a second vial (7 mL). 
The DCM soluble material was dried thoroughly under N2 flow and 
dissolved in ACN (60 JlL). Aliquots (15 JlL) were injected in four 
replicate runs·on an analytical reverse phase C18 column, equilibrated to 
40% ACN/H20 (1 mL/min). A gradient elution of 40% ACN/H20 to 
80% ACNIH20 (12 min) followed by 80% ACNIH20 (3 min) was used 
from which seven fractions were collected. The peak eluting at Rt = 9.0 
min was the gymnodamine-urea maleimide linker (63), while the peak 
eluting at Rt = 10.3 min was considered to be the gymnodamine-di-
urea/carbamate maleimide linker (64). 
Gymnodamine-urea maleimide linker (63): HRFABMS (NOBA) (NIH); 
[M+H]+ 724.3990, C43H54N307 requires 724.3961. NMR data: 
OH (CDC}J) 7.43 (2H, d J = 8.3, H3'/H7' or H4'/H6'), 7.23 (2H, obs.d J 
unresolved, H3'/H7' or H4'/H6'), 6.85 (lH, brs, H3), 6.82 (2H, s, 
H9'H10'), 5.72 (1H, brs, H4), 5.37 (1H, brm, H18), 5.22(1H, brd J = 
11.2, H8), 4.14 (lH, brm, H13), 3.98 (lH, obs, HlO), 3.92 (lH brs, 
H16), 3.65 (1H, brs, H7), 1.93 (3H, s, Me25), 1.78 (3H, s, Me27), 1.65 
(3H, s, Me26), 1.60 (3H, s, Me29), 1.08 (3H, d J = 6.8, Me28). 
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Gymnodamine-di-linked product (64): LRFABMS (NOBA) (NIH); no 
molecular ion observed. NMR data: 
OH (CDCb) 7.45 (4H, brm, H3'/H7'/H3"/H7" or H4'/H6'/H4"/H6"), 7.25 
(4H, obs, H3'/H7'/H3"/H7'' or H4'/H6'/H4"/H6"), 6.83 (2H, s, H9'/H10' 
or H9"/H10"), 6.82 (2H, s, H9'/H10' or H9"/H10"), 6.61 (1H, brs, H3), 
5.69 (lH, brs, H4), 5.45 (1H, brm, H10), 5.40 (lH, brm, H18), 5.09 (lH, 
brd J = 11.0, H8), 4.18 (lH, brm, H13), 3.93 (lH, brs, H16), 1.92 (3H, s, 
Me25), 1.78 (3H, s, Me27), 1.66 (3H, s, Me26), 1.60 ( obs, Me29), 1.08 
(3H, brd J unresolved). 
6.5.5 Large Scale Isolation Scheme 
First Extraction 
Frozen oysters (12.5 kg) were lyophilised (2 days). The dried oysters 
(2.5 kg) were crushed to form a coarse powder and weighed into 
portions (100 g). 
The following protocol was applied to each portion: 
(1) One portion of freeze dried oysters (100 g) was stirred with DCM 
(250 mL, 60 min) and filtered. This was process was repeated 
twice with DCM (2 x 250 mL, 30 min), on the filter cake. All 
three extracts were combined as the total DCM extract. 
(2) The filter cake was stirred with 80% MeOH/H20 (250 mL, 60 
min) and filtered. This process was repeated twice more with 80% 
MeOHIH20 (2 x 250 mL, 30 min). All three aq. MeOH extracts 
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were combined and residual DCM removed by under vacuum. 
This afforded the total aq. MeOH extract. 
(3) The total DCM extract was evaporated to dryness and dissolved in 
PE (250mL). 
(4) The extracts from steps (2) and (3) were shaken together 
vigorously (5 min) in a separating funnel (2L) and left for the two 
phases to separate. 
(5) The aq. MeOH layer was run off and poured into a second 
separating funnel (2L). This solution was then shaken further with 
PE (2 x 250 mL, 5 min). 
(6) All three PE partitions were combined and PE removed by roto-
vap. The PE extract was coded as OPhex· 
(7) The aq. MeOH layer was run off. 
Scheme 5.5.1 
(Elution solvents and volumes not referred to in text are recorded in scheme) 
The total aq. MeOH partition (5.A(M/W)) was concentrated, in vacuo, to 
H20 (2 L). The aqueous extract was subsequently partitioned against 
EtOAc five times (1000, 2 x 750, 2 x 500 mL), to afford 5.A(Et0Ac) 
and 5.A(H20). 
The pH of 5.A(H20) was checked with narrow band (4-6) pH paper. 
This extract was made to pH 8.5, by slow addition of NaHC03 (with 
stirring) and the pH checked regularly with narrow band (8-10) pH 
paper. The volume was made to 2.5 L with H20 and partitioned against 
· EtOAc (2 L). The resulting emulsion was broken by filtration through a 
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bed of celite. The aqueous layer was then partitioned three times against 
EtOAc (3 x 1 L). 
Purification of Gymnodimine 
The total EtOAc partition ( 450 mg) was coated onto celite (900 mg) and 
solvents removed, in vacuo. The dried residue was wetted with PE (1 
mL) and slurried onto the head of a column (25 mm i.d.), containing diol 
(20 g), equilibrated to PE. Step gradient elution using 
PE/DCM/EtOAc/MeOH mixtures afforded twelve fractions (50 
mL/fraction), with 100% mass recovery. 
Fractions 4- 6 were combined (124 mg) and dried, in vacuo. The dried 
solid was dissolved in 5% MeOH/DCM (2 mL) and pipetted onto the 
head of a column (10 mm i.d.), containing carboxylic acid phase 
material (2.5 g), prepared by washing with MeOH (40 mL) and 
equilibrated to 5% MeOH/DCM. Subsequent elution was achieved with 
5% MeOH/DCM (20 mL), MeOH (20 mL) and 1% NH3/MeOH (40 
mL). 
The 1% NH3/MeOH fraction (5.5 mg) was dried thoroughly, in vacuo, 
dissolved in DCM (200 ~-tL) and pipetted onto. a cartridge containing 
cyano phase material (200 mg), equilibrated to DCM. Elution was 
achieved with DCM (5 mL), 25% IPA/DCM (5 mL), 50% IPA/DCM (5 
mL), IP A (5 mL) and MeOH (5 mL). 
The fraction eluting with DCM (3.0 mg) was dried, under N2 flow and 
dissolved in MeOH (300 ~-tL). This solution was injected on to a semi-
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preparative cyano HPLC column, equilibrated to 60% 
Me0H!ff20(0.05% TFA) (5 mL/min). Three fractions were collected 
with UV detection at 210 nm. The fractions collected had retention 
times of 0- 12, 12- 15, 15 - 24 min, respectively. 
The fraction eluting at 15- 24 min was dried, in vacuo and dissolved in 
MeOH (1 00 J.tL). This solution was injected (in five replicate HPLC 
runs of 20 J.tL each) on to an analytical cyano HPLC column, 
equilibrated to 70% MeOH/H20(0.05% TFA) (1 mL/min). The peak 
eluting at 17.5 min was gymnodimine (1 mg, 8xl0-6 yield, wet weight)). 
Second Extraction 
Scheme 5.5.2 
Frozen oysters (5 kg) were thawed in MeOH (4 L), blended (5 min) and 
filtered through a bed of celite. This process was repeated twice more 
with MeOH (4, 2 L). The extracts were all combined and concentrated 
to H20 (2 L), in vacuo. The aqueous extract was then made to a volume 
of 3 L with H20. The pH was lowered to 4.5 by gradual addition of 
AcOH (with stirring) and monitoring with narrow band (4-6) pH paper. 
The acidic aqueous extract was subsequently partitioned twice against 
DCM (2 x 2.5 L) to afford 5.B(DCM) as the organic phase. The aqueous 
phase was then adjusted to pH 8.5, with gradual addition of NaHC03 
(with stirring) and monitoring with narrow band (8-10) pH paper. The 
alkaline aqueous extract was then partitioned four times against EtOAc 
(4 x 1.5 L). 
245 
Chapter Six - Experimental 
Aliquots (25 mg each) of 5.B(DCM) and 5.B(Et0Ac) were dissolved in 
0.1% AcOH 190% MeOH 110% H20 (500 IlL each) and pipetted onto 
separate carboxylic acid cartridges (1 g), prepared by washing with 
MeOH (5 mL) and 0.1% AcOH I 90% MeOH I 10% H20 (10 mL). 
Each cartridge was washed with 0.1% AcOH 190% MeOH 110% H20 
(2.5 mL), MeOH (1 mL) and 2% NH3/MeOH (5 mL). 
Scheme 5.5.3 
Fraction 5.B(DCM) (13 g, Scheme 5.5.2) was dried, in vacuo and 
partitioned between ether (2 x 2 L) and 0.1% AcOHIH20 (2, 1, 1 L). 
The acidic aqueous phase was adjusted to pH 8.5 by gradual addition of 
NaHC03 (with stirring) and monitoring with narrow band (8-10) pH 
paper. The resulting alkaline aqueous solution was partitioned three 
times against EtOAc (3 x 1.5 L) to afford 5.E(Et0Ac) and 5.E(H20). 
Scheme 5.5.4 
Fraction 5.E(Et0Ac) (150 mg, Scheme 5.5.3) was dried, in vacuo and 
dissolved in 0.1% AcOH I 90% MeOH I 10% H20 (3 mL). This 
solution was subsequently pipetted onto the head of a column (25 mm 
i.d.), containing carboxylic acid phase material (30 g), prepared by 
washing with 0.1% AcOH I% MeOH 110% H20 (250 mL), 2% AcOH I 
88% MeOH 110% H20 (250 mL) and 0.1% AcOH /90% MeOH 110% 
H20 (250 mL). Solvent elution afforded fractions 5.F1 - 5.F3. 
Fraction 5.F3 (11.5 mg) was dissolved in MeOH (200 IlL) and 
chromatographed (in ten replicate runs of 20 ~-tL/run) on an analytical 
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reverse phase C18 HPLC column, equilibrated to 70% 
MeOHIH20(0.05% TFA) (1 mLimin). The peak eluting at 4.1 min was 
gymnodimine (5 mg, 1x10-4 yield, wet weight). 
Third Extraction 
Scheme 5.5.5 
Frozen oysters (1 0 kg) were lyophilised. The dried flesh was crushed to 
form a coarse powder (2 kg). The powder was then divided into three 
equal portions and each extracted separately as follows: 
The powder was extracted with 60% MeOH I 39% H20 I 1% AcOH (3 
L) and filtered through a bed of celite. The extraction process was then 
repeated twice more with the same solvent system (2 x 2 L). The 
aqueous methanol extracts were all combined and concentrated, in 
vacuo, to H20 (1.5 L). The volume was then increased to 3 L with 
further H20, and the pH adjusted to 7 by careful addition of NH3 (with 
stirring) and pH monitoring with narrow band (4-6 and 8-10) pH paper. 
After neutralisation, the solution was adjusted to pH 8.5 with gradual 
addition of NaHC03 (with stirring) and monitoring by narrow band (8-
10) pH paper. Each alkaline aqueous extract was subsequently 
partitioned three times against DCM (2, 2, 1 L). Combination of each 
DCM partition gave the total DCM extract (5.G(DCM). 
Extract 5.G(DCM) was dried, in vacuo and partitioned twice between 
ether (2 x 2 L) and 0.5% AcOH/H20 (2 x 2 L). Residual ether was 
removed from the acidic H20 phase, in vacuo and the acidic aqueous 
solution neutralised by careful addition of NH3, with constant stirring 
and frequent monitoring with narrow band (4-6 and 8-10) pH paper. The 
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neutral solution was then adjusted to pH 8.5 with gradual addition of 
NaHC03 (with stirring) and by monitoring with narrow band (8-10) pH 
paper. The alkaline solution was then partitioned three times against 
EtOAc (3 x 1.5 L). The EtOAc phase was dried with anhydrous Na2S04 
to afford 5.G(Et0Ac). 
Final Purification of Gymnodimine 
Fraction 5.G(Et0Ac) (230 mg, Scheme 5.5.5) was dissolved in DCM (2 
mL) and pipetted onto the head of a column (25 mm i.d.), containing 
diol(Mk) (25 g), equilibrated to 50% DCM/PE. Step gradient elution of 
50% DCM/PE (50 mL), 65% DCM/PE (50 mL), 80% DCM/PE (100 
mL), DCM (100 mL), 1 %TEA/DCM (100 mL) and MeOH (100 mL) 
afforded six fractions, with 99% mass recovery. 
The fraction eluting at 80% DCM/PE was acidified by addition of AcOH 
(0.5 mL). Excess AcOH was removed, in vacuo. This sample (48 mg) 
was dissolved in DCM (1 mL) and pipetted onto the head of a column 
(15 mm i.d.), containing diol(Bb) phase material (5 g), equilibrated to 
DCM. Step gradient elution of DCM (6 mL), DCM (9 mL), 50% 
EtOAc/DCM (12 mL), EtOAc (15 mL), 10% MeOH/EtOAc (15 mL) 
and MeOH (20 mL) afforded six fractions, with 100% mass recovery. 
Fourth Extraction 
Frozen oysters (5 kg) were thawed in 80% MeOH/19% H20/1% AcOH 
(4 L), blended and filtered through a bed of celite. This extraction 
process was repeated with the same solvent system (4 L). Extracts were 
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combined and concentrated, in vacuo, to H20 (2 L). The volume was 
increased to 3 L by the addition of further H20 and the pH adjusted to 7 
by careful addition of NH3, with constant stirring and frequent 
monitoring with narrow band ( 4-6 and 8-1 0) pH paper. The neutral 
solution was then adjusted to pH 8.5 with gradual addition of NaHC03 
(with stirring) and monitoring by narrow band (8-1 0) pH paper. The 
alkaline solution was partitioned three times against DCM (3, 2, 2 L). 
The DCM phase was dried, in vacuo and partitioned twice between ether 
(2 x 250 mL) and 0.5% AcOH/H20 (2 x 250 mL). Residual ether was 
removed, in vacuo and the resulting solution adjusted to pH 7 by careful 
addition of NH3, with constant stirring and frequent monitoring with 
narrow band (4-6 and 8-10) pH paper. The neutral solution was then 
adjusted to pH 8.5 with gradual addition of NaHC03 (with stirring) and 
monitoring by narrow band (8-1 0) pH paper. The alkaline aqueous 
solution was partitioned three times against EtOAc (3 x 200 mL). The 
EtOAc phase was subsequently dried over anhydrous Na2S 04, to 
achieve the total EtOAc partition. 
The total EtOAc partition (298 mg) was dried, in vacuo, dissolved in 
50% DCM/PE (1 mL) and pipetted onto the head of a column (25 mm 
i.d.), containing diol(Mk) (30 g), equilibrated to 50% DCM/PE. Step 
gradient elution of 50% DCM/PE (4 fractions), 65% DCM/PE (3 
fractions), 75% DCM/PE (3 fractions), 80% DCM/PE (5 fractions), and 
MeOH (1 fraction) (20 mL fraction volumes) afforded sixteen fractions, 
with a 97% mass recovery. 
Fractions containing gymnodimine were combined (79 mg) and dried, in 
vacuo. The residue was dissolved in MeOH (1 mL) and pipetted onto 
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the head of a column (17 mm i.d.), containing amino phase (10 g), 
prepared by washing with 2% NH3/MeOH (50 mL) and MeOH (250 
mL). Elution with MeOH afforded gymnodimine (8.4 mg, 1.68xl0-4 
yield, wet weight). 
6.5.6 Development of a Chromatography Based 
Assay for Gymnodimine 
Methodology 
Shellfish: 
(1) Take shucked and frozen shellfish (75 g) and thaw in 
0.1 %AcOH/80% MeOH/20% H20 (180 mL)(5 minutes). Blend 
(30 seconds) and filter, under vacuum, through Whatman filter 
paper (grade 1, 9 em diameter) into a Buchner flask (1000 mL). 
Note: filtration is slow. 
(2) Re-extract with the same solvent (120 mL), filter as before and 
combine both extracts. 
(3) Transfer into a r.b. flask (1000 mL) and remove the MeOH by 
rotary evaporation until only water remains in the extract. Note: 
care should be taken as foaming or bumping may occur. 
(4) Dilute the extract with distilled water to achieve a volume of 200 
mL. Adjust the pH to 8 - 8.5 using NaHC03 and transfer into a 
separating funnel (500 mL). Wash the insoluble material in with 
DCM (2 x 100 mL). 
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(5) Shake the separating funnel (with the pressure released as 
required) and leave the phases to separate. Run the lower DCM 
layer off. 
(6) Repeat step (5) with more DCM (200 mL). Combine DCM 
partitions and remove solvent by rotary evaporation. 
(7) Dissolve the extract in diethyl ether (200 mL) and transfer into the 
same separating funnel as before. Wash the r.b. flask with 0.5% 
AcOH/H20 (2 x 100 mL) and add to the separating funnel. 
(8) Shake the separating funnel as before and let phases separate. Run 
off lower aqueous phase. Repeat with 0.5% AcOHIH20 (200 mL) 
and combine aqueous layers. 
(9) Wash the aqueous partition once more with diethyl ether (50 mL). 
(1 0) Take aqueous partition and remove residual ether by rotary 
evaporation. Adjust the pH to 8- 8.5 as in step (4). 
(11) Partition 3 times with EtOAc (3 x 200 mL). Combine the EtOAc 
partitions. 
(12) Run the EtOAc partition through a bed of Na2S04 (2 g) into a r.b. 
flask (1000 mL). 
(13) Remove EtOAc by rotary evaporation and dissolve in MeOH (3 x 
2 mL) and transfer to a vial (7 mL). 
(14) Remove solvent under N2 and dissolve sample 1n 5% 
MeOH/DCM (100 ~L) for TLC analysis. 
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Algae: 
Algae were received impregnated onto filter paper at 0 °C. 
(1) Take frozen algae/filter paper and blend in 0.1 %AcOH/80% 
MeOH/20% H20 (150 mL)(30 seconds) and filter, under vacuum, 
through Whatman filter paper (grade 1, 9 em diameter) into a 
Buchner flask (1000 mL). Note: filtration is slow. 
(2) Re-extract with the same solvent (100 mL), filter as before and 
combine both extracts. 
(3) Transfer into a r.b. flask (500 mL) and remove the MeOH by 
rotary evaporation until only water remains in the extract. Note: 
care should be taken as foaming or bumping may occur. 
(4) Dilute the extract with distilled water to achieve a volume of 50 
mL. Adjust the pH to 8 8.5 using NaHC03 and transfer into a 
separating funnel (250 mL). Wash the insoluble material in with 
DCM (2 x 25 mL). 
(5) Shake the separating funnel (with the pressure released as 
required) and leave the phases to separate. Run the lower DCM 
layer off. 
(6) Repeat step (5) with more DCM (50 mL). Combine DCM 
partitions and remove solvent by rotary evaporation. 
(7) Dissolve the extract in diethyl ether (50 mL) and transfer into the 
same separating funnel as before. Wash the r.b. flask with 0.5% 
AcOH/H20 (2 x 25 mL) and add to the separating funnel. 
(8) Shake the separating funnel as before and let phases separate. Run 
off lower aqueous phase. Repeat with 0.5% AcOHIH20 (50 mL) 
and combine aqueous layers. 
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(9) Wash the aqueous partition once more with diethyl ether (50 mL). 
(10) Take aqueous partition and remove residual ether by rotary 
evaporation. Adjust the pH to 8 8.5 as in step (4). 
(11) Partition 3 times with EtOAc (3 x 50 mL). Combine the EtOAc 
partitions. 
(12) Run the EtOAc partition through a bed of NazS04 (1 g) into a r.b. 
flask (250 mL). 
(13) Remove EtOAc by rotary evaporation and dissolve in MeOH (3 x 
2 mL) and transfer into a vial (7 mL). 
(14) Remove solvent under Nz and dissolve sample 1n 5% 
MeOH/DCM (100 jlL) for TLC analysis. 
253 
eferences 
References 
1. Smith, P.; Chang, F.H.; Mackenzie, L. Toxic Phytoplankton and 
Algal Blooms, Summer 1992/93. Marine Toxins and New 
Zealand Shellfish, 1993, 11-17. The Royal Society of New 
Zealand, Wellington, New Zealand. 
2. Toxic Marine Phytoplankton. Graneli, E.; Sundstrom, B.; Edler, 
L.; Anderson, D.M., Eds., 1989, Elsevier, New York, U.S.A. 
3. Till, D.G. Public Health Issues. Marine Toxins and New 
Zealand Shellfish, 1993, 41-44. The Royal Society of New 
Zealand, Wellington, New Zealand. 
4. Eastaugh, J.; Shepherd, S. Infectious and Toxic Syndromes from 
Fish and Shellfish Consumption. A Review. Archives of Internal 
Medicine, 1989, 149, 1735-1740. 
5. Yasumoto, T.; Murata, M. Chem. Rev., 1993, 93, 1897-1909. 
6. Shimizu, Y. Chem. Rev., 1993,93, 1685-1698. 
7. Harada, T.; Oshima, Y.; Yasumoto, T. Agric. Biol. Chem., 
1983, 47, 191. 
8. Carmichael, W.W. The Toxins of Cyanobacteria. Scientific 
American, 1994, 2 70(1 ), 68. Diagram re-produced by kind 
permission of Scientific American, Inc. 
9. Laverty, R. Modes of Action of Shellfish Toxins. Marine 
Toxins and New Zealand Shellfish, 1993, 31-34. The Royal 
Society of New Zealand, Wellington, New Zealand. 
10. Yasumoto, T.; Yasumara, D.; Yotsu, M.; Michishita, T.; Endo, 
A.; Kotaki, J. Agric. Biol. Chem., 1986, 50, 793-795. 
11. Simidu, U.; Kita-Tsukamoto, K.; Yasumoto, T.; Yotsu, M. Int. J. 
System. Bacterial., 1990, 40, 331. 
12. Noguchi, T.; Jeon, J.K.; Arakawa, 0.; Sugita, H.; Deguchi, Y.; 
Shida, Y.; Hashimoto, K. J. Biochem., 1986,99, 311-314. 
255 
References 
13. Simidu, U.; Noguchi, T.; Hwang, D.F.; Shida, Y.; Hashimoto, K. 
Appl. Env. Microbial., 1987, 53, 1714-1715. 
14. Matsui, T.; Taketsugu, S.; Kodama, K.; Ishii, A.; Yamamori, K.; 
Shimizu, C. Nippon Suisan Gakkaishi, 1989, 55, 2199. 
15. Yasumoto, T.; Michishita, T. Agric. Biol. Chern., 1985, 49, 
893. 
16. Yotsu, M.; Endo, A.; Yasumoto, T. Agric. Biol. Chern., 1989, 
53, 893. 
17. Davis, C.C. Bot. Gaz., 1947, 109, 358-360. 
18. Bates, M.; Baker, M.; Wilson, N.; Lane, L.; Handford, S. 
Epidemiologic Overview of the New Zealand Shellfish Toxicity 
Outbreak. Marine Toxins and New Zealand Shellfish., 1993, 35-
40. The Royal Society of New Zealand, Wellington, New 
Zealand. 
19. Lin, Y.-Y; Risk, M.; Ray, S.M.; Van Engen, D.; Clardy, J.; 
Galik, J.; James, J.C.; Nakanishi, K. J. Am. Chern. Soc., 1981, 
103, 6773-6775. 
20. Schreibmayer, W.; Jeglitsch, G. Biochimica et Biophysica Acta, 
1992, 1104, 233-242. 
21. Borison H.L.; Ellis, S.; McCarthy, L.E. British Journal of 
Pharmacology, 1980, 70, 249-256. 
22. Lee, J.S.; Igarashi, T.; Fraga, S.; Dahl, E.; Hovgaard, P.; 
Yasumoto, T. J. Appl. Phycol., 1989, 1, 147. 
23. Yasumoto, T.; Murata, M.; Oshima, Y.; Sano, M.; Matsumoto, 
G.K.; Clardy, J. Tetrahedron, 1985, 41, 1019-1025. 
24. Murata, M.; Kumagai, M.; Lee, J.S.; Yasumoto, T. Tetrahedron 
Lett., 1987, 28, 5869-5872. 
256 
References 
25. Mackenzie, L. Proceedings of the Marine Biotoxin Science 
Workshop No 7., 1997. Ministry of Agriculture, Wellington, 
New Zealand (In print). 
26. Yasumoto, T.; Oshima, Y.; Yamaguchi, M. Nippon Suisan 
Gakkaishi, 1978, 44, 1249. 
27. Terao, K.; Ito, E.; Oarada, M.; Murata, M.; Yasumoto, T. 
Toxicon, 1990, 28, 1095-1104. 
28. Tachibana, K.; Scheuer, P.J.; Tsukitani, Y.; Kikuchi, H.; Van 
Engen, D.; Clardy, J.; Gopichand, Y.; Schmitz, F.J. J. Am. 
Chern. Soc., 1981, 103, 2469-2471. 
29. Murakami, Y.; Oshima, Y.; Yasumoto, T. Nippon Suisan 
Gakkaishi, 1982, 48, 69-72. 
30. Yasumoto, T.; Oshima, Y.; Sugawara, W.; Fukuyo, Y.; Oguri, 
H.; Igarashi, T.; Fujita, N. Nippon Suisan Gakkaishi, 1980, 46, 
1405-1411. 
31. Satake, M.; Terasawa, K.; Kadowaki, Y.; Yasumoto, T. 
Tetrahedron Lett., 1996, 37, 5955-5958. 
32. Takahashi, H.; Kusumi, T.; Kan, Y.; Satake, M.; Yasumoto, T. 
Tetrahedron Lett., 1996, 37, 7087-7090. 
33. Yasumoto, T. Proceedings of the Marine Biotoxin Science 
Workshop No 7., 1997. Ministry of Agriculture, Wellington, 
New Zealand (In print). 
34. YTX Confirmed In Mussels Harvested from Coromandel 
Peninsula as Part of This Research Project. 
35. YTX Confirmed In Shellfish Harvested from Wedge Point By 
Fluorescence HPLC. Yasumoto, T. Tohoku University, Japan. 
Pers. Comm. 
257 
References 
36. Quilliam, M.A.; Wright, J.L.C. Analytical Chemistry, 1989,61, 
1053-1060. 
37. Takemoto, T.; Daigo, K. Chern. Pharm. Bull., 1958, 6, 578-
580. 
38. Subba Rao, D.V.; Quilliam, M.A.; Pocklington, R. Can. J. 
Fisheries Aq. Sci., 1988, 45, 2076-2079. 
39. Bates, S.S.; Bird, C.J.; deFreitas, A.S.W.; Foxall, R.A.; Gilgan, 
M.; Hanic, L.A.; Johnson, G.B.; McCulloch, A.W.; Odense, P.; 
Pocklington, R.; Quilliam, M.A.; Sim, P.G.; Smith, J.C.; Subba 
Rao, D.V.; Todd, E.C.D.; Walter, J.A.; Wright, J.L.C. Can. J. 
Fisheries Aq. Sci., 1989, 46, 1203-1215. 
40. Yasumoto, T.; Bagnis, R.; Vernoux, J.P. Bull. Jpn. Soc. Sci. 
Fish., 1976, 42, 359-365. 
41. Yasumoto, T.; Nakajima, 1.; Ohshima, Y.; Bagnis, R. Toxic 
Dinoflagellate Blooms, Taylor, D.L., Seligner, H., Eds., 1979, 
65. Elsevier, North Holland. 
42. Bagnis, R. Hawaii Med. J., 1965, 28, 25. 
43. (a) Scheuer, P.J.; Takahashi, W.; Tsutsumi, J.; Yoshida, T. 
Science, 1976, 155, 1267. (b) Tachibana, K. Ph.D. Thesis, 
University of Hawaii, 1980. (c) Nukina, M.; Koyanagi, L.M.; 
Scheuer, P.J. Toxicon, 1984, 22, 169-176. 
44. (a) Murata, M.; Legrand, A.M.; Ishibashi, Y.; Yasumoto, T. J. 
Am. Chern. Soc., 1989, Ill, 8927-8931. (b) Murata, M.; 
Legrand, A.M.; Ishibashi, Y.; Fukui, M.; Yasumoto, T. J. Am. 
Chern. Soc., 1990, 112, 4380-4386. 
45. (a) Lewis, R.J.; Sellin, M.; Poli, M.A.; Norton, R.S.; MacLeod, 
J.K.; Sheil, M.M. Toxicon, 1991, 29, 1115-1127. (b) Satake, 
M.; Murata, M.; Yasumoto, T. Symposium Papers, 34th 
258 
References 
Symposium On the Chemistry of Natural Products, Tokyo, 
1992, 87. Organizing Committee of the Symposium, Tokyo. 
46. Satake, M.; Murata, M.; Yasumoto, T. Tetrahedron Lett., 1993, 
34, 1975-1978. 
47. Li, K.M. Science, 1965, 147, 1580. 
48. Rayner, M.D.; Kosaki, T.I.; Fellmeth, E.L. Science, 1968, 160, 
70. 
49. Yokoyama, A.; Murata, M.; Oshima, Y.; !washita, T.; Yasumoto, 
T. J. Biochem., 1988, 104, 184-187. 
50. Zheng, W.; DeMattei, J.A.; Wu, J.P.; Duan, J.J.W.; Cook, L.R.; 
Oinuma, H.; Kishi, Y. J. Am. Chern. Soc., 1996, 118, 7946-
7968. 
51. Nonomura, T.; Sasaki, M.; Matsumori, N.; Murata, M.; 
Tachibana, K.; Yasumoto, T. Angew. Chern. Int. Ed. Engl., 
1996, 35, 1675-1678. 
52. Kosuge T.; Tsuji, K.; Hirai K. Chern. Pharm. Bull., 1982, 30, 
3255-3259. 
53. Kosuge T.; Tsuji, K.; Hirai K.; Fukuyama, T.; Nukaya, H.; 
Ishida, H. Chern. Pharm. Bull., 1985, 33, 2890-2895. 
54. Kosuge T.; Tsuji, K.; Hirai K.; Fukuyama, T. Chern. Pharm. 
Bull., 1985, 33, 3059. 
55. Kobayashi, J.; Ishibashi, M.; Walchli, M.R.; Nakamura, H.; 
Hirata, Y.; Sasaki, T.; Ohizumi, Y. J. Am. Chern. Soc., 1988, 
110, 490-494. 
56. Ishibashi, M.; Kobayashi, J. Heterocycles, 1997, 44, 543-572. 
57. Nakajima, I.; Oshima, Y.; Yasumoto, T. Nippon Suisan 
Gakkaishi, 1981, 47, 1029-1033. 
259 
References 
58. Paul, G.K.; Matsumori, N.; Murata, M.; Tachibana, K. 
Tetrahedron Lett., 1995, 36, 6279-6282. 
59. Murakami, M.; Makabe, K.; Yamaguchi, K.; Konosu, S.; 
Walchli, M.R. Tetrahedron Lett., 1988,29, 1149-1152. 
60. Torigoe, K.; Murata, M.; Yasumoto, T.; !washita, T. J. Am. 
Chem. Soc., 1988, 110, 7876-7877. 
61. Hu, T.; deFreitas A.S.W.; Curtis, J.M.; Oshima, Y.; Walter, J.A.; 
Wright, J.L.C. J. Nat. Prod., 1996, 59, 1010-1014. 
62. Hu, T.; Curtis, J.M.; Walter, J.A.; Wright, J.L.C. Tetrahedron 
Lett., 1996, 37, 7671-7674. 
63. Uemura, D.; Chou, T.; Haino, T.; Nagatsu, A.; Fukuzawa, S.; 
Zheng, S.; Chen, H. J. Am. Chem. Soc., 1995,117, 1155-1156. 
64. Chou, T.; Kamo, 0.; Uemura, D. Tetrahedron Lett., 1996, 37, 
4023-4026. 
65. Chou, T.; Haino, T.; Kuramoto, M.; Uemura, D. Tetrahedron 
Lett., 1996, 37, 4027-4030. 
66. Hu, T.; Curtis, J.M.; Oshima, Y.; Quilliam, M.A.; Walter, J.A.; 
Watson-Wright, W.M.; Wright, J.L.C. J. Chem. Soc. Chem. 
Commun., 1995, 2159-2161. 
67. Seki, T.; Satake, M.; Mackenzie, L.; Kaspar, H.F.; Yasumoto, T. 
Tetrahedron Lett., 1995, 36, 7093-7096. 
68. Hannah, D.J.; Till, D.G.; Benseman, B.; Jones, P.D.; Pickston, 
L.; Walker, N. Toxins and Assay Techniques. Marine Toxins 
and New Zealand Shellfish, 1993, 28-30. The Royal Society of 
New Zealand, Wellington, New Zealand. 
69. Gardner, T. A Little P, D and NSP. Proceedings of the Marine 
Biotoxin Science Workshop No 6., 1996. Ministry of 
Agriculture, Wellington, New Zealand. 
260 
References 
70. Yasumoto, T.; Murata, M.; Oshima, Y.; Matsumoto, G.K.; 
Clardy, J. Seafood Toxins. Ragelis, E.P., Ed., 1984, 207-214. 
American Chemical Society, Washington, DC, U.S.A. 
71. Official Methods of Analysis of the Association of Official 
Analytical Chemists. Helrich, K. Ed., 1990, 959-968. AOAC, 
Washington, DC, U.S.A. 
72. Comesana-Losada, M.; Gago-Martfnez, A.; Leao-Martins, J.M.; 
Rodriguez-Vazquez, J.A. Analyst, 1996, 121, 1665-1670. 
73. Steidinger, K.A.; Joyce, E.A. Florida Red Tides., Educational 
Series 17, 1973. State of Florida Department of Natural 
Resources, U.S.A. 
74. Garthwaite, I.; Ross, K.M.; Poli, M.; Towers, N.R. Comparison 
of Immunoassay, Cellular, and Classical Mouse Bioassay Methods 
for Detection of Neurotoxic Shellfish Toxins. Immunoassays for 
Residue Analysis. Beier, R.C. and Stanker, L.H. Eds., 1996, 
Chapter 32, 404-412. American Chemical Society Symposium 
Series 621, U.S.A. 
75. Hannah, D.J.; Till, D.G.; Deverall, T.; Jones, P.D.; Fry, J.M. J. 
Assoc. Off. Anal. Chem., 1995, 78, 480-483. 
76. Ishida, H.; Nozawa, A.; Totoribe, K.; Muramatsu, N.; Nukaya, 
H.; Tsuji, K.; Yamaguchi, K.; Yasumoto, T.; Kaspar, H.; Berkett, 
N.; Kosuge, T. Tetrahedron Lett., 1995, 36, 725-728. 
77. Yasumoto, T. Marine Toxins Occurring in the Oceanian Waters. 
Symposium On Oceanian-Japanese Organic Chemistry Synthesis 
and Natural Products: Sacs 12 - Tokushima, 1996. Tokushima 
Bunri University, Japan. 
78. Morohashi, A.; Satake, M.; Murata, K.; Naoki, H.; Kaspar, H.F.; 
Yasumoto, T. Tetrahedron Lett., 1995, 36, 8995-8998. 
261 
References 
79. Yasumoto, T. Tohoku University, Japan. Pers. Comm. 
80. Aune, T. Toxicity of Marine and Freshwater Algal Biotoxins 
Towards Freshly Prepared Hepatocytes. Mycotoxins and 
Phycotoxins '88. Natori S. Et. Al. Eds., 1989, Pp 461-468. 
Elsevier, Netherlands. 
81. Karplus, M. J. Am. Chem. Soc., 1963, 85, 2870-2871. 
82. Encyclopedia of Reagents for Organic Synthesis. Paquette L.A., 
Ed-In-Chief, 1995, 3837-3845 John Wiley & Sons Ltd, England. 
83. Miles C. AgResearch, Ruakura, Hamilton, New Zealand. Pers. 
Comm . 
. 84. Mackenzie, L. Seafood New Zealand, 1994, 2, 47-50. 
85. Krebs, K.G.; Heusser, D.; Wimmer, H. Thin Layer 
Chromatography, A Laboratory Handbook, 2nd Edition. Stahl, 
E. Ed., 1969, 873-874. Spray Reagent No. 97. Springer-
Verlag, New York, U.S.A. 
86. Borrell, T. Marine Biotoxin Science Workshop No 6, 1996, 
Wellington, New Zealand. 
87. Falk, M.; Spierenburg, P.F.; Walter, J.A. J. Camp. Chem., 
1996, 17, 409-417. 
88. Ohtani, I.; Kusumi, T.; Kashman, Y.; Kakisawa, H. J. Org. 
Chem., 1991, 56, 1296-1298. 
89. Kusumi, T; Fujita, Y.; Ohtani, I.; Kakisawa, H. Tetrahedron 
Lett., 1991, 32, 2923-2926. 
90. Blunt J.W. University of Canterbury, New Zealand. Pers. 
Comm. 
91. Chem3D™ Version 3.2, 1986-1995. Cambridgesoft 
Corporation, Massachusetts, U.S.A. 
92. PC Spartan, 1996. Wavefunction Inc., California, U.S.A. 
262 
References 
93. Dewar, M.J.S.; Zoebisch, E.G.; Healy, E.F.; Stewart, J.J.P. J. 
Am. Chem. Soc., 1985, 107, 3902-3909. 
94. Basha, A.; Lipton, M.; Weinreb, S.M. Tetrahedron Lett., 1977, 
48, 4171-4174. 
95. Encyclopedia of Reagents for Organic Synthesis. Paquette L.A., 
Ed-In-Chief, 1995, 2854-2860. John Wiley & Sons Ltd, 
England. 
96. Irwin, N. Recommended Procedures for the Examination of 
Seawater and Shellfish; 1970, 4th Edition, 61-65 and Table 4.4. 
American Public Health Association, Inc., U.S.A. 
97. Evans, M.B.; Dale, A.D.; Little, C.J. Chromatographia, 1980, 
13, 5-10. 
98. Laboratory Procedures for the Examination of Seawater and 
Shellfish. Greenberg & Hunt Eds, 5th Edition, 1985, American 
Public Health Association, Inc., U.S.A. 
99. Truman, P.; Lake, R.J. J. Assoc. Off. Anal. Chem. International, 
1996, 79, 1130-1133. 
263 
A pendix One 
Assays 
Appendix One - Assays 
The Mouse Bioassay 
Sample extracts were prepared for injection by suspending them in a 
sterile solution, which contained 1% Tween 60 and 0.85% NaCl in 
water. Diluent was added to the extract residue to achieve known final 
concentrations. A one or two mouse system was generally used. 
Samples were injected into the intraperitoneal cavity (i.p.) of the mice, 
in known volumes. Mice were observed for symptoms prior to death. 
For brevetoxin containing samples the symptoms observed were 
panting and hind leg paralysis leading to a protracted death. For 
gymnodimine containing samples the symptoms observed were a fast 
onset of gasping with fits prior to rapid death. Where rapid mouse 
deaths occurred (within 2 hours), in most cases subsequent dilutions 
were carried out on a 1 mouse system. Mouse units/mg sample 
(MU/mg) were calculated from Table A1.98 
Table Al is designed for calculation of MU for brevetoxin containing 
samples. Consequently, gymnodimine containing samples were 
calculated as the amount of extract required to kill a 20 g mouse (19-21 
g). 
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Table Al Relationship of Dose to Death Time and Weight of 
Mice Injected with Ptychodiscus brevis Toxin( s) 
Extracted .f!om Shel{fish 
Mouse Weight Correction 
Death Time Mouse 
min units Mouse Correction 
(20 g mice) MU/mL Weight, g_ Factor 
6-7 11.0 15 0.69 
8-9 10.0 15.5 0.72 
10-11 9.0 16 0.75 
12-13 8.0 16.5 0.78 
14-15 7.0 17 0.81 
16-17 6.0 17.5 0.84 
18-19 5.0 18 0.87 
20-25 4.5 18.5 0.90 
30-34 4.0 19 0.94 
38-41.5 3.8 19.5 0.97 
45-52.5 3.6 20 1.00 
60-71.5 3.4 20.5 1.03 
83-94 3.2 21 1.06 
105-122.5 3.0 21.5 1.09 
140-160 2.8 22 1.12 
180-207 2.6 22.5 1.15 
234-267 2.4 23 1.18 
300-330 2.2 23.5 1.21 
360-397.5 2.0 24 1.24 
435-487.5 1.8 24.5 1.27 
540-592.5 1.6 25 1.30 
645-712.5 1.4 25.5 1.33 
780-855 1.2 26 1.36 
930 1.0 
Appendix One - Assays 
The P388 Antitumour Assay 
The in vitro "antitumour" assay used the P388 cell line (murine 
leukaemia cells) and is extremely sensitive to cytotoxicity effects. Thus 
the P388 assay is a cytotoxicity-based assay against a specific leukaemia 
cell type. The ICso result obtained from this assay represented the 
concentration of the test compound at which the number of viable cells 
is reduced by fifty per cent relative to the control. 
For the P388 assay, a two fold dilution series of the sample was 
incubated for 72 hours with P388 (Murine Leukaemia) cells. The 
concentration of sample required to reduce the P388 cell growth by 
50% (comparative to control cells) was determined using the 
absorbance values obtained when the yellow dye [3-( 4,5-
dimethylthiazol-2-yl]-2,5-diphenyl-2H-tetrazolium bromide (MTT) 
(65) was reduced by healthy cells to the purple colour MTT formazan 
(66). 
(65) 
NH 
I 
o-~ sy C-N=N-<'N~ 
(66) 
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The absorbance was expressed as a percentage cell viability relative to 
the control. This absorbance was plotted against the logarithm of the 
sample concentration in the well to generate a sample concentration vs 
cell viability curve (Figure Al). The antilogarithm of the concentration 
producing a fifty per cent reduction in the number of viable cells gave 
the ICso value. This value was expressed in units of either ng/mL or 
~g/mL.. Those samples not intersecting the fifty percent line were 
either too dilute (always above, compound "g") or too concentrated 
(always below, compounds "c" and "e") to return an ICso value (Figure 
Al). 
60 
40 ~---~------~····~,--·~--~··==~====A----····-
20 
0 ~···~-=~·~==·~~·~~~~---··~--~-----=~~·-~----~ 
(J) 
co 
(J) 
Fig Al 
(J) 
C\1 
C\1 
.,..... 
(J) 
[.() 
C\1 
C\1 
(J) 
co 
C\1 
(f) 
(J) 
,..... 
A Typical Graph Generated From the P388 Assay 
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The Neuroblastoma Assay 
The neuroblastoma cell culture assay was run at the Communicable 
Disease Centre, in Porirua, New Zealand. The neuroblastoma assay 
was run using mouse neuroblastoma cells (Neuro 2A). This assay is 
designed to detect compounds that exert their toxicity by affecting 
voltage-gated sodium channels. For this research the assay was 
designed for brevetoxin detection, as described in Fig A2. 
Samples were prepared by suspension in methanol (100 JlL). An 
aliquot (10 JlL) of each sample was added to assay medium (0.99 mL). 
Further dilutions were made from this 1/100 stock. The sample 
medium used was RPMI 1640 complete medium (Gibco, Grand Island, 
NY) supplemented with 10% fetal bovin serum, 20 mM Hepes, 25 mM 
bicarbonate, 1.7 mM glutamine, 1 mM sodium pyruvate and 55 Jlg 
gentomicin sulfate/mL. 99 
Cell viability was determined using MTT dye in a similar fashion to the 
P388 assay. 
The results were expressed in 11BTX 11 equivalents as determined by the 
standard curve for brevetoxin-B (BTX-B). 
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l===JJ 
+ 
kc:--dc:;c:--dc:;c-:.dc-:.c-:.d 
t + 
hc-vJ l~~r.::I 
no o/v + o/v 
control 
t t t t 
no no 
sample sample sample sample 
control control 
bcwd b~d bcud hcud 
t 
hcud 
b 
1 Mouse neuroblastoma 
cells (Neuro 2A) seeded 
into 96 well plate 
2a Ouabain and veratridine 
added to wells to sensitise 
cells 
2b Standards and samples to 
be assayed added to wells 
2c Cells incubated (18 hr) 
to give toxins time to act 
3 Cell Viability Assay 
3a Medium and reagents 
removed. Cells 
incubated with MTT 
3b MTT removed, cells 
solubilised and 
absorbance assessed 
Fig A2 The Neuroblastoma Assay Protocol 
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The 
Assay 
nzyme-Linked lmmunosorbent 
The competitive ELISA is based on the use of antibodies, specific to a 
known compound. These antibodies (or antisera) are able to bind to 
the compound of interest allowing a quantitative measurement of 
concentration to be made. 
At the time of writing either the direct or indirect competitive ELISA 
was being developed, depending on what was more appropriate for the 
toxin. A brief overview of each is illustrated in Fig A3. The direct 
competitive ELISA is described in detail as for the brevetoxin 
ELISA.74 
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The direct cELISA 
1 2 
Anti· I y ·;:dyl ~dim Blocking ~\olutlon w 
Incubate, wash 1x Incubate, wash 4x 
4 • 5 
Incubate 
at655nm 
3 Sample +enzyme-
• toxin 
2\onJugate 
Incubate, wash 4x 
Stop 
solution 
at460nm 
The indirect cELISA 
1 Protein-toxin + conjugate 
LJ 
Incubate, wash 1 x 
Incubate, wash 4x 
2 lfi. Blocking 
~solution 
L:.J 
Incubate, wash 4x 
Incubate 
3 Antibody+ )..+a sample/ 
"\standard 
J.. A 
Read absorbance 
at450nm 
Fig A3 The Direct and Indirect ELISA Procedures 
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Appendix Two - X-Ray Data For Crystal Structure 
Table A2.1 
B r 
0(1) 
0(4) 
0(10) 
C( 1) 
C(2) 
C(3) 
C(4) 
C(5) 
C(6) 
C(7) 
C(8) 
C(9) 
C( 1 0) 
C(ll) 
C(l2) 
C(l3) 
C(l4) 
C(l5) 
C(l6) 
C(l7) 
C(l8) 
C( 19) 
C(20) 
Atomic coordinates ( x 104) and equivalent isotropic 
displacement parameters (A2 x J03) for (56). 
U( eq) is defined as one third of the trace of the 
orthogonalized Uij tensor 
X y z U(eq) 
966(1) 3156(1) 8151(1) 73(1) 
8171(4) 7129(2) 10514(2) 58(2) 
9205(4) 7156(2) 9675(2) 42(1) 
13318(3) 6820(2) 6646(2) 53(1) 
9035(7) 6859(4) 10210(3) 44(2) 
9952(6) 6250(4) 10331(3) 44(2) 
10737(6) 6179(3) 9879(3) 46(2) 
10309(6) 6733(3) 9427(3) 42(2) 
9872(6) 6303(3) 8879(3) 34(2) 
10633(6) 6201(3) 8422(3) 32(2) 
10247(6) 5692(3) 7902(3) 33(2) 
10694(5) 6124(3) 7365(2) 24(2) 
11714(6) 5962(3) 7045(3) 30(2) 
12061(5) 6495(3) 6558(3) 39(2) 
12111(5) 6076(3) 5972(3) 43(2) 
10766(6) 5814(3) 5755(2) 46(2) 
10869(6) 5375(3) 5184(3) 51(2) 
9515(6) 5092(3) 4980(3) 50(2) 
9705(6) 4224(3) 4852(2) 44(2) 
10804(6) 4004(3) 5248(3) 40(2) 
10442(6) 3797(3) 5871(3) 35(2) 
9251(6) 3869(3) 6061(3) 37(2) 
8840(6) 3818(3) 6676(2) 46(2) 
9071(6) 4626(3) 6955(2) 35(2) 
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C(21) 8562(5) 4657(3) 7571(2) 29(2) 
N 7188(5) 4470(3) 7594(2) 29(2) 
C(32) 6317(5) 5061(3) 7348(2) 35(2) 
C(31) 6483(5) 5845(3) 7645(2) 37(2) 
C(30) 7909(5) 6084(3) 7662(2) 32(2) 
C(22) 8787(5) 5447(3) 7907(3) 26(2) 
C(23) 8423(5) 5246(3) 8529(2) 35(2) 
C(24) 8550(5) 5943(3) 8935(2) 42(2) 
C(25) 9933(6) 5803(3) 10870(2) 71(2) 
C(26) 11996(4) 6530(3) 8393(2) 54(2) 
C(27) 12659(5) 5315(3) 7158(2) 45(2) 
C(28) 10139(5) 4098(3) 4235(2) 69(2) 
C(29) 11579(5) 3544(3) 6221(2) 57(2) 
0(13) 11655(4) 4682(2) 5248(2) 44(1) 
0(1 ') 7550(4) 3279(2) 7986(2) 63(2) 
C(l ') 6811(6) 3794(4) 7813(3) 36(2) 
C(2') 5355(6) 3654(4) 7889(3) 29(2) 
c (3') 4676(7) 3207(4) 7500(3) 52(2) 
c ( 4 ') 3355(7) 3078(4) 7587(3) 47(2) 
C(5 ') 2756(6) 3351(4) 8047(3) 43(2) 
C(6') 3387(7) 3786(4) 8441(3) 64(3) 
C(7 ') 4701(7) 3935(4) 8355(3) 62(3) 
C(l ") 7696(3) 7070(1) 5282(1) 131(6) 
C(2") 6796(3) 6870(1) 5682(1) 112(4) 
C(3 ") 5796(3) 6470(1) 5482(1) 127(5) 
C(4") 5596(3) 6270(1) 4882(1) 177(8) 
C(5 ") 6596(3) 6630(1) 4582(1) 146(6) 
C(6") 7596(3) 6970(1) 4782(1) 169(7) 
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Table A2.2 Bond 
Bond lengths Bond lengths 
[AJ [AJ 
Br-C(5') 1.911(6) C( 16)-C( 17) 1.562(7) 
O(l)-C(1) 1.242(7) C( 17)-C( 18) 1.325(7) 
0(4)-C(1) 1.377(6) C(17)-C(29) 1.509(7) 
0(4)-C(4) 1.483(6) C(18)-C(l9) 1.519(7) 
0(10)-C(lO) 1.441(6) C(l9)-C(20) 1.560(5) 
C(1)-C(2) 1.449(9) C(20)-C(21) 1.550(7) 
C(2)-C(3) 1.352(7) C(21)-N 1.469(6) 
C(2)-C(25) 1.490(7) C(21)-C(22) 1.595(6) 
C(3)-C(4) 1.501(7) N-C(l') 1.333(6) 
C(4)-C(5) 1.559(7) N-C(32) 1.485(5) 
C(5)-C(6) 1.352(7) C(32)-C(31) 1.534(6) 
C(5)-C(24) 1.517(7) C(31 )-C(30) 1.543(6) 
C(6)-C(26) 1.532(7) C(30)-C(22) 1.542(6) 
C(6)-C(7) 1.564(7) C(22)-C(23) 1.556(7) 
C(7)-C(8) 1.544(6) C(23)-C(24) 1.545(6) 
C(7)-C(22) 1.579(7) 0( 1')-C( 1') 1.245(6) 
C(8)-C(9) 1.335(7) C( 1')-C(2') 1.548(8) 
C(9)-C(27) 1.512(6) C(2')-C(7') 1.383(8) 
C(9)-C(10) 1.515(7) C(2')-C(3') 1.394(8) 
C(lO)-C(ll) 1.563(7) C(3')-C(4') 1.409(7) 
C(11)-C(l2) 1.561(7) C(4')-C(5') 1.341(8) 
C(l2)-C(13) 1.549(6) C(5')-C(6') 1.364(8) 
C(l3)-0(13) 1.457(6) C(6')-C(7') 1.408(7) 
C(13)-C(l4) 1.570(8) C(l")-C(6") 1.1991 
C(14 )-C(l5) 1.539(6) C(1")-C(2") 1.3760 
C( 15)-C( 16) 1.527(7) C(2")-C(3") 1.3362 
C(15)-C(28) 1.544(6) C(3")-C(4") 1.4746 
C(l6)-0(13) 1.467(6) C(4")-C(5") 1.4052 
C(5")-C(6") 1.2860 
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Table A2.3 Bond 
Bond angles Bond angles 
[0] [0] 
C(1)-0(4)-C(4) 106.3(5) C(29)-C(17)-C(16) 113.1(5) 
0(1)-C(1)-0(4) 119.1(7) C(l7)-C(18)-C(19) 125.6(6) 
0( 1 )-C( 1 )-C(2) 129.5(8) C(18)-C(19)-C(20) 108.1(4) 
0( 4 )-C( 1 )-C(2) 111.4(6) C(21 )-C(20)-C( 19) 112.1(4) 
C(3)-C(2)-C(1) 108.0(7) N-C(21 )-C(20) 111.2(5) 
C(3 )-C(2)-C(25) 129.6(7) N-C(21)-C(22) 108.2(5) 
C( 1 )-C(2)-C(25) 122.4(7) C(20)-C(21 )-C(22) 116.6(5) 
C(2)-C(3)-C( 4) 109.0(6) C(1')-N-C(21) 119.6(5) 
0( 4 )-C( 4 )-C(3) 105.2(5) C(1')-N-C(32) 124.8(5) 
0( 4 )-C( 4 )-C( 5) 109.6(5) C(21)-N-C(32) 115.5(5) 
C(3)-C(4)-C(5) 112.1(5) N-C(32)-C(31) 110.8(4) 
C(6)-C(5)-C(24) 123.3(6) C(32)-C(31)-C(30) 110.8(4) 
C(6)-C{5)-C(4) 123.7(6) C(22)-C(30)-C(31) 113.0(5) 
C(24)-C(5)-C(4) 112.8(6) C(30)-C(22)-C(23) 111.7(5) 
C{ 5)-C( 6)-C(26) 122.1(6) C(30)-C(22)-C(7) 112.3(5) 
C( 5)-C( 6)-C(7) 123.4(6) C(23 )-C(22)-C(7) 107.6(5) 
C(26)-C( 6)-C(7) 114.3(5) C(30)-C(22)-C(21) 109.5(5) 
C(8)-C(7)-C(6) 107 .3(5) C(23)-C(22)-C(21) 104.1(5) 
C(8)-C(7)-C(22) 115.2(5) C(7)-C(22)-C(21) 111.4(5) 
C( 6)-C(7)-C(22) 113.1 (5) C(24 )-C(23 )-C(22) 113.1(5) 
C(9)-C(8)-C(7) 127.3(6) C( 5)-C(24 )-C(23) 110.0(5) 
C(8)-C(9)-C(27) 124.9(6) C(l3)-0( 13 )-C( 16) 108.2(4) 
C(8)-C(9)-C(10) 119.7(6) 0(1')-C(1')-N 124.6(6) 
C(27)-C(9)-C( 1 0) 115.2(5) 0( 1')-C( l')-C(2') 117.2(6) 
0(10)-C(10)-C(9) 110.1(5) N-C(l')-C(2') 118.1(6) 
Appendix Two- X-Ray Data For Crystal Structure 278 
0(10)-C(10)-C(11) 106.1(5) C(7')-C(2')-C(3') 118.0(6) 
C(9)-C(10)-C(11) 113.7(5) C(7')-C(2')-C(1') 121.5(7) 
C(12)-C(11)-C(10) 113.3(5) C(3')-C(2')-C( 1') 120.5(7) 
C(l3)-C(12)-C(l1) 111.5(6) C(2')-C(3 ')-C( 4') 119.2(7) 
0(13)-C(13)-C(12) 110.4(5) C(5')-C( 4')-C(3 ') 121.2(7) 
0(13)-C(13)-C(14) 106.4(4) C( 4')-C(5')-C( 6') 121.5(7) 
C( 12)-C(13)-C(l4) 110.9(6) C(4')-C(5')-Br 119.8(6) 
C(15)-C(14)-C(13) 104.3(5) C(6')-C(5')-Br 118.7(6) 
C(l6)-C(15)-C(14) 102.5(5) C( 5')-C( 6')-C(7') 118.1(8) 
C( 16)-C( 15)-C(28) 108.9(5) C(2')-C(7')-C( 6') 122.0(8) 
C( 14 )-C(15)-C(28) 111.1(5) C(6")-C(1")-C(2") 125.6 
0( 13)-C( 16)-C( 15) 104.9(5) C(3")-C(2")-C(1 ") 114.7 
0(13)-C(16)-C(l7) 109.2(5) C(2 ")-C(3")-C( 4") 124.8 
C( 15)-C( 16)-C( 17) 117.0(6) C(5")-C(4")-C(3") 106.1 
C( 18)-C( 17)-C(29) 125.3(7) C(6")-C(5")-C(4") 128.1 
C(18)-C(l7)-C(l6) 121.6(7) C(l")-C(6")-C(5") 119.9 
Symmetry transformations used to generate equivalent atoms 
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Table A2.4 Anisotropic displacement parameters (A2 x J03) for 
(56). The anisotropic displacement factor exponent 
takes the form: -2 rc2 [ h2 a*2 U11 + ... + 2hka*b*Un] 
Br 31(1) 59(1) 129(1) 15(1) -5(1) -6(1) 
0(1) 47(3) 61(4) 65(4) -8(3) 11(3) -1(3) 
0(4) 42(3) 37(3) 46(4) -6(3) 5(4) 3(3) 
0(10) 41(2) 41(3) 77(4) -23(3) 24(3) -17(3) 
C(l) 46(5) 44(5) 41(6) -12(5) 7(6) 15(6) 
C(2) 30(5) 62(6) 41(6) 7(5) -9(5) 6(5) 
. C(3) 41(5) 56(5) 42(5) 4(5) -18(5) 10(5) 
C(4) 33(4) 41(4) 52(5) -23(5) 5(4) -9(4) 
C(5) 21(4) 37(4) 42(6) 2(4) -6(4) -7(4) 
C(6) 25(5) 34(4) 37(5) 4(4) 6(4) -6(4) 
C(7) 29(4) 25(4) 45(5) 16(4) 4(4) 1(3) 
C(8) 23(4) 23(4) 25(5) 2(3) -6(4) 4(4) 
C(9) 36(4) 21(4) 35(5) 7(4) 0(4) 3(4) 
C(lO) 29(4) 27(4) 61(6) -4(4) 14(5) -2(4) 
C(ll) 43(5) 28(4) 57(6) 1(4) 20(5) 0(4) 
C(l2) 52(6) 37(4) 47(5) 5(4) 5(5) -1(5) 
C(l3) 49(5) 47(4) 59(6) -9(4) 15(6) 0(5) 
C(l5) 36(5) 61(5) 34(5) -1(4) 0(4) -3(4) 
C(l6) 34(5) 40(4) 47(6) -10( 4) -1(5) 0(5) 
C(17) 31(4) 34(4) 40(5) -20(4) -5(5) 1(4) 
C(18) 36(5) 44(4) 31(5) -14(4) -9(5) -12(5) 
C(19) 52(5) 34(4) 52(5) -13(4) 14(5) -2(4) 
C(20) 23(4) 38(4) 46(5) -17(4) 10(5) -9(4) 
C(21) 22(4) 26(4) 38(5) -3(4) -5(4) 1(3) 
N 23(3) 25(3) 39(4) 7(3) -7(3) 4(3) 
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C(32) 17(4) 40(4) 48(5) 0(4) -5(4) -6(4) 
C(31) 26(4) 28(4) 57(5) 7(4) -4(4) 11(4) 
C(30) 29(4) 39(4) 27(5) -8(4) 4(4) -3(4) 
C(22) 24(5) 24(4) 30(5) 7(3) 3(4) 5(3) 
C(23) 14(4) 37(4) 53(5) -2(4) -3(4) 0(4) 
C(24) 38(5) 52(5) 36(5) -5(4) 7(4) -1(4) 
C(25) 63(6) 98(6) 52(6) 17(5) 6(5) 11(5) 
C(26) 32(4) 62(5) 67(6) -32(4) -7(5) -13(4) 
C(27) 43(5) 38(4) 54(6) -10(4) 9(5) 13(4) 
C(28) 68(6) 90(6) 48(6) -3(4) -2(5) 8(5) 
C(29) 57(5) 66(5) 47(5) -14(4) -10(5) 12(4) 
0(13) 45(3) 33(2) 55(3) -6(3) 3(3) 4(3) 
0(1') 39(3) 42(3) 106(5) 32(4) 2(3) -1(3) 
C(l') 37(5) 26(5) 46(6) 0(4) 0(5) 2(4) 
C(2') 28(4) 24(4) 35(6) 7(4) -10(4) 7(4) 
C(3') 54(5) 48(5) 53(6) -6(5) -7(5) 4(5) 
C(4') 33(5) 45(5) 63(7) -10(5) -11(5) -17(5) 
C(5') 31(4) 30(5) 67(7) 22(5) 5(5) -10(4) 
C(6') 39(5) 86(7) 67(7) -13(5) -1(5) -19(5) 
C(7') 37(5) 84(6) 65(7) -33(5) -9(5) -23(5) 
C(1") 84(9) 71(7) 239(17) 37(9) -49(10) -11(7) 
C(2") 190(12) 80(8) 65(7) -38(7) 18(8) 13(8) 
C(3") 77(8) 71(7) 232(14) -21(7) 31(10) 34(6) 
C(4") 100(10) 96(8) 340(2) -75(11) -112(12) 6(7) 
C(5") 212(16) 116(10) 108(8) -32(8) -114(12) 62(10) 
C(6") 171(15) 139(11) 196(17) 86(10) 37(10) 100(10) 
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Table A2.5 Hydrogen coordinates (x J04) and isotropic 
displacement parameters (A 2 x 1 Q3) for (56) 
X y z U(eq) 
H(lO) 13250 7255 6803 79 
H(3) 11446 5835 9852 56 
H(4) 11016 7105 9336 50 
H(7) 10760 5203 7926 40 
H(8) 10186 6553 7250 28 
H(lOA) 11420 6926 6539 47 
H(l1A) 12498 6432 5691 51 
H(llB) 12674 5616 6003 51 
H(12A) 10362 5471 6040 55 
H(12B) 10210 6275 5706 55 
H(l3) 11256 5723 4892 62 
H(14A) 8863 5167 5280 60 
H(l4B) 9242 5376 4637 60 
H(15) 8912 3919 4939 52 
H(16) 11277 3555 5080 48 
H(l8) 8598 3961 5788 44 
H(19A) 9347 3415 6874 55 
H(19B) 7921 3677 6700 55 
H(20A) 10002 4740 6955 42 
H(20B) 8637 5031 6728 42 
H(21) 9020 4241 7786 35 
H(32A) 5417 4886 7387 42 
H(32B) 6505 5121 6939 42 
H(31A) 6147 5810 8036 44 
H(31B) 5983 6246 7442 44 
H(30A) 8196 6209 7273 38 
H(30B) 7998 6560 7894 38 
H(23A) 7527 5056 8538 41 
H(23B) 8984 4821 8663 41 
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H(24A) 7887 6335 8845 50 
H(24B) 8415 5768 9329 50 
H(25A) 9107 5536 10908 106 
H(25B) 10052 6158 11189 106 
H(25C) 10627 5419 10867 106 
H(26A) 12244 6729 8765 81 
H(26B) 12024 6953 8116 81 
H(26C) 12592 6120 8278 81 
H(27A) 12456 5069 7521 67 
H(27B) 13530 5529 7172 67 
H(27C) 12604 4929 6855 67 
H(28A) 10223 3541 4160 103 
H(28B) 10969 4352 4175 103 
· H(28C) 9502 4321 3977 103 
H(29A) 11919 3056 6070 85 
H(29B) 11309 3467 6614 85 
H(29C) 12246 3944 6205 85 
H(3') 5098 2990 7181 62 
H(4') 2881 2793 7314 57 
H(6') 2953 3982 8764 77 
H(7') 5152 4238 8626 74 
H(1") 8462 7308 5414 157 
H(2") 6879 7006 6070 134 
H(3") 5167 6302 5746 152 
H(4") 4926 5960 4730 213 
H(5") 6524 6621 4182 175 
H(6") 8254 7142 4534 203 
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The Absolute Stereochemistry of the New Zealand Shellfish 
Toxin Gymnodimine 
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Abstract: The absolute stereochemistry of the New Zealand shellfish toxin gymnodimine 1 has 
been determined by X-ray crystal structure analysis of the p-bromobenzamide derivative 3 of 
gymnodamine 2. 
Commercial oyster beds in Southland, New Zealand were closed in early 1994 
due to high levels in the oysters of a biotoxin showing neurotoxic shellfish poisoning 
(NSP) features in a mouse bioassay) The toxin, named gymnodimine 1, was 
isolated and the structure elucidated by NMR spectroscopy.2 Gymnodimine 1 is 
structurally related to the pinnatoxins3 and the spirolides,4 with the unusual 
spirocentre and imine functionalities. The phmmacological action of these compounds 
has not yet been fully defined, although the cyclic imine functionality has been 
suggested as the pharmacophore of the spirolides.4 This suggestion has been 
supported by our observation of the inactivity of the reduced form of 1, gymnodamine 
2, in the mouse bioassay. 5 A better understanding of the pharmacology of these 
compounds might be aided by a knowledge of their shape. The relative 
stereochemistries of only the distantly related pinnatoxins3 have been reported, while 
the absolute stereochemistry has not been elucidated for of any of these compounds. 
We now report the crystal structure and absolute configuration of the p-
bromobenzamide derivative 3 of gymnodamine 2, from which the stereochemistry of 
gymnodimine 1 follows. 
Gymnodimine 1 was reisolated from Foveaux Strait oysters,6 but all attempts at 
forming crystalline derivatives of 1 at the ClO hydroxyl were impeded by low 
reactivity at this position. Furthermore, degradation was observed, possibly due to 
instability of the imine functionality. After reduction of the imine functionality of 
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gymnodimine 1 the resultant secondary amine gymnodamine 2 was found to be more 
stable and tractable towards the formation of derivatives. This reduction was achieved 
stereospecifically with NaCNBH31MeOH in quantitative yield.? Gymnodamine 2 was 
then converted to the p-bromobenzamide 3 by standard methods. 8 
OH 
0 0 
1 
0 
2 R=H 
3 R = p-BrC6H4CO 
Recrystallisation of the amide 3 from C6H6/CHzClz gave irregular shaped, 
transparent crystals suitable for single crystal X-ray structure analysis. The data were 
collected using a Siemens P4 diffractometer. The structure of 3 was solved by direct 
methods (SHELXS-96) and refined by a full-matrix least-squares refinement 
(SHELXL-96) after being corrected for absorption by using the psi-scan method.9 
The absolute configuration was determined from the anomalous scattering of the 
bromine atom and stereocentres assigned as 4S, 7S, lOS, 13R, 15R, 16R, 21S, 22R, 
as shown in the perspective view (see figure). From this it follows that the absolute 
stereochemistry of gymnodimine 1 is 4S, 7S, lOS, 13R, 15R, 16R, 22R. 
The 1 H NMR spectrum of the amide 3 showed doubling of various 
resonances (3: 1 ratio), interpreted as arising from two amide conformations. 
Comparison of the solution conformation of amide 3 with that in the crystalline state 
showed good agreement, principally by the observation of NOE interactions (%) 
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H4/Me26 (2.1), H7/H21 (5.5), H7/Me27 (2.9), H8/H10 (10.1), H16/H15 (2.8), 
H16/Me28 (1.5), and Hl8/H15 (10.0), all of which are expected from the parameters 
derived from the crystal structure. Except for H7/H21, all of these interactions were 
also observed for imine 1, together with interactions for H8/H30, Hl3/Me28 (0.9) 
and Me29/H16 (4.1). However, additional interactions for H18/Hl6 (0.7) and 
H18/Me27 (0.8) in the NOB spectra of the imine 1 suggest the presence in solution of 
additional conformations for 1. This is supported by a large change in the chemical 
shift for Hl8 (5.00 for 1, 5.45 for 2 and 5.38 ppm for 3). 
010 
C27 
The reactivity of the amine group in 2 is now being utilised to form haptens for 
the development of an immunoassay for the more sensitive, quantitative and direct 
detection of gymnodimine 1 in shellfish. 
Acknowledgments. We thank Mr B M Clark (UC) for mass spectra and Dr P Truman 
(ESR) for mouse bioassays. 
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5. Minimum Lethal Doses (MLD) (intraperitoneal): gymnodamine 2, >4040 llg/kg; 
gymnodimine 1, 700 llg/kg. 
6. Oysters Tiostrea chilensis (5 kg), collected at Foveaux Strait, were extracted with 0.1% 
AcOH/80% MeOH/20% HzO. After removal of MeOH the extract was neutralised with NH3, 
adjusted to pH 8.5 with NaHC03 and partitioned against CH2Cl2. The organic layer was dried 
in vacuo and partitioned between ether and 0.5% aq. AcOH. The aqueous layer was neutralised 
with NH3, adjusted to pH 8.5 with NaHC03 and partitioned against EtOAc. The organic layer 
was successively chromatographed on DIOL with 3:1 CH2Ch:pet. ether and on AMINO with 
MeOH to afford gyrnnodimine 1 (8.4 mg). 
7. Gymnodimine 1 (8 rng) was reacted with NaCNBH3 (2 mg) in MeOH (1 mL) and AcOH (5 
IlL) for 4.5 hr. All solvents were removed in vacuo and reaction mixture filtered through a 
0.45 11m filter in CH2Cl2 (5 x 1 mL) to give gymnodamine 2 (8 mg, 99%) as a colourless 
oil. HREIMS: C32H47N04 (M+ mlz 509.3495 6 -2.01 ppm). All spectral data were 
consistent with 2. 
8. Gymnodamine 2 (8 mg) was reacted withp-bromobenzoyl chloride (4.4 mg) and DMAP (244 
llg) in dry CH2Cl2 (1 mL) and diisopropylethylamine (3.47 IlL) at 0 oc for 30 min. H20 (10 
drops) was added and all solvents removed in vacuo. The reaction mixture was partitioned 
between CH2Cl2 and aq. citric acid (10% w/v) and the organic phase purified on nmmal phase 
HPLC (DIOL) in CH2Ch to give the p-bromobenzamide 3 (4.0 mg, 37 %) which was 
recrystallised from C6H6/CH2Cl2 to give irregular shaped crystals; mp 251-254 °C; 
HRFABMS: C39H51BrNOs (MH+ mlz 692.2971 A 2.90 ppm); OH (CDCl3) (major 
conformation) 7.52, d, J = 8.8, 2H, H4' H6'; 7.19, d, J = 8.3, 2H, H3' H7'; 6.88, bs, lH, H3; 
5.72, bs, lH, H4; 5.38, t, J:::: 6.3, 7.8, lH, H18; 5.20, d, J = 10.7, lH, H8; 4.50, dd, J = 3.4, 
8.8, 2.9, lH, H21; 4.15, m, lH, H13; 3.94, obs, lH, H10; 3.92, bs, lH, H16; 3.46, dd, J = 
5.4, 10.3, 1.4, lH, H32a; 2.99, d, J = 11.2, lH, H7; 2.95, obs, H32b; 2.48, m, lH, H15; 
2.15, m, H19; 2.00, obs, Hila; 1.94, s, 3H, Me25; 1.77, s, 3H, Me27; 1.67, s, 3H, Me29; 
1.60, s, 3H, Me26; 1.08, d, J 7.3, 3H, Me28. 
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9. Crystal data: C39HsoBrNOs•C6H6, F. W. = 770.82, orthorhombic, space group P21212 t. a 
10.424(7), b 17.236(12), c = 23.642(16) A, a 90, f3 = 90, r= 90, v 4248(5) A3, z = 
4, D c = 1.205 Mg/m3, absorption coefficient 1.011 mm-1, minimum and maximum 
transmission coefficients 0.506, 0.552. Final conventional R factors : [l>2a(l)] R1 = 0.0360, 
wR2 0.0376. R1 for inverse stucture 0.0574. 
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Model GM-1 
Heat ofF onnation: -150.1 kcal/mol 
Appendix Four - Models Created By Spartan 291 
Model GM-2 
Heat ofF onnation: -14 2. 7 kcal/mol 
Appendix Four - Models Created By Spartan 292 
Model GM-3 
Heat ofF ormation: -13 9. 0 kcal/mol 
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Model GM-3a 
Heat of Formation: -143.7 kcal/mol 
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Model GM-4 
Strain energy = 45 .6579 kcaVmol 
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Model GM-5 
Heat of Fonnation: -254.1 kcal/mol 
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Model GM-6 
Heat of Formation: -287.1 kcal/mol 
